Satellogic (SATL) F-4 4 Dec 23 Registration of securities (foreign) Financial data

Document And Entity Information

Document And Entity Information	9 Months Ended
	Sep. 30, 2023
Document Information [Line Items]
Entity Central Index Key	0001874315
Entity Registrant Name	Satellogic Inc.
Amendment Flag	false
Document Type	F-4
Entity Incorporation, State or Country Code	D8
Entity Address, Address Line One	Ruta 8 Km 17,500, Edificio 300 Oficina 324 Zonamerica
Entity Address, City or Town	Montevideo
Entity Address, Postal Zip Code	91600
Entity Address, Country	UY
City Area Code	00-598
Local Phone Number	25182302
Entity Emerging Growth Company	true
Entity Ex Transition Period	false
Business Contact [Member]
Document Information [Line Items]
Entity Address, Address Line One	210 Delburg Street
Entity Address, City or Town	Davidson
Entity Address, Postal Zip Code	28036
City Area Code	704
Local Phone Number	894-4482
Contact Personnel Name	Rick Dunn
Entity Address, State or Province	NC

Consolidated Statements of Oper

Consolidated Statements of Operations and Comprehensive Loss - USD ($) $ in Thousands	3 Months Ended		9 Months Ended		12 Months Ended
	Sep. 30, 2023	Sep. 30, 2022	Sep. 30, 2023	Sep. 30, 2022	Dec. 31, 2022		Dec. 31, 2021		Dec. 31, 2020
Revenue	$ 1,196	$ 2,158	$ 4,380	$ 4,546	$ 6,012		$ 4,247		$ 0
Costs and expenses
Cost of sales, exclusive of depreciation shown separately below	1,046	969	3,159	2,298	3,284		1,876		0
General and administrative expenses	5,865	6,308	15,732	30,917	37,191		36,640	[1],[2]	8,003	[1],[2]
Research and development	2,169	3,941	7,996	9,657	13,055		9,636	[3]	5,924	[3]
Depreciation expense	5,420	4,031	14,030	10,516	14,326		10,728	[3]	3,031	[3]
Other operating expenses	4,852	6,992	17,930	20,728	29,023		14,002		5,449
Total costs and expenses	19,352	22,241	58,847	74,116	96,879		72,882		22,407
Operating loss	(18,156)	(20,083)	(54,467)	(69,570)	(90,867)		(68,635)		(22,407)
Other income (expense), net
Finance costs, net	389	381	1,471	(1,225)	(652)		(9,738)	[2],[4]	35	[2],[4]
Change in fair value of financial instruments	1,940	6,270	7,520	50,866	58,311		17,983	[4]	9,637	[4]
Loss on extinguishment of debt					0		(37,216)	[4]	(9,240)	[4]
Other income, net	2,277	1,592	4,199	2,111	1,140		1,069	[2]	594	[2]
Total other income (expense), net	4,606	8,243	13,190	51,752	58,799		(27,902)		1,026
Loss before income tax	(13,550)	(11,840)	(41,277)	(17,818)	(32,068)		(96,537)		(21,381)
Income tax (expense) benefit	(4,069)	(2,983)	(6,193)	(5,126)	(4,573)		232		(148)
Net loss available to common stockholders	(17,619)	(14,823)	(47,470)	(22,944)	(36,641)		(96,305)		(21,529)
Other comprehensive loss
Foreign currency translation loss, net of tax	(294)	(373)	(218)	(695)	(226)		(86)		0
Comprehensive loss	$ (17,913)	$ (15,196)	$ (47,688)	$ (23,639)	$ (36,867)		$ (96,391)		$ (21,529)
Basic loss per share for the period attributable to common stockholders (in dollars per share)	$ (0.2)	$ (0.17)	$ (0.53)	$ (0.28)	$ (0.44)		$ (5.78)	[5]	$ (1.34)	[5]
Basic weighted-average common shares outstanding (in shares)	89,739,310	89,002,430	89,476,065	81,221,550	83,188,276	[6]	16,655,634	[5],[6]	16,029,826	[5],[6]
Diluted loss per share for the period attributable to common stockholders (in dollars per share)	$ (0.2)	$ (0.37)	$ (0.53)	$ (0.5)	$ (0.66)		$ (5.78)	[5]	$ (1.34)	[5]
Diluted weighted-average common shares outstanding (in shares)	89,739,310	90,413,087	89,476,065	82,632,207	83,798,149		16,655,634	[5]	16,029,826	[5]
[1]Certain awards granted by us have a service inception date preceding the grant date. Under IFRS, this resulted in the recognition of stock-based compensation expense prior to the grant date. Under U.S. GAAP, the stock-based compensation expense shall not be recognized until authorization at the grant date.[2]Under IFRS, all recognized leases are accounted for similarly to finance leases. Under U.S. GAAP, there is a dual classification on-balance sheet lease accounting model for lessees: finance and operating leases. Operating leases create a straight-line expense, and no interest expense is recognized on the lease liability.[3]Under IFRS, certain development expenditures may be capitalized. Under U.S. GAAP, all of our costs relating to R&D activities are expensed as incurred.[4]Under IFRS, the redeemable Series X preferred shares and convertible notes contained conversion features that resulted in a bifurcated derivative component with changes in fair value recognized as gain or (loss). Under U.S. GAAP, the conversion features did not result in a material bifurcated embedded derivative, resulting in the elimination of the change in fair value of financial instruments, reduction in interest expense and preferred dividends expense, and increase in the gain (loss) on extinguishment of debt. Under IFRS, it was determined that the redeemable Series X preferred shares should be classified as a liability since there is a contractual obligation to deliver cash or another financial asset and certain conversion events being beyond our control. Under U.S. GAAP, it was determined that the redeemable Series X preferred shares should be classified as mezzanine equity since the shares are redeemable based on events outside of our control. Under IFRS, it was determined that the Columbia Warrant should be classified as equity since settlement would only occur by exchanging a fixed amount of cash for a fixed number of our own equity instruments. Changes in fair value are not recognized. Under U.S. GAAP, it was determined that the Columbia Warrant should be classified as a liability since the number and type of shares received could be different pre- and post- Merger. The Columbia Warrant is recorded at fair value with changes recognized in the Consolidated Statement of Operations and Comprehensive Loss. Additionally, the resulting gain (loss) on extinguishment of the amended convertible notes differed under IFRS versus U.S. GAAP.[5]The change in net loss in the adoption of U.S. GAAP as described in items a-d above impacted net loss per share as follows:[6]After applying the 3.3028 Exchange Ratio as described in Note 4 (Reverse Recapitalization).

Consolidated Balance Sheets

Consolidated Balance Sheets - USD ($) $ in Thousands	Dec. 31, 2022	Dec. 31, 2021
Current assets
Cash and cash equivalents	$ 76,528	$ 8,533
Restricted cash	126	0
Accounts receivable, net of allowance of $3,317 and $3,237, respectively	1,388	1,196
Prepaid expenses and other current assets	3,198	2,695
Total current assets	81,240	12,424
Property and equipment, net	47,981	32,530
Operating lease right-of-use assets	8,171	2,955
Deferred income tax assets	0	1,640
Other non-current assets	6,463	369
Total assets	143,855	49,918
Current liabilities
Accounts payable	9,850	6,650
Debt	0	108,473
Warrant liabilities	8,335	143,237
Earnout liabilities	1,353	0
Operating lease liabilities	2,176	985
Contract liabilities	1,941	935
Accrued expenses and other liabilities	6,417	23,435
Total current liabilities	30,072	283,715
Operating lease liabilities	6,063	2,083
Contract liabilities	1,000	1,000
Other non-current liabilities	522	2,552
Total liabilities	37,657	289,350
Commitments and contingencies (Note 17)
Redeemable preferred stock	0	21,306
Stockholders' equity
Preferred stock, $0.0001 par value	0	0
Common stock, $0.0001 par value, unlimited shares authorized; 76,292,604 Class A shares issued and outstanding; and 13,582,642 Class B shares issued and outstanding as of September 30, 2023 and 75,612,795 Class A shares issued and outstanding and 13,582,642 Class B shares issued and outstanding as of December 31, 2022	0	0
Treasury stock, at cost	(8,603)	(170,949)
Additional paid-in capital	337,928	96,471
Accumulated other comprehensive loss	(312)	(86)
Accumulated deficit	(222,815)	(186,174)
Total stockholders’ equity	106,198	(260,738)
Total liabilities, redeemable preferred stock and stockholders’ equity	$ 143,855	$ 49,918

Consolidated Balance Sheets (Pa

Consolidated Balance Sheets (Parentheticals) - USD ($) $ in Thousands	Sep. 30, 2023	Dec. 31, 2022	Dec. 31, 2021
Accounts receivable, allowance	$ 3,317	$ 3,237	$ 1,794
Redeemable preferred shares par value (in dollars per share)		$ 0.0001	$ 0.0001
Preferred stock, par value (in dollars per share)	$ 0.0001	0.0001	0.0001
Common stock, par value (in dollars per share)	$ 0.0001	$ 0.0001	$ 0.0001

Consolidated Statements of Rede

Consolidated Statements of Redeemable Preferred Stock and Stockholders' Equity (Deficit) - USD ($) $ in Thousands	Cumulative Effect, Period of Adoption, Adjustment [Member] Redeemable Series X Preferred Stockholders [Member]	Cumulative Effect, Period of Adoption, Adjustment [Member] Additional Paid-in Capital [Member]	Cumulative Effect, Period of Adoption, Adjustment [Member] Treasury Stock, Common [Member]	Cumulative Effect, Period of Adoption, Adjustment [Member] AOCI Attributable to Parent [Member]	Cumulative Effect, Period of Adoption, Adjustment [Member] Retained Earnings [Member]	Cumulative Effect, Period of Adoption, Adjustment [Member]	Hanover Holdings S A [Member] Redeemable Series X Preferred Stockholders [Member]	Hanover Holdings S A [Member] Preferred Stock [Member]	Hanover Holdings S A [Member] Common Stock [Member]	Hanover Holdings S A [Member] Additional Paid-in Capital [Member]	Hanover Holdings S A [Member] Treasury Stock, Common [Member]	Hanover Holdings S A [Member] AOCI Attributable to Parent [Member]	Hanover Holdings S A [Member] Retained Earnings [Member]	Hanover Holdings S A [Member]	Convertible Debt [Member] Redeemable Series X Preferred Stockholders [Member]	Convertible Debt [Member] Common Stock [Member]	Convertible Debt [Member] Additional Paid-in Capital [Member]	Convertible Debt [Member] Treasury Stock, Common [Member]	Convertible Debt [Member] AOCI Attributable to Parent [Member]	Convertible Debt [Member] Retained Earnings [Member]	Convertible Debt [Member]	Canter Loan [Member] Redeemable Series X Preferred Stockholders [Member]	Canter Loan [Member] Common Stock [Member]	Canter Loan [Member] Additional Paid-in Capital [Member]	Canter Loan [Member] Treasury Stock, Common [Member]	Canter Loan [Member] AOCI Attributable to Parent [Member]	Canter Loan [Member] Retained Earnings [Member]	Canter Loan [Member]	Forward Purchase Contract Warrant [Member] Redeemable Series X Preferred Stockholders [Member]	Forward Purchase Contract Warrant [Member] Common Stock [Member]	Forward Purchase Contract Warrant [Member] Additional Paid-in Capital [Member]	Forward Purchase Contract Warrant [Member] Treasury Stock, Common [Member]	Forward Purchase Contract Warrant [Member] AOCI Attributable to Parent [Member]	Forward Purchase Contract Warrant [Member] Retained Earnings [Member]	Forward Purchase Contract Warrant [Member]	Pipe Warrant [Member] Redeemable Series X Preferred Stockholders [Member]	Pipe Warrant [Member] Common Stock [Member]	Pipe Warrant [Member] Additional Paid-in Capital [Member]	Pipe Warrant [Member] Treasury Stock, Common [Member]	Pipe Warrant [Member] AOCI Attributable to Parent [Member]	Pipe Warrant [Member] Retained Earnings [Member]	Pipe Warrant [Member]	Liberty Subscription Agreement [Member] Redeemable Series X Preferred Stockholders [Member]	Liberty Subscription Agreement [Member] Common Stock [Member]	Liberty Subscription Agreement [Member] Additional Paid-in Capital [Member]	Liberty Subscription Agreement [Member] Treasury Stock, Common [Member]	Liberty Subscription Agreement [Member] AOCI Attributable to Parent [Member]	Liberty Subscription Agreement [Member] Retained Earnings [Member]	Liberty Subscription Agreement [Member]	Public Warrants [Member] Redeemable Series X Preferred Stockholders [Member]	Public Warrants [Member] Preferred Stock [Member]	Public Warrants [Member] Common Stock [Member]	Public Warrants [Member] Additional Paid-in Capital [Member]	Public Warrants [Member] Treasury Stock, Common [Member]	Public Warrants [Member] AOCI Attributable to Parent [Member]	Public Warrants [Member] Retained Earnings [Member]	Public Warrants [Member]	Redeemable Series X Preferred Stockholders [Member]	Preferred Stock [Member]	Common Stock [Member]	Additional Paid-in Capital [Member]	Treasury Stock, Common [Member]	AOCI Attributable to Parent [Member]	Retained Earnings [Member]	Total
Balance (in shares) at Dec. 31, 2019																																																										0	8,740,398	15,961,703
Balance at Dec. 31, 2019	$ 0	$ (123)			$ (1,261)	$ (1,384)																																																				$ 0			$ 61,635	$ 0	$ 0	$ (67,084)	$ (5,449)
Issuance of stock (in shares)																																																										0	0	318,657
Issuance of stock																																																										$ 0			802	0	0	0	802
Net loss																																																										0			0	0	0	(21,529)	(21,529)
Stock-based compensation																																																										$ 0			1,727	0	0	5	1,732
Balance (in shares) at Dec. 31, 2020																																																										0	8,740,398	16,280,360
Balance at Dec. 31, 2020																																																										$ 0			64,041	0	0	(89,869)	(25,828)
Net loss																																																										0			0	0	0	(96,305)	(96,305)
Stock-based compensation																																																										$ 0			10,881	0	0	0	10,881
Issuance of Redeemable Series X preferred stock (in shares)																																																										2,033,230	0	0
Issuance of Redeemable Series X preferred stock																																																										$ 20,332			0	0	0	0	0
Dividends on Redeemable Series X preferred stock																																																										974			0	0	0	0	0
Extinguishment of Convertible Notes																																																										0			39,009	0	0	0	39,009
Exercise of stock options																																																										$ 0			791	0	0	0	791
Exercise of stock options (in shares)																																																											0	1,102,494
Preferred stockholder transaction (Note 11) (in shares)																																																										0	(4,128,413)	0
Preferred stockholder transaction (Note 11)																																																										$ 0			(18,251)	(170,949)	0	0	(189,200)
Comprehensive loss																																																										0			0	0	(86)	0	(86)
Repurchase of shares																																																										0			(18,251)	(170,949)	0	0	(189,200)
Other comprehensive loss																																																										$ 0			0	0	(86)	0	(86)
Balance (in shares) at Dec. 31, 2021																																																										2,033,230	4,611,985	17,382,854
Balance at Dec. 31, 2021																																																										$ 21,306			96,471	(170,949)	(86)	(186,174)	(260,738)
Issuance of stock (in shares)																							26,050
Issuance of stock																								$ 167				$ 167
Net loss																																																													0	0	0	(22,944)	(22,944)
Stock-based compensation																																																													6,624				6,624
Exercise of stock options																																																													37				37
Exercise of stock options (in shares)																																																											0	21,927
Preferred stockholder transaction (Note 11) (in shares)								149,817	51,700																																																			(516,123)
Preferred stockholder transaction (Note 11)																																																														(8,603)			(8,603)
Comprehensive loss																																																													0	0	(695)	0	(695)
Hannover Holdings Transaction (Note 11)										$ 0	$ 0	$ 0	$ 0	$ 0
Merger transaction and Reverse Recapitalization																																																													(166,634)	170,949	0	0	4,315
Merger transaction and Reverse Recapitalization (in shares)																																																											(4,462,168)	22,630,545
Issuance of Class A ordinary shares																	$ 64,051				$ 64,051			7,880				7,880			$ 10,000				$ 10,000			$ 47,430				$ 47,430			$ 121,182				$ 121,182				$ 5,628				$ 5,628
Issuance of Class A ordinary shares (in shares)																17,980,954							788,021							1,250,000							6,108,332							20,619,835								613,111
Conversion of redeemable Series X preferred stock and accrued dividends in connection with the Reverse Recapitalization (in shares)																																																												2,140,340
Conversion of redeemable Series X preferred stock and accrued dividends in connection with the Reverse Recapitalization																																																													21,403				21,403
Reclassification of Columbia Warrant to equity																																																													124,805				124,805
Repayment of Columbia Loan																																																													(3,418)				(3,418)
Reclassification of Forfeiture Earnout Liability to equity																																																													1,005				1,005
Repurchase of shares																																																														(8,603)			(8,603)
Other comprehensive loss																																																													0	0	(695)	0	(695)
Balance (in shares) at Sep. 30, 2022																																																											0	88,994,146
Balance at Sep. 30, 2022																																																													336,631	(8,603)	(781)	(209,118)	118,129
Balance (in shares) at Dec. 31, 2021																																																										2,033,230	4,611,985	17,382,854
Balance at Dec. 31, 2021																																																										$ 21,306			96,471	(170,949)	(86)	(186,174)	(260,738)
Issuance of stock (in shares)																							26,050
Issuance of stock																						$ 0		167	$ 0	$ 0	$ 0	167
Net loss																																																										0			0	0	0	(36,641)	(36,641)
Stock-based compensation																																																										0			8,368	0	0	0	8,368
Dividends on Redeemable Series X preferred stock																																																										97				0	0	0	0
Exercise of stock options																																																										$ 0			144	0	0	0	$ 144
Exercise of stock options (in shares)																																																										0	0	223,218					102,825
Preferred stockholder transaction (Note 11) (in shares)								(149,817)	(51,700)																																																			(516,123)
Preferred stockholder transaction (Note 11)																																																										$ 0				(2,750)	0	0	$ (2,750)
Comprehensive loss																																																										0			0	0	(226)	0	(226)
Hannover Holdings Transaction (Note 11)							$ 0			0	(5,853)	0	0	(5,853)
Merger transaction and Reverse Recapitalization																																																										$ 0			(165,804)	170,949	0	0	5,145
Merger transaction and Reverse Recapitalization (in shares)																																																											(4,462,168)	22,630,545
Issuance of Class A ordinary shares															$ 0		$ 64,051	$ 0	$ 0	$ 0	$ 64,051	$ 0		$ 7,880	$ 0	$ 0	$ 0	$ 7,880	$ 0		$ 10,000	$ 0	$ 0	$ 0	$ 10,000	$ 0		$ 47,028	$ 0	$ 0	$ 0	$ 47,028	$ 0		$ 120,506	$ 0	$ 0	$ 0	$ 120,506	$ 0			$ 5,628	$ 0	$ 0	$ 0	$ 5,628
Issuance of Class A ordinary shares (in shares)																17,980,954							788,021							1,250,000							6,108,332							20,619,835						0	0	613,111
Conversion of redeemable Series X preferred stock and accrued dividends in connection with the Reverse Recapitalization (in shares)																																																										(2,033,230)		2,140,340
Conversion of redeemable Series X preferred stock and accrued dividends in connection with the Reverse Recapitalization																																																										$ (21,403)			21,403	0	0	0	21,403
Reclassification of Columbia Warrant to equity																																																										0			124,805	0	0	0	124,805
Repayment of Columbia Loan																																																										0			(3,418)	0	0	0	(3,418)
Reclassification of Forfeiture Earnout Liability to equity																																																										0			1,005	0	0	0	1,005
Repurchase of shares																																																										0				(2,750)	0	0	(2,750)
Other comprehensive loss																																																										0			0	0	(226)	0	(226)
Withholding of stock units to satisfy tax withholding obligations upon the vesting of restricted stock units and exercise of stock options																																																										$ 0			(306)	0	0	0	(306)
Balance (in shares) at Dec. 31, 2022																																																										0	0	89,195,437
Balance at Dec. 31, 2022																																																										$ 0			337,928	(8,603)	(312)	(222,815)	106,198
Balance (in shares) at Jun. 30, 2022																																																											0	88,994,146
Balance at Jun. 30, 2022																																																													335,306	(8,603)	(408)	(194,295)	132,000
Net loss																																																													0	0	0	(14,823)	(14,823)
Stock-based compensation																																																													2,139	0	0	0	2,139
Exercise of stock options																																																													16	0	0	0	16
Preferred stockholder transaction (Note 11)																																																													0	(5,853)	0	0	(5,853)
Comprehensive loss																																																													0	0	(373)	0	(373)
Hannover Holdings Transaction (Note 11)										$ 0	$ 5,853	$ 0	$ 0	$ 5,853
Merger transaction and Reverse Recapitalization																																																													(830)	0	0	0	(830)
Repurchase of shares																																																													0	(5,853)	0	0	(5,853)
Other comprehensive loss																																																													0	0	(373)	0	(373)
Balance (in shares) at Sep. 30, 2022																																																											0	88,994,146
Balance at Sep. 30, 2022																																																													336,631	(8,603)	(781)	(209,118)	118,129
Balance (in shares) at Dec. 31, 2022																																																										0	0	89,195,437
Balance at Dec. 31, 2022																																																										$ 0			337,928	(8,603)	(312)	(222,815)	106,198
Net loss																																																													0	0	0	(47,470)	(47,470)
Stock-based compensation																																																													4,254	0	0	0	4,254
Exercise of stock options																																																													249	0	0	0	$ 249
Exercise of stock options (in shares)																																																											0	186,307					186,307
Comprehensive loss																																																													0	0	(218)	0	$ (218)
Other comprehensive loss																																																													0	0	(218)	0	(218)
Withholding of stock units to satisfy tax withholding obligations upon the vesting of restricted stock units and exercise of stock options																																																													(272)	0	0	0	(272)
Balance (in shares) at Sep. 30, 2023																																																											0	89,875,246
Balance at Sep. 30, 2023																																																													342,159	(8,603)	(530)	(270,285)	62,741
Balance (in shares) at Jun. 30, 2023																																																											0	89,661,530
Balance at Jun. 30, 2023																																																													340,750	(8,603)	(236)	(252,666)	79,245
Net loss																																																													0	0	0	(17,619)	(17,619)
Stock-based compensation																																																													1,413	0	0	0	1,413
Exercise of stock options																																																													49	0	0	0	49
Exercise of stock options (in shares)																																																											0	80,626
Comprehensive loss																																																													0	0	(294)	0	(294)
Other comprehensive loss																																																													0	0	(294)	0	(294)
Withholding of stock units to satisfy tax withholding obligations upon the vesting of restricted stock units and exercise of stock options																																																													(53)	0	0	0	(53)
Balance (in shares) at Sep. 30, 2023																																																											0	89,875,246
Balance at Sep. 30, 2023																																																													$ 342,159	$ (8,603)	$ (530)	$ (270,285)	$ 62,741

Consolidated Statements of Cash

Consolidated Statements of Cash Flows - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021		Dec. 31, 2020
Cash flows from operating activities:
Net loss	$ (36,641)	$ (96,305)		$ (21,529)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation expense	14,326	10,728	[1]	3,031	[1]
Operating lease expense	2,015	548		298
Deferred tax expense (benefit)	1,601	(1,619)		(38)
Stock-based compensation	8,368	10,881		1,732
Interest expense	1,693	9,703		43
Change in fair value of financial instruments	(58,311)	(17,983)	[2]	(9,637)	[2]
Loss on debt extinguishment	0	37,216	[2]	9,240	[2]
Expenses related to Merger	9,859	0		0
Foreign exchange differences	(4,578)	(2,385)		(1,507)
Loss on disposal of property and equipment and right of use assets	996	579		372
Bad debt expense	1,736	1,794		0
Changes in operating assets and liabilities:
Accounts receivable	(1,928)	(4,691)		(221)
Prepaid expenses and other current assets	(1,855)	21		(14)
Accounts payable	(3,202)	1,421		6,474
Contract liabilities	1,006	480		455
Accrued expenses and other liabilities	(1,562)	21,622		497
Operating lease liabilities	(1,985)	(449)		(370)
Net cash used in operating activities	(68,462)	(28,439)		(11,174)
Cash flows from investing activities:
Acquisitions of property and equipment	(27,252)	(11,233)		(15,787)
Equity investment in OS	(3,653)	0		0
Other	53	3		14
Net cash used in investing activities	(30,852)	(11,230)		(15,773)
Cash flows from financing activities:
Proceeds from issuance of redeemable Series X preferred stock	0	20,332		0
Proceeds from issuance of debt	0	7,513		17,348
Repurchase of stock	(8,603)	0		0
Proceeds from exercise of Public Warrants	5,291	0		0
Proceeds from sale of common stock	167,504	0		0
Proceeds from exercise of stock options	144	791		802
Net cash provided by financing activities	164,336	28,636		18,150
Net increase in cash, cash equivalents and restricted cash	65,022	(11,033)		(8,797)
Effect of foreign exchange rate changes	4,237	2,299		1,507
Cash, cash equivalents and restricted cash - beginning of period	8,533	17,267		24,557
Cash, cash equivalents and restricted cash - end of period	$ 77,792	$ 8,533		$ 17,267
[1]Under IFRS, certain development expenditures may be capitalized. Under U.S. GAAP, all of our costs relating to R&D activities are expensed as incurred.[2]Under IFRS, the redeemable Series X preferred shares and convertible notes contained conversion features that resulted in a bifurcated derivative component with changes in fair value recognized as gain or (loss). Under U.S. GAAP, the conversion features did not result in a material bifurcated embedded derivative, resulting in the elimination of the change in fair value of financial instruments, reduction in interest expense and preferred dividends expense, and increase in the gain (loss) on extinguishment of debt. Under IFRS, it was determined that the redeemable Series X preferred shares should be classified as a liability since there is a contractual obligation to deliver cash or another financial asset and certain conversion events being beyond our control. Under U.S. GAAP, it was determined that the redeemable Series X preferred shares should be classified as mezzanine equity since the shares are redeemable based on events outside of our control. Under IFRS, it was determined that the Columbia Warrant should be classified as equity since settlement would only occur by exchanging a fixed amount of cash for a fixed number of our own equity instruments. Changes in fair value are not recognized. Under U.S. GAAP, it was determined that the Columbia Warrant should be classified as a liability since the number and type of shares received could be different pre- and post- Merger. The Columbia Warrant is recorded at fair value with changes recognized in the Consolidated Statement of Operations and Comprehensive Loss. Additionally, the resulting gain (loss) on extinguishment of the amended convertible notes differed under IFRS versus U.S. GAAP.

Condensed Consolidated Statemen

Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended		12 Months Ended
	Sep. 30, 2023	Sep. 30, 2022	Sep. 30, 2023	Sep. 30, 2022	Dec. 31, 2022		Dec. 31, 2021		Dec. 31, 2020
Revenue	$ 1,196	$ 2,158	$ 4,380	$ 4,546	$ 6,012		$ 4,247		$ 0
Costs and expenses
Cost of sales, exclusive of depreciation shown separately below	1,046	969	3,159	2,298	3,284		1,876		0
General and administrative expenses	5,865	6,308	15,732	30,917	37,191		36,640	[1],[2]	8,003	[1],[2]
Research and development	2,169	3,941	7,996	9,657	13,055		9,636	[3]	5,924	[3]
Depreciation expense	5,420	4,031	14,030	10,516	14,326		10,728	[3]	3,031	[3]
Other operating expenses	4,852	6,992	17,930	20,728	29,023		14,002		5,449
Total costs and expenses	19,352	22,241	58,847	74,116	96,879		72,882		22,407
Operating loss	(18,156)	(20,083)	(54,467)	(69,570)	(90,867)		(68,635)		(22,407)
Other income (expense), net
Finance costs, net	389	381	1,471	(1,225)	(652)		(9,738)	[2],[4]	35	[2],[4]
Change in fair value of financial instruments	1,940	6,270	7,520	50,866	58,311		17,983	[4]	9,637	[4]
Other income, net	2,277	1,592	4,199	2,111	1,140		1,069	[2]	594	[2]
Total other income (expense), net	4,606	8,243	13,190	51,752	58,799		(27,902)		1,026
Loss before income tax	(13,550)	(11,840)	(41,277)	(17,818)	(32,068)		(96,537)		(21,381)
Income tax (expense) benefit	(4,069)	(2,983)	(6,193)	(5,126)	(4,573)		232		(148)
Net loss available to common stockholders	(17,619)	(14,823)	(47,470)	(22,944)	(36,641)		(96,305)		(21,529)
Other comprehensive loss
Foreign currency translation loss, net of tax	(294)	(373)	(218)	(695)	(226)		(86)		0
Comprehensive loss	$ (17,913)	$ (15,196)	$ (47,688)	$ (23,639)	$ (36,867)		$ (96,391)		$ (21,529)
Basic loss per share for the period attributable to common stockholders (in dollars per share)	$ (0.2)	$ (0.17)	$ (0.53)	$ (0.28)	$ (0.44)		$ (5.78)	[5]	$ (1.34)	[5]
Basic weighted-average common shares outstanding (in shares)	89,739,310	89,002,430	89,476,065	81,221,550	83,188,276	[6]	16,655,634	[5],[6]	16,029,826	[5],[6]
Diluted loss per share for the period attributable to common stockholders (in dollars per share)	$ (0.2)	$ (0.37)	$ (0.53)	$ (0.5)	$ (0.66)		$ (5.78)	[5]	$ (1.34)	[5]
Diluted weighted-average common shares outstanding (in shares)	89,739,310	90,413,087	89,476,065	82,632,207	83,798,149		16,655,634	[5]	16,029,826	[5]
[1]Certain awards granted by us have a service inception date preceding the grant date. Under IFRS, this resulted in the recognition of stock-based compensation expense prior to the grant date. Under U.S. GAAP, the stock-based compensation expense shall not be recognized until authorization at the grant date.[2]Under IFRS, all recognized leases are accounted for similarly to finance leases. Under U.S. GAAP, there is a dual classification on-balance sheet lease accounting model for lessees: finance and operating leases. Operating leases create a straight-line expense, and no interest expense is recognized on the lease liability.[3]Under IFRS, certain development expenditures may be capitalized. Under U.S. GAAP, all of our costs relating to R&D activities are expensed as incurred.[4]Under IFRS, the redeemable Series X preferred shares and convertible notes contained conversion features that resulted in a bifurcated derivative component with changes in fair value recognized as gain or (loss). Under U.S. GAAP, the conversion features did not result in a material bifurcated embedded derivative, resulting in the elimination of the change in fair value of financial instruments, reduction in interest expense and preferred dividends expense, and increase in the gain (loss) on extinguishment of debt. Under IFRS, it was determined that the redeemable Series X preferred shares should be classified as a liability since there is a contractual obligation to deliver cash or another financial asset and certain conversion events being beyond our control. Under U.S. GAAP, it was determined that the redeemable Series X preferred shares should be classified as mezzanine equity since the shares are redeemable based on events outside of our control. Under IFRS, it was determined that the Columbia Warrant should be classified as equity since settlement would only occur by exchanging a fixed amount of cash for a fixed number of our own equity instruments. Changes in fair value are not recognized. Under U.S. GAAP, it was determined that the Columbia Warrant should be classified as a liability since the number and type of shares received could be different pre- and post- Merger. The Columbia Warrant is recorded at fair value with changes recognized in the Consolidated Statement of Operations and Comprehensive Loss. Additionally, the resulting gain (loss) on extinguishment of the amended convertible notes differed under IFRS versus U.S. GAAP.[5]The change in net loss in the adoption of U.S. GAAP as described in items a-d above impacted net loss per share as follows:[6]After applying the 3.3028 Exchange Ratio as described in Note 4 (Reverse Recapitalization).

Condensed Consolidated Balance

Condensed Consolidated Balance Sheets (Unaudited) - USD ($) $ in Thousands	Sep. 30, 2023	Dec. 31, 2022
Current assets
Cash and cash equivalents	$ 30,971	$ 76,528
Restricted cash	0	126
Accounts receivable, net of allowance of $3,317 and $3,237, respectively	1,718	1,388
Prepaid expenses and other current assets	3,245	3,198
Total current assets	35,934	81,240
Property and equipment, net	42,728	47,981
Operating lease right-of-use assets	9,331	8,171
Other non-current assets	5,349	6,463
Total assets	93,342	143,855
Current liabilities
Accounts payable	6,492	9,850
Warrant liabilities	1,945	8,335
Earnout liabilities	223	1,353
Operating lease liabilities	2,034	2,176
Contract liabilities	3,286	1,941
Accrued expenses and other liabilities	7,481	6,417
Total current liabilities	21,461	30,072
Operating lease liabilities	7,641	6,063
Contract liabilities	1,000	1,000
Other non-current liabilities	499	522
Total liabilities	30,601	37,657
Commitments and contingencies (Note 17)
Stockholders' equity
Preferred stock, $0.0001 par value	0	0
Common stock, $0.0001 par value, unlimited shares authorized; 76,292,604 Class A shares issued and outstanding; and 13,582,642 Class B shares issued and outstanding as of September 30, 2023 and 75,612,795 Class A shares issued and outstanding and 13,582,642 Class B shares issued and outstanding as of December 31, 2022	0	0
Treasury stock, at cost: 516,123 shares at September 30, 2023, and 516,123 shares at December 31, 2022	(8,603)	(8,603)
Additional paid-in capital	342,159	337,928
Accumulated other comprehensive loss	(530)	(312)
Accumulated deficit	(270,285)	(222,815)
Total stockholders’ equity	62,741	106,198
Total liabilities, redeemable preferred stock and stockholders’ equity	$ 93,342	$ 143,855

Condensed Consolidated Balanc_2

Condensed Consolidated Balance Sheets (Unaudited) (Parentheticals) - USD ($) $ in Thousands	9 Months Ended	12 Months Ended
	Sep. 30, 2023	Dec. 31, 2022
Accounts receivable, allowance	$ 3,317	$ 3,237
Preferred stock, par value (in dollars per share)	$ 0.0001	$ 0.0001
Common stock, par value (in dollars per share)	$ 0.0001	$ 0.0001
Common stock, authorized	Unlimited	Unlimited
Treasury stock, shares (in shares)	516,123	516,123
Common Class A [Member]
Common stock, par value (in dollars per share)	$ 0.0001	$ 0.0001
Common stock, issued (in shares)	76,292,604	75,612,795
Common stock, outstanding (in shares)	76,292,604	75,612,795
Common Class B [Member]
Common stock, par value (in dollars per share)	$ 0.0001	$ 0.0001
Common stock, issued (in shares)	13,582,642	13,582,642
Common stock, outstanding (in shares)	13,582,642	13,582,642

Condensed Consolidated Statem_2

Condensed Consolidated Statements of Redeemable Preferred Stock and Stockholders' Equity (Unaudited) - USD ($) $ in Thousands	Series X Preferred Stock [Member]	Preferred Stock [Member] Hanover Holdings S A [Member]	Preferred Stock [Member] Public Warrants [Member]	Preferred Stock [Member]	Common Stock [Member] Hanover Holdings S A [Member]	Common Stock [Member] Convertible Debt [Member]	Common Stock [Member] Canter Loan [Member]	Common Stock [Member] Forward Purchase Contract Warrant [Member]	Common Stock [Member] Pipe Warrant [Member]	Common Stock [Member] Liberty Subscription Agreement [Member]	Common Stock [Member] Public Warrants [Member]	Common Stock [Member]	Additional Paid-in Capital [Member] Hanover Holdings S A [Member]	Additional Paid-in Capital [Member] Convertible Debt [Member]	Additional Paid-in Capital [Member] Canter Loan [Member]	Additional Paid-in Capital [Member] Forward Purchase Contract Warrant [Member]	Additional Paid-in Capital [Member] Pipe Warrant [Member]	Additional Paid-in Capital [Member] Liberty Subscription Agreement [Member]	Additional Paid-in Capital [Member] Public Warrants [Member]	Additional Paid-in Capital [Member]	Treasury Stock, Common [Member] Hanover Holdings S A [Member]	Treasury Stock, Common [Member] Convertible Debt [Member]	Treasury Stock, Common [Member] Canter Loan [Member]	Treasury Stock, Common [Member] Forward Purchase Contract Warrant [Member]	Treasury Stock, Common [Member] Pipe Warrant [Member]	Treasury Stock, Common [Member] Liberty Subscription Agreement [Member]	Treasury Stock, Common [Member] Public Warrants [Member]	Treasury Stock, Common [Member]	AOCI Attributable to Parent [Member] Hanover Holdings S A [Member]	AOCI Attributable to Parent [Member] Convertible Debt [Member]	AOCI Attributable to Parent [Member] Canter Loan [Member]	AOCI Attributable to Parent [Member] Forward Purchase Contract Warrant [Member]	AOCI Attributable to Parent [Member] Pipe Warrant [Member]	AOCI Attributable to Parent [Member] Liberty Subscription Agreement [Member]	AOCI Attributable to Parent [Member] Public Warrants [Member]	AOCI Attributable to Parent [Member]	Retained Earnings [Member] Hanover Holdings S A [Member]	Retained Earnings [Member] Convertible Debt [Member]	Retained Earnings [Member] Canter Loan [Member]	Retained Earnings [Member] Forward Purchase Contract Warrant [Member]	Retained Earnings [Member] Pipe Warrant [Member]	Retained Earnings [Member] Liberty Subscription Agreement [Member]	Retained Earnings [Member] Public Warrants [Member]	Retained Earnings [Member]	Hanover Holdings S A [Member]	Convertible Debt [Member]	Canter Loan [Member]	Forward Purchase Contract Warrant [Member]	Pipe Warrant [Member]	Liberty Subscription Agreement [Member]	Public Warrants [Member]	Total
Balance (in shares) at Dec. 31, 2019				8,740,398								15,961,703
Balance at Dec. 31, 2019																				$ 61,635								$ 0								$ 0								$ (67,084)								$ (5,449)
Net loss																				0								0								0								(21,529)								(21,529)
Stock-based compensation																				1,727								0								0								5								1,732
Balance (in shares) at Dec. 31, 2020				8,740,398								16,280,360
Balance at Dec. 31, 2020																				64,041								0								0								(89,869)								(25,828)
Issuance of stock (in shares)				0								318,657
Issuance of stock																				802								0								0								0								802
Net loss																				0								0								0								(96,305)								(96,305)
Other comprehensive loss																				0								0								(86)								0								(86)
Exercise of stock options (in shares)				0								1,102,494
Exercise of stock options																				791								0								0								0								791
Stock-based compensation																				10,881								0								0								0								10,881
Balance (in shares) at Dec. 31, 2021	2,033,230			4,611,985								17,382,854
Balance at Dec. 31, 2021	$ 21,306																			96,471								(170,949)								(86)								(186,174)								(260,738)
Repurchase of shares																				(18,251)								(170,949)								0								0								(189,200)
Hannover Holdings Transaction (Note 11) (in shares)				4,128,413								0
Dividends on Redeemable Series X preferred stock																				0								0								0								0								0
Preferred stockholder transaction (Note 11) (in shares)				(4,128,413)								0
Net loss																				0								0								0								(22,944)								(22,944)
Other comprehensive loss																				0								0								(695)								0								(695)
Exercise of stock options (in shares)				0								21,927
Exercise of stock options																				37																																37
Stock-based compensation																				6,624																																6,624
Balance (in shares) at Sep. 30, 2022	0			0								88,994,146
Balance at Sep. 30, 2022	$ 0																			336,631								(8,603)								(781)								(209,118)								118,129
Hannover Holdings Transaction (Note 11)													$ 0								$ 0								$ 0								$ 0								$ 0
Merger transaction and Reverse Recapitalization																				(166,634)								170,949								0								0								4,315
Repurchase of shares																												(8,603)																								(8,603)
Hannover Holdings Transaction (Note 11) (in shares)		(149,817)			(51,700)							516,123
Merger transaction and Reverse Recapitalization (in shares)				(4,462,168)								22,630,545
Issuance of Class A ordinary shares (in shares)						17,980,954	788,021	1,250,000	6,108,332	20,619,835	613,111
Issuance of Class A ordinary shares														$ 64,051	$ 7,880	$ 10,000	$ 47,430	$ 121,182	$ 5,628																											$ 64,051	$ 7,880	$ 10,000	$ 47,430	$ 121,182	$ 5,628
Dividends on Redeemable Series X preferred stock	$ 97
Conversion of redeemable Series X preferred stock and accrued dividends in connection with the Reverse Recapitalization (in shares)	(2,033,230)											2,140,340
Conversion of redeemable Series X preferred stock and accrued dividends in connection with the Reverse Recapitalization	$ (21,403)																			21,403																																21,403
Reclassification of Columbia Warrant to equity																				124,805																																124,805
Repayment of Columbia Loan																				(3,418)																																(3,418)
Reclassification of Forfeiture Earnout Liability to equity																				1,005																																1,005
Preferred stockholder transaction (Note 11) (in shares)		149,817			51,700							(516,123)
Issuance of stock (in shares)							26,050
Issuance of stock															167																																167
Balance (in shares) at Dec. 31, 2021	2,033,230			4,611,985								17,382,854
Balance at Dec. 31, 2021	$ 21,306																			96,471								(170,949)								(86)								(186,174)								(260,738)
Net loss																				0								0								0								(36,641)								(36,641)
Other comprehensive loss																				0								0								(226)								0								$ (226)
Exercise of stock options (in shares)				0								223,218																																								102,825
Exercise of stock options																				144								0								0								0								$ 144
Withholding of stock units to satisfy tax withholding obligations upon the vesting of restricted stock units and exercise of stock options																				(306)								0								0								0								(306)
Stock-based compensation																				8,368								0								0								0								8,368
Balance (in shares) at Dec. 31, 2022				0								89,195,437
Balance at Dec. 31, 2022																				337,928								(8,603)								(312)								(222,815)								106,198
Hannover Holdings Transaction (Note 11)													0								(5,853)								0								0								(5,853)
Merger transaction and Reverse Recapitalization																				(165,804)								170,949								0								0								5,145
Repurchase of shares																												(2,750)								0								0								(2,750)
Hannover Holdings Transaction (Note 11) (in shares)		149,817			51,700							516,123
Merger transaction and Reverse Recapitalization (in shares)				(4,462,168)								22,630,545
Issuance of Class A ordinary shares (in shares)			0			17,980,954	788,021	1,250,000	6,108,332	20,619,835	613,111
Issuance of Class A ordinary shares														$ 64,051	7,880	$ 10,000	$ 47,028	$ 120,506	$ 5,628			$ 0	$ 0	$ 0	$ 0	$ 0	$ 0			$ 0	$ 0	$ 0	$ 0	$ 0	$ 0			$ 0	$ 0	$ 0	$ 0	$ 0	$ 0			$ 64,051	7,880	$ 10,000	$ 47,028	$ 120,506	$ 5,628
Dividends on Redeemable Series X preferred stock																												0								0								0								0
Conversion of redeemable Series X preferred stock and accrued dividends in connection with the Reverse Recapitalization (in shares)												2,140,340
Conversion of redeemable Series X preferred stock and accrued dividends in connection with the Reverse Recapitalization																				21,403								0								0								0								21,403
Reclassification of Columbia Warrant to equity																				124,805								0								0								0								124,805
Repayment of Columbia Loan																				(3,418)								0								0								0								(3,418)
Reclassification of Forfeiture Earnout Liability to equity																				1,005								0								0								0								1,005
Preferred stockholder transaction (Note 11) (in shares)		(149,817)			(51,700)							(516,123)
Issuance of stock (in shares)							26,050
Issuance of stock															$ 167								$ 0								$ 0								$ 0								$ 167
Balance (in shares) at Jun. 30, 2022				0								88,994,146
Balance at Jun. 30, 2022																				335,306								(8,603)								(408)								(194,295)								132,000
Net loss																				0								0								0								(14,823)								(14,823)
Other comprehensive loss																				0								0								(373)								0								(373)
Exercise of stock options																				16								0								0								0								16
Stock-based compensation																				2,139								0								0								0								2,139
Balance (in shares) at Sep. 30, 2022	0			0								88,994,146
Balance at Sep. 30, 2022	$ 0																			336,631								(8,603)								(781)								(209,118)								118,129
Hannover Holdings Transaction (Note 11)													$ 0								$ 5,853								$ 0								$ 0								$ 5,853
Merger transaction and Reverse Recapitalization																				(830)								0								0								0								(830)
Repurchase of shares																				0								(5,853)								0								0								(5,853)
Balance (in shares) at Dec. 31, 2022				0								89,195,437
Balance at Dec. 31, 2022																				337,928								(8,603)								(312)								(222,815)								106,198
Net loss																				0								0								0								(47,470)								(47,470)
Other comprehensive loss																				0								0								(218)								0								$ (218)
Exercise of stock options (in shares)				0								186,307																																								186,307
Exercise of stock options																				249								0								0								0								$ 249
Withholding of stock units to satisfy tax withholding obligations upon the vesting of restricted stock units and exercise of stock options																				(272)								0								0								0								(272)
Stock-based compensation (in shares)				0								493,502
Stock-based compensation																				4,254								0								0								0								4,254
Balance (in shares) at Sep. 30, 2023				0								89,875,246
Balance at Sep. 30, 2023																				342,159								(8,603)								(530)								(270,285)								62,741
Balance (in shares) at Jun. 30, 2023				0								89,661,530
Balance at Jun. 30, 2023																				340,750								(8,603)								(236)								(252,666)								79,245
Net loss																				0								0								0								(17,619)								(17,619)
Other comprehensive loss																				0								0								(294)								0								(294)
Exercise of stock options (in shares)				0								80,626
Exercise of stock options																				49								0								0								0								49
Withholding of stock units to satisfy tax withholding obligations upon the vesting of restricted stock units and exercise of stock options																				(53)								0								0								0								(53)
Stock-based compensation (in shares)				0								133,090
Stock-based compensation																				1,413								0								0								0								1,413
Balance (in shares) at Sep. 30, 2023				0								89,875,246
Balance at Sep. 30, 2023																				$ 342,159								$ (8,603)								$ (530)								$ (270,285)								$ 62,741

Condensed Consolidated Statem_3

Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2023	Sep. 30, 2022
Cash flows from operating activities:
Net loss	$ (47,470)	$ (22,944)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation expense	14,030	10,516
Operating lease expense	2,112	1,475
Deferred tax expense (benefit)	0	5,126
Stock-based compensation	4,254	6,624
Interest expense	0	1,685
Change in fair value of financial instruments	(7,520)	(50,866)
Expenses related to Merger	0	10,937
Foreign exchange differences	(5,507)	(5,511)
Property and equipment impairments	379	0
Loss on disposal of property and equipment and right of use assets	24	128
Bad debt expense	80	1,736
Loss on equity-method investment	66	0
Non-cash change in contract liabilities	771	0
Changes in operating assets and liabilities:
Accounts receivable	(508)	(2,129)
Prepaid expenses and other current assets	1,035	(3,765)
Accounts payable	(290)	(3,687)
Contract liabilities	574	1,162
Accrued expenses and other liabilities	3,534	(3,938)
Operating lease liabilities	(1,696)	(1,312)
Net cash used in operating activities	(36,132)	(54,763)
Cash flows from investing activities:
Acquisitions of property and equipment	(12,304)	(19,862)
Equity investment in OS	0	(3,604)
Other	0	(30)
Net cash used in investing activities	(12,304)	(23,496)
Cash flows from financing activities:
Repurchase of stock	0	(8,603)
Tax withholding payments for vested equity-based compensation awards	(272)	0
Proceeds from exercise of Public Warrants	0	5,291
Proceeds from sale of common stock	0	166,675
Proceeds from exercise of stock options	249	37
Net cash provided by financing activities	(23)	163,400
Net increase in cash, cash equivalents and restricted cash	(48,459)	85,141
Effect of foreign exchange rate changes	2,789	3,633
Cash, cash equivalents and restricted cash - beginning of period	77,792	8,533
Cash, cash equivalents and restricted cash - end of period	$ 32,122	$ 97,307

Note 1 - Nature of the Business

Note 1 - Nature of the Business and Basis of Presentation	9 Months Ended	12 Months Ended
	Sep. 30, 2023	Dec. 31, 2022
Notes to Financial Statements
Business Description and Basis of Presentation [Text Block]	1. Nature of the Business On January 25, 2022 ( July 5, 2021 ( 1 2 Nettar was, prior to the transaction, the holding company of the Satellogic group and was incorporated on October 7, 2014 173 D8 VG1110. References to “Nettar” contained herein refer to Nettar Group Inc. prior to the mergers, and references to “the Company,” “we,” “our,” “us” or “Satellogic” refer to Satellogic Inc. prior to the mergers and to the combined company following the mergers. Through our subsidiaries, we invest in the software, hardware, and optics of the aerospace industry focusing on satellite and image analytics technologies. Our strategy is to build a planetary scale analytics platform based on a proprietary satellite constellation with the capability to generate insights from images and information, with focus on multi-temporal analysis and high frequency of revisits. We also intend to leverage our ability to quickly build and launch high quality, sub-meter satellites at a low cost by selling satellites to certain key customers. Basis of Presentation The accompanying unaudited interim condensed consolidated financial statements have been prepared in accordance with generally accepted accounting principles in the United States (“U.S. GAAP”) and the rules and regulations of the U.S. Securities and Exchange Commission (“SEC”). The Company conducts business through one operating segment. The accompanying Condensed Consolidated Financial Statements include our accounts and those of our wholly owned subsidiaries. All intercompany accounts and transactions have been eliminated in consolidation. The Condensed Consolidated Financial Statements are presented in United States dollars (hereinafter “U.S. dollars” or “$”). The accompanying Condensed Consolidated Financial Statements are unaudited and reflect all adjustments of a normal, recurring nature that are, in the opinion of management, necessary for a fair presentation of the interim period financial statements. The results of operations for these interim periods are not Emerging Growth Company We are an “emerging growth company,” as defined in Section 2 1933, 2012 not not 1934, not may not Going Concern and Liquidity The accompanying unaudited condensed consolidated financial statements have been prepared assuming we will continue as a going concern. The going concern basis of presentation assumes that we will continue in operation one Pursuant to the requirements of ASC Topic 205 40, one not not not 1 one 2 one We have evaluated whether there are any conditions and events, considered in the aggregate, that raise substantial doubt about our ability to continue as a going concern over the next twelve September 2024. nine September 30, 2023. September 30, 2023, not may second third 2024 In order for us to proceed and reach larger scale revenue generation, we will need to raise additional funds through the issuance of additional equity, debt or both. Until such time that we can generate revenue sufficient to achieve profitability, we expect to finance our operations through equity or debt financings, which may not may may may no As a result of these uncertainties, and notwithstanding our plans and efforts to date, there is substantial doubt about our ability to continue as a going concern for one	1. Nature of the Business On January 25, 2022 ( July 5, 2021 ( 1 2 Nettar was, prior to the transaction, the holding company of the Satellogic group and was incorporated on October 7, 2014, 173 D8 VG1110. References to “Nettar” contained herein refer to Nettar Group Inc. prior to the mergers, and references to “the Company,” “we,” “our,” “us” or “Satellogic” refer to Satellogic Inc. prior to the mergers and to the combined company following the mergers. Through our subsidiaries, we invest in the software, hardware, and optics of the aerospace industry focusing on satellite and image analytics technologies. Our strategy is to build a planetary scale analytics platform based on a proprietary satellite constellation with the capability to generate insights from images and information, with focus on multi-temporal analysis and high frequency of revisits. We also intend to leverage our ability to quickly build and launch high quality, sub-meter satellites at a low cost by selling satellites to certain key customers. Basis of Presentation The accompanying Consolidated Financial Statements as of December 31, 2022 2021 December 31, 2022, 2021 2020 The accompanying Consolidated Financial Statements include our accounts and those of our wholly owned subsidiaries. All intercompany accounts and transactions, including the intercompany portion of transactions with equity method investees, have been eliminated in consolidation. The Consolidated Financial Statements are presented in United States dollars (hereinafter “U.S. dollars” or “$”). Historically the consolidated financial statements were prepared in accordance with International Financial Reporting Standards (“IFRS”) as issued by the International Accounting Standards Board. For the Consolidated Financial Statements, we have prepared our consolidated financial statements in accordance with U.S. GAAP. The change from reporting in IFRS to U.S. GAAP was treated as a change in accounting standard, whereby we retrospectively applied the change to all prior reporting periods contained in these Consolidated Financial Statements. Where the initial adoption of U.S. GAAP resulted in a material change in an asset or liability, the adjustment was reported to the opening balance of accumulated deficit and additional paid-in capital as of January 1, 2020. 19 Certain prior year amounts have been reclassified to conform to the current year presentation. Emerging Growth Company We are an “emerging growth company,” as defined in Section 2 1933, 2012 not not 1934, not may not Liquidity Since our formation, we have devoted substantial effort and capital resources to the development of our satellite constellation and image technologies. As of December 31, 2022, December 31, 2022, December 31, 2022, We anticipate losses and negative operating cash flows to continue, primarily as a result of our satellite constellation expansion as we obtain adequate sources of funding through revenue growth. We believe we will have sufficient funding for at least the next 12 Failure to generate revenue growth with sufficient positive cash flows from operations or to raise additional funding in the longer term may

Note 2 - Summary of Significant

Note 2 - Summary of Significant Accounting Policies	9 Months Ended	12 Months Ended
	Sep. 30, 2023	Dec. 31, 2022
Notes to Financial Statements
Significant Accounting Policies [Text Block]	2. Use of Estimates The preparation of the Condensed Consolidated Financial Statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent liabilities at the date of the financial statements, and the reported amounts of revenue and expenses during the reporting period. Significant estimates and assumptions reflected in these Condensed Consolidated Financial Statements include, but are not may Revenue Recognition We recognize revenue in accordance with Topic 606, Revenue from contracts with customers. five Our main revenue stream is from services. We recognize as revenues, the amount of the transaction price that is allocated to the respective performance obligation when or as the performance obligation is satisfied. Revenue is recognized ratably over the subscription period or at the point in time upon delivery. Our satellite imagery can be delivered to customers in two The nature of our contracts does not not We evaluate contracts with a minimum purchase commitment to determine whether we expect to be entitled to a breakage amount. We consider the requirements on constraining estimates variable consideration. The following factors are evaluated when assessing the increased likelihood of a significant revenue reversal: (i) the amount of consideration is highly susceptible to factors outside our influence or control (e.g., volatility in a market, judgment of action of third not We exclude amounts collected on behalf of third Contract liabilities consist of payments received from customers, or such consideration that is contractually due, in advance of providing the product or performing services. We generally do not not may Fair Value Measurement Certain assets and liabilities are carried at fair value in accordance with U.S. GAAP. Valuation techniques used to measure fair value requires us to utilize observable and unobservable inputs. The hierarchy gives the highest priority to quoted prices in active markets for identical assets or liabilities (Level 1 3 one three first two • Level 1: • Level 2: • Level 3: Assets and liabilities recognized at fair value on a recurring basis in the Condensed Consolidated Financial Statements are re-assessed at the end of each reporting period to determine whether any transfers have occurred between levels in the hierarchy. For fair value disclosures, classes of assets and liabilities are based on the nature, characteristics and risks of the asset or liability and the level of the fair value hierarchy. Credit risk management Credit risk is the risk that a counterparty fails to discharge an obligation to us. We are exposed to credit risk from financial assets including cash, cash equivalents and restricted cash held at banks, trade and other receivables. The credit risk is managed based on our credit risk management policies and procedures. Credit risk of any entity doing business with us is systematically analyzed, including aspects of a qualitative nature. The measurement and assessment of our total exposure to credit risk covers all financial instruments involving any counterparty risk. The credit risk in respect of cash balances held with banks and deposits with banks are managed via diversification of bank deposits and are only with major reputable financial institutions. As our risk exposure is mainly influenced by the individual characteristics of each customer, we continuously analyze the creditworthiness of significant debtors. Accounts receivable are non-interest bearing and generally on terms of 30 90 September 30, 2023 two December 31, 2022, one Two customers accounted for more than 10% of our revenue totaling $0.9 million for the three September 30, 2023 one three September 30, 2022. nine September 30, 2023 nine September 30, 2022. The Company contracts with certain third Impairment of Assets We assess potential impairments to long-lived assets whenever events or changes in circumstances indicate that the carrying amount may not September 30, 2023 not Estimates of future cash flows are highly subjective judgments based on management’s experience and knowledge of the Company's operations. These estimates can be significantly impacted by many factors, including changes in global economic conditions, operating costs, obsolescence of technology and competition. If estimates or underlying assumptions change in the future, we may Equity Method Investments We account for equity investments in which we have significant influence, but not may not September 30, 2023. Stock-Based Compensation We measure and recognize all stock-based compensation expense based on estimated fair values for all stock-based awards made to employees and non-employees. Compensation cost is recognized over the requisite service period for each separate tranche, as though each tranche of the award is, in substance, a separate award. The expense calculation includes estimated forfeiture rates, which have been developed based upon historical experience. The fair values for stock options are calculated using the Black-Scholes option pricing model using the following inputs: Expected term - The simplified method is used to calculate the expected term. Expected volatility - We determine the expected stock price volatility based on the historical volatilities of guideline companies from comparable industries. Expected dividend yield - We do not not Risk-free interest rate - We base our interest rate on a treasury instrument for which the term is commensurate with the maximum expected life of the stock options. The fair values for restricted stock units ("RSUs") with service-based vesting conditions are calculated based upon our closing stock price on the date of the grant. Foreign Currencies The financial position and results of operations of certain of our foreign subsidiaries are measured using the local currency as the functional currency. Revenues and expenses of these subsidiaries have been translated into U.S. dollars at average exchange rates prevailing during the period. Assets and liabilities of these subsidiaries have been translated at the exchange rates as of the balance sheet date. Translation gains and losses are recorded in accumulated other comprehensive loss. Aggregate foreign currency gains and losses, such as those resulting from the settlement of receivables or payables, foreign currency contracts and short-term intercompany advances in a currency other than the relevant subsidiary’s functional currency, are recorded currently in the Condensed Consolidated Statements of Operations and Comprehensive Loss (included in other income, net) and resulted in gains of $1.8 million and $1.1 million during the three September 30, 2023 2022, nine September 30, 2023 2022, Leases We determine if a contract is a lease or contains a lease at inception. On the lease commencement date, we recognize a right-of-use (“ROU”) asset and lease liability related to operating type leases. The cost of ROU assets includes the amount of lease liabilities recognized, initial direct costs incurred, and lease payments made at or before the commencement date less any lease incentives received. Operating lease liabilities are recorded based on the present value of the future lease fixed payments. In determining the present value of future lease payments, we use our incremental borrowing rate applicable to the economic environment and the duration of the lease based on the information available at the commencement date as the majority of leases do not 12 not We remeasure and reallocate the consideration in a lease when there is a modification of the lease that is not We account for lease agreements with contractually required lease and non-lease components on a combined basis. Lease payments made for cancellable leases, variable amounts that are not 12 For the periods presented, the Company does not For the three September 30, 2023 2022, nine September 30, 2023 2022, September 30, 2023 December 31, 2022 nine September 30, 2023. Accounts Receivable and Allowance for Credit Losses Trade accounts receivable are stated at the amount owed by the customer, net of allowances for estimated credit losses, discounts, returns and rebates. We measure the allowance for credit losses based on the estimated loss. In calculating an allowance for credit losses, we use our historical experience, external indicators and an aging method. We assess impairment of trade accounts receivable on a collective basis as they possess shared credit risk characteristics, which have been grouped based on customer industry type. The Company also considers account size in its groupings and the days past due in its analysis. Accounts are written off against the allowance account when they are determined to be no nine September 30, 2023 2022: Nine Months Ended September 30, 2023 2022 Allowance for credit losses as of beginning of period $ 3,237 $ 1,794 Provision 80 1,736 Allowance for credit losses as of end of period $ 3,317 $ 3,530 Cash, Cash Equivalents and Restricted Cash Cash and cash equivalents include deposits in banks and short-term (original maturities of three three Restricted cash, including amounts in Other non-current assets, represents amounts pledged as guarantees for sales and lease agreements as contractually required. September 30, December 31, Cash and cash equivalents $ 30,971 $ 76,528 Restricted cash — 126 Restricted cash included in Other non-current assets 1,151 1,138 Total cash, cash equivalents and restricted cash $ 32,122 $ 77,792	2. Use of Estimates The preparation of the Consolidated Financial Statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent liabilities at the date of the financial statements, and the reported amounts of revenue and expenses during the reporting period. Significant estimates and assumptions reflected in these Consolidated Financial Statements include, but are not may Revenue Recognition We recognize revenue in accordance with Topic 606 Revenue from contracts with customers. five Our main revenue stream is from services. We recognize as revenues the amount of the transaction price that is allocated to the respective performance obligation when or as the performance obligation is satisfied. Generally, our performance obligations are transferred to customers at a point in time, typically upon delivery. Our satellite imagery can be delivered to customers in two The nature of our contracts does not not We evaluate contracts with a minimum purchase commitment to determine whether we expect to be entitled to a breakage amount. We consider the requirements on constraining estimates variable consideration. The following factors are evaluated when assessing the increased likelihood of a significant revenue reversal: (i) the amount of consideration is highly susceptible to factors outside our influence or control ( e.g., third not We exclude amounts collected on behalf of third Contract liabilities consist of payments received from customers, or such consideration that is contractually due, in advance of providing the product or performing services. We generally do not not may Fair Value Measurement Certain assets and liabilities are carried at fair value in accordance with U.S. GAAP. Valuation techniques used to measure fair value requires us to utilize observable and unobservable inputs. The hierarchy gives the highest priority to quoted prices in active markets for identical assets or liabilities (Level 1 3 one three first two • Level 1: • Level 2: • Level 3: Assets and liabilities recognized at fair value on a recurring basis in the Consolidated Financial Statements are re-assessed at the end of each reporting period to determine whether any transfers have occurred between levels in the hierarchy. For fair value disclosures, classes of assets and liabilities are based on the nature, characteristics and risks of the asset or liability and the level of the fair value hierarchy. Credit risk management Credit risk is the risk that a counterparty fails to discharge an obligation to us. We are exposed to credit risk from financial assets including cash, cash equivalents and restricted cash held at banks, trade and other receivables. The credit risk is managed based on our credit risk management policies and procedures. Credit risk of any entity doing business with us is systematically analyzed, including aspects of a qualitative nature. The measurement and assessment of our total exposure to credit risk covers all financial instruments involving any counterparty risk. The credit risk in respect of cash balances held with banks and deposits with banks are managed via diversification of bank deposits and are only with major reputable financial institutions. As our risk exposure is mainly influenced by the individual characteristics of each customer, we continuously analyze the creditworthiness of significant debtors. Accounts receivable are non-interest bearing and generally on terms of 30 90 Impairment of Assets We assess potential impairments to long-lived assets whenever events or changes in circumstances indicate that the carrying amount may not December 31, 2022, 2021 2020 not Estimates of future cash flows are highly subjective judgments based on management’s experience and knowledge of the Company's operations. These estimates can be significantly impacted by many factors, including changes in global economic conditions, operating costs, obsolescence of technology and competition. If estimates or underlying assumptions change in the future, we may Equity Method Investments We account for equity investments in which we have significant influence, but not may not December 31, 2022. not 2021 2020. Stock-Based Compensation We measure and recognize all stock-based compensation expense based on estimated fair values for all stock-based awards made to employees and non-employees. Compensation cost is recognized over the requisite service period for each separate tranche, as though each tranche of the award is, in substance, a separate award. The expense calculation includes estimated forfeiture rates, which have been developed based upon historical experience. The fair values for stock options are calculated using the Black-Scholes option pricing model using the following inputs: Expected term - Expected volatility - Expected dividend yield - not not Risk-free interest rate - The fair values for restricted stock units ("RSUs") with service-based vesting conditions are calculated based upon our closing stock price on the date of the grant. Foreign Currencies The financial position and results of operations of certain of our foreign subsidiaries are measured using the local currency as the functional currency. Revenues and expenses of these subsidiaries have been translated into U.S. dollars at average exchange rates prevailing during the period. Assets and liabilities of these subsidiaries have been translated at the exchange rates as of the balance sheet date. Translation gains and losses are recorded in accumulated other comprehensive loss. Aggregate foreign currency gains and losses, such as those resulting from the settlement of receivables or payables, foreign currency contracts and short-term intercompany advances in a currency other than the relevant subsidiary’s functional currency, are recorded currently in the Consolidated Statements of Operations and Comprehensive Loss (included in other income, net) and resulted in gains of $1,576, $1,022, and $594 during the years ended December 31, 2022, 2021, 2020, Leases We determine if a contract is a lease or contains a lease at inception. On the lease commencement date, we recognize a right-of-use (“ROU”) asset and lease liability related to operating type leases. The cost of ROU assets includes the amount of lease liabilities recognized, initial direct costs incurred, and lease payments made at or before the commencement date less any lease incentives received. Operating lease liabilities are recorded based on the present value of the future lease fixed payments. In determining the present value of future lease payments, we use our incremental borrowing rate applicable to the economic environment and the duration of the lease based on the information available at the commencement date as the majority of leases do not 12 not We remeasure and reallocate the consideration in a lease when there is a modification of the lease that is not We account for lease agreements with contractually required lease and non-lease components on a combined basis. Lease payments made for cancellable leases, variable amounts that are not 12 For the periods presented, we do not Accounts Receivable and Allowance for Doubtful Accounts Trade accounts receivable are stated at the amount owed by the customer, net of allowances for estimated doubtful accounts, discounts, returns and rebates. We measure the allowance for doubtful accounts based on the estimated loss. In calculating an allowance for doubtful accounts, we use our historical experience, external indicators and an aging method. We assess impairment of trade accounts receivable on a collective basis as they possess shared credit risk characteristics which have been grouped based on the days past due. Accounts are written off against the allowance account when they are determined to be no December 31, 2022 2021: December 31, 2022 2021 Allowance for doubtful accounts as of beginning of period $ 1,794 $ — Provision 1,736 1,794 Write-offs — — Foreign exchange and other (293 ) — Allowance for doubtful accounts as of end of period $ 3,237 $ 1,794 Cash, Cash Equivalents and Restricted Cash Cash and cash equivalents include deposits in banks and short-term (original maturities of three three Restricted cash, including amounts in Other non-current assets, represents amounts pledged as guarantees for sales and lease agreements as contractually required. December 31, 2022 2021 Cash and cash equivalents $ 76,528 $ 8,533 Restricted cash 126 — Restricted cash included in Other non-current assets 1,138 — Total cash, cash equivalents and restricted cash $ 77,792 $ 8,533 Cash Flow Information Year Ended December 31, 2022 2021 2020 Cash paid during the period for: Income tax, net of refunds $ 758 $ 96 $ 59 Interest $ 3,520 $ 49,283 $ 27,286

Note 3 - Accounting Standards U

Note 3 - Accounting Standards Updates (ASU)	9 Months Ended	12 Months Ended
	Sep. 30, 2023	Dec. 31, 2022
Notes to Financial Statements
Accounting Standards Update and Change in Accounting Principle [Text Block]	3. ASU ) Accounting Standard Recently Adopted In June 2016, No. 2016 13, 2016 13” 2016 13 January 1, 2023. not	3. ASU ) Accounting Standards Recently Adopted In May 2021, 2021 04, Earnings per Share (Topic 260 470 50 718 s Own Equity (Subtopic 815 40 December 15, 2021, January 1, 2022. not In January 2020, 2020 01, Investments Equity Securities (Topic 321 Equity Method and Joint Ventures (Topic 323 815 Clarifying the Interactions between Topic 321, 323, 815 December 15, 2021, January 1, 2022. not In December 2019, No. 2019 12, Income Taxes (Topic 740 2019 12” 2019 12 2019 12 December 15, 2021, December 15, 2022, January 1, 2022. not Accounting Standards Not In June 2016, No. 2016 13, Credit Losses - Measurement of Credit Losses on Financial Instruments 2016 13” 2016 13 January 1, 2023 not

Note 4 - Reverse Recapitalizati

Note 4 - Reverse Recapitalization	9 Months Ended	12 Months Ended
	Sep. 30, 2023	Dec. 31, 2022
Notes to Financial Statements
Reverse Recapitalization Disclosure [Text Block]	4. On January 25, 2022 no The transaction resulted in net cash proceeds of $168 million, after transaction expenses and debt repayment, through the contribution of cash held in CF V’s trust account, net of redemptions by CF V’s public stockholders, and a concurrent private placement offering led by SoftBank’s SBLA Advisers Corp. and Cantor Fitzgerald & Co. (“CF&Co.”), among other institutional investors, and the Liberty Investment, as defined and described further below. On the Closing Date, the Company consummated the Merger contemplated by the Merger Agreement, including the following: Private Placement ( PIPE ) Investment Pursuant to the relevant subscription agreement, the Company issued 5,816,770 Class A ordinary shares and a non-redeemable warrant (“PIPE Warrant”) to purchase 2,500,000 Class A ordinary shares to a PIPE investor at an exercise price of $20.00 per share, for an aggregate purchase price of $58.2 million. Forward Purchase Agreement In July 2021, Cantor Loan Satellogic and Cantor Fitzgerald Securities (“CF Securities”) entered into a Secured Promissory Note, dated December 23, 2021 ( January 18, 2022, Redeemable Series X Per the transaction, the 2,033,230 outstanding shares of redeemable Series X Liberty Investment On January 18, 2022, “$10.00 “$15.00 $10.00 February 10, 2022 ( An advisory fee is payable by Satellogic in exchange for advisory services to be provided to Satellogic from time to time until a Cessation Event (as defined in the Liberty Subscription Agreement). The advisory fee includes a warrant to purchase 2,500,000 of Satellogic’s Class A ordinary shares at an exercise price of $10.00 per share (the “Liberty Advisory Fee Warrant”), which was issued at the Liberty Closing, and for so long as a Cessation Event has not not five three 18 The Liberty Advisory Fee Warrant became exercisable as of and from February 10, 2023, fifth February 10, 2027). Transaction Fees On January 18, 2022, Company Stockholders In connection with the Merger Transaction: • the ordinary shares and preferred shares of Nettar that were issued and outstanding immediately prior to the Merger were automatically cancelled and ceased to exist in exchange for Satellogic’s Class A ordinary shares, as determined in accordance with the Merger Agreement; • all Convertible Notes of Nettar converted into Nettar Preferred Shares which were exchanged for shares of Satellogic’s Class A ordinary shares as determined in the Merger Agreement; • all options to purchase ordinary shares of Nettar were assumed by the Company and became options to purchase Satellogic’s Class A ordinary shares as determined in accordance with the Merger Agreement; • the Columbia Warrant (as defined below) outstanding immediately prior to the Merger became exercisable for that number of Satellogic’s Class A ordinary shares as determined in accordance with the Merger Agreement. The following table illustrates the shares issued to our stockholders after giving effect to the 3.3028 Exchange Ratio in accordance with the transactions contemplated by the Merger Agreement as of the Closing Date and the issuance of shares pursuant to the transactions described above: Company stockholders Shares Class A stockholders immediately prior to merger 17,215,336 Series A preferred stockholders 7,968,316 Series B preferred stockholders 4,597,928 Series B-1 preferred stockholders 2,171,399 2018 convertible noteholders 5,581,416 2019 convertible noteholders 7,846,333 2020 convertible noteholders 4,553,205 Redeemable Series X preferred stockholders 2,140,340 Liberty investors 20,000,000 PIPE investors 5,816,770 Shares issued for Cantor loan repayment 788,021 Shares issued to Sponsor under Forward Purchase Securities Agreement 1,250,000 Issuance of shares for transaction fees 2,058,229 CF V shares 6,837,354 88,824,647	4. On January 25, 2022, no The transaction resulted in net cash proceeds of $168 million, after transaction expenses and debt repayment, through the contribution of cash held in CF V’s trust account, net of redemptions by CF V’s public stockholders, and a concurrent private placement offering led by SoftBank’s SBLA Advisers Corp. and Cantor Fitzgerald & Co. (“CF&Co.”), among other institutional investors, and the Liberty Investment, as defined and described further below. On the Closing Date, the Company consummated the Merger contemplated by the Merger Agreement, including the following: Private Placement ( PIPE ) Investment Pursuant to the relevant subscription agreement, Satellogic issued 5,816,770 Class A ordinary shares and a non-redeemable warrant (“PIPE Warrant”) to purchase 2,500,000 Class A ordinary shares to a PIPE investor at an exercise price of $20.00 per share, for an aggregate purchase price of $58.2 million. Forward Purchase Agreement In July 2021, Cantor Loan Satellogic and Cantor Fitzgerald Securities (“CF Securities”) entered into a Secured Promissory Note, dated December 23, 2021 ( January 18, 2022, Redeemable Series X Per the transaction, the 2,033,230 outstanding shares of redeemable Series X Liberty Investment On January 18, 2022, “$10.00 “$15.00 $10.00 February 10, 2022 ( An advisory fee is payable by Satellogic in exchange for advisory services to be provided to Satellogic from time to time until a Cessation Event (as defined in the Liberty Subscription Agreement). The advisory fee includes a warrant to purchase 2,500,000 of Satellogic’s Class A ordinary shares at an exercise price of $10.00 per share (the “Liberty Advisory Fee Warrant”), which was issued at the Liberty Closing, and for so long as a Cessation Event has not not five three 18 The Liberty Advisory Fee Warrant became exercisable as of and from February 10, 2023, fifth February 10, 2027). Transaction Fees On January 18, 2022, Company Stockholders In connection with the Merger transaction: • the common stock and preferred stock of Nettar that were issued and outstanding immediately prior to the Merger were automatically canceled and ceased to exist in exchange for Satellogic’s Class A ordinary shares, as determined in accordance with the Merger Agreement; • all Convertible Notes of Nettar converted into Nettar Preferred Shares which were exchanged for shares of Satellogic’s Class A ordinary shares as determined in the Merger Agreement; • all options to purchase common stock of Nettar were assumed by the Company and became options to purchase Satellogic’s Class A ordinary shares as determined in accordance with the Merger Agreement; • the Columbia Warrant (as defined below) outstanding immediately prior to the Merger became exercisable for that number of Satellogic’s Class A ordinary shares as determined in accordance with the Merger Agreement. The following table illustrates the shares issued to our stockholders after giving effect to the 3.3028 Exchange Ratio in accordance with the transactions contemplated by the Merger Agreement as of the Closing Date and the issuance of shares pursuant to the transactions described above: Company stockholders Shares Class A stockholders immediately prior to merger 17,215,336 Series A preferred stockholders 7,968,316 Series B preferred stockholders 4,597,928 Series B-1 preferred stockholders 2,171,399 2018 convertible noteholders 5,581,416 2019 convertible noteholders 7,846,333 2020 convertible noteholders 4,553,205 Redeemable Series X preferred stockholders 2,140,340 Liberty investors 20,000,000 PIPE investors 5,816,770 Shares issued for Cantor loan repayment 788,021 Shares issued to Sponsor under Forward Purchase Securities Agreement 1,250,000 Issuance of shares for transaction fees 2,058,229 CF V shares 6,837,354 88,824,647

Note 5 - Revenue from Contracts

Note 5 - Revenue from Contracts with Customers	9 Months Ended	12 Months Ended
	Sep. 30, 2023	Dec. 31, 2022
Notes to Financial Statements
Revenue from Contract with Customer [Text Block]	5. As described below, during the three September 30, 2023 2022, nine September 30, 2023 2022, Three Months Ended September 30, Nine Months Ended September 30, 2023 2022 2023 2022 Revenue by timing Over time $ 413 $ — $ 1,236 $ 1,524 Point-in time 783 2,158 3,144 3,022 Total revenue $ 1,196 $ 2,158 $ 4,380 $ 4,546 Information about the Company’s revenue by geography is as follows: Three Months Ended September 30, Nine Months Ended September 30, 2023 2022 2023 2022 Revenue by geography (1) (2) Asia Pacific $ 82 $ 232 $ 351 $ 1,946 Europe 513 43 1,506 80 North America 588 1,817 2,467 2,435 South America 13 66 56 85 Total revenue $ 1,196 $ 2,158 $ 4,380 $ 4,546 ( 1 Revenue by geography is based on the geographical location of the customer. ( 2 Certain comparative figures have been reclassified to conform to the current year presentation. Contract liabilities and Remaining Performance Obligations Our contract liabilities consist of payments received from customers, or such consideration contractually due, in advance of providing the relevant satellite imagery or related service. Amounts included in Contract liabilities are as follows: September 30, December 31, 2023 2022 Non-current $ 1,000 $ 1,000 Current 3,286 1,941 Total $ 4,286 $ 2,941 During the nine September 30, 2023, December 31, 2022. nine September 30, 2022, December 31, 2021. A contract’s transaction price is allocated to each distinct performance obligation and recognized as revenue when, or as, the performance obligation is satisfied. The following table represents the total transaction price for the remaining performance obligations as of September 30, 2023 12 Within 1 Year Years 2 Years 3 Thereafter Remaining performance obligations $ 6,852 $ 5,648 $ 5,005 $ 1,000	5. During the year ended December 31, 2022, December 31, 2021, not 2020. Information about our revenue by geography is as follows: Year Ended December 31, 2022 2021 Revenue by geography (1) Asia Pacific $ 1,531 $ 3,988 North America 3,438 201 Other 1,043 58 Total revenue $ 6,012 $ 4,247 ( 1 Revenue by geography is based on the geographical location of the customer. Two December 31, 2022. December 31, 2021. Contract Liabilities and Remaining Performance Obligations Our contract liabilities consist of payments received from customers, or such consideration contractually due, in advance of providing the relevant satellite imagery or related service. Amounts included in Contract liabilities are as follows: December 31, 2022 2021 Non-current $ 1,000 $ 1,000 Current 1,941 935 Total $ 2,941 $ 1,935 During the year ended December 31, 2022, December 31, 2021. December 31, 2021, December 31, 2020. A contract’s transaction price is allocated to each distinct performance obligation and recognized as revenue when, or as, the performance obligation is satisfied. The following table represents the total transaction price for the remaining performance obligations as of December 31, 2022 12 Within 1 Year Years 1-2 Years 2-3 Thereafter Remaining performance obligations $ 6,422 $ 11,296 $ 3,860 $ —

Note 6 - Warrant Liabilities

Note 6 - Warrant Liabilities	9 Months Ended	12 Months Ended
	Sep. 30, 2023	Dec. 31, 2022
Notes to Financial Statements
Warrant Liabilities Disclosure [Text Block]	6. Liberty Warrants and Liberty Advisory Fee Warrant PIPE Warrant $8.63 Warrants Total Warrants As of December 31, 2022 $ 6,191 $ 311 $ 1,833 $ 8,335 Warrants issued $ — $ — $ — $ — Change in fair value of financial instruments (5,009 ) (252 ) (1,129 ) (6,390 ) As of September 30, 2023 $ 1,182 $ 59 $ 704 $ 1,945 Liberty Warrants and Liberty Advisory Fee Warrant The Liberty Warrants and the Liberty Advisory Fee Warrant were initially recognized as a liability with a fair value of $30.9 million. The Liberty Warrants and the Liberty Advisory Fee Warrant remain unexercised and were remeasured to fair value of $1.2 million as of September 30, 2023. PIPE Warrant The PIPE Warrant was initially recognized as a liability with a fair value of $1.3 million. The PIPE Warrant remains unexercised and was remeasured to fair value of $59 thousand as of September 30, 2023. $8.63 Warrants In connection with the Merger, we entered into an Assignment, Assumption and Amendment Agreement (the “Amended Warrant Agreement”), dated January 25, 2022 January 28, 2021. Pursuant to the Existing Warrant Agreement we issued Public Warrants to purchase 8,333,333 Class A ordinary shares and 200,000 Private Placement Warrants. Additionally, we agreed to issue the Forward Purchase Warrant to purchase 333,333 Class A ordinary shares pursuant to the Amended and Restated Forward Purchase Agreement (together, with the Public Warrants and the Private Placement Warrants, the “$8.63 All of the $8.63 Warrants are governed by the Existing Warrant Agreement. The $8.63 Warrants became exercisable 30 February 25, 2022, five January 25, 2027), The $8.63 Warrants were initially recognized as a liability with a fair value of $4.9 million. On April 1, 2022, January 28, 2021, January 25, 2022, Public Warrants to purchase 613,111 shares of Class A ordinary shares were exercised during the nine September 30, 2022.	6. Liberty Warrants and Liberty Advisory Fee Warrant PIPE Warrant Columbia Warrant $8.63 Warrants Total Warrant Liabilities As of December 31, 2021 $ — $ — $ 143,237 $ — $ 143,237 Warrants issued $ 30,853 $ 1,312 $ — $ 4,872 $ 37,037 Change in fair value of financial instruments (24,662 ) (1,001 ) (18,635 ) (2,702 ) (47,000 ) Write-off of deferred costs — — 203 — 203 Settlements — — — (337 ) (337 ) Reclassification to equity — — (124,805 ) — (124,805 ) As of December 31, 2022 $ 6,191 $ 311 $ — $ 1,833 $ 8,335 Liberty Warrants and Liberty Advisory Fee Warrant The Liberty Warrants and the Liberty Advisory Fee Warrant were initially recognized as a liability with a fair value of $30.9 million. The Liberty Warrants and the Liberty Advisory Fee Warrant remain unexercised and were remeasured to fair value of $6.2 million as of December 31, 2022. PIPE Warrant The PIPE Warrant was initially recognized as a liability with a fair value of $1.3 million. The PIPE Warrant remains unexercised and was remeasured to fair value of $0.3 million as of December 31, 2022. Columbia Warrant In March 2021, The Columbia Warrant is exercisable the earlier of 25 years from the effective date or the date in which the warrant is exercised in full. The Columbia Warrant was initially recognized on March 8, 2021 December 31, 2021. December 31, 2022. $8.63 Warrants In connection with the Merger, we entered into an Assignment, Assumption and Amendment Agreement (the “Amended Warrant Agreement”), dated January 25, 2022, January 28, 2021. Pursuant to the Existing Warrant Agreement, we issued Public Warrants to purchase 8,333,333 Class A ordinary shares and 200,000 private placement Warrants. Additionally, we agreed to issue the Forward Purchase Warrant to purchase 333,333 Class A ordinary shares pursuant to the Amended and Restated Forward Purchase Agreement (together, with the Public Warrants and the private placement Warrants, the “$8.63 All of the $8.63 Warrants are governed by the Existing Warrant Agreement. The $8.63 Warrants became exercisable 30 February 25, 2022, five January 25, 2027), The $8.63 Warrants were initially recognized as a liability with a fair value of $4.9 million. On April 1, 2022, January 28, 2021, January 25, 2022, Public Warrants to purchase 613,111 Class A ordinary shares were exercised during the year ended December 31, 2022.

Note 7 - Earnout Liabilities

Note 7 - Earnout Liabilities	9 Months Ended	12 Months Ended
	Sep. 30, 2023	Dec. 31, 2022
Notes to Financial Statements
Earnout Liability [Text Block]	7. Sponsor Earnout As of December 31, 2022 $ 1,353 Change in fair value of financial instruments (1,130 ) As of September 30, 2023 $ 223 Sponsor Earnout Pursuant to that certain Sponsor Support Agreement, dated as of July 5, 2021, five not 30% no 10 20 not nine September 30, 2023. not The estimated fair value of the Sponsor Earnout liability is based on a Monte Carlo simulation valuation model using a distribution of potential outcomes on a semi-annual basis over the earnout period, using the most reliable information available. Assumptions used in the valuation are as follows: September 30, 2023 December 31, 2022 Expected term (in years) 3.32 4.07 Dividend yield (%) — % — % Expected volatility 67.3 % 50.4 % Risk-free interest rate 4.8 % 4.1 % Expected number of shares 1,775,962 1,775,962 Forfeiture Earnout In connection with the closing of the Merger (the “Closing”), we delivered 310,127 shares of our Class A ordinary shares to an escrow account (“Forfeiture Escrow Shares”). The Forfeiture Escrow Shares were held in escrow for a 30 five 10 20 not The shares were forfeited because the VWAP was below $10.00. The Forfeiture Earnout was initially recognized as a liability with a fair value of $6.1 million. The liability was remeasured to a fair value of $1.0 million at the end of the adjustment period and reclassified as an equity instrument.	7. Sponsor Earnout Forfeiture Earnout Total Earnout Liabilities As of December 31, 2021 $ — $ — $ — Additions $ 8,022 $ 6,135 $ 14,157 Change in fair value of financial instruments (6,669 ) (5,130 ) (11,799 ) Reclassification to equity — (1,005 ) (1,005 ) As of December 31, 2022 $ 1,353 $ — $ 1,353 Sponsor Earnout Pursuant to that certain Sponsor Support Agreement, dated as of July 5, 2021, five not 30% no 10 20 not December 31, 2022. not The estimated fair value of the Sponsor Earnout liability is based on a Monte Carlo simulation valuation model using a distribution of potential outcomes on a semi-annual basis over the earnout period, using the most reliable information available. Assumptions used in the valuation are as follows: January 25, December 31, 2022 2022 Expected term (in years) 5.00 4.07 Dividend yield (%) — — Expected volatility 30 % 50.4 % Risk-free interest rate 1.6 % 4.1 % Expected number of shares 1,842,759 1,775,962 Forfeiture Earnout In connection with the closing of the Merger (the “Closing”), we delivered 310,127 shares of our Class A ordinary shares to an escrow account (“Forfeiture Escrow Shares”). The Forfeiture Escrow Shares were held in escrow for a 30 five 10 20 not The shares were forfeited because the VWAP was below $10.00. The Forfeiture Earnout was initially recognized as a liability with a fair value of $6.1 million. The liability was remeasured to a fair value of $1.0 million at the end of the adjustment period and reclassified as an equity instrument. SATELLOGIC INC. Notes to Consolidated Financial Statements (in thousands of U.S. dollars, except share and per share information, unless otherwise stated)

Note 8 - Property and Equipment

Note 8 - Property and Equipment	9 Months Ended	12 Months Ended
	Sep. 30, 2023	Dec. 31, 2022
Notes to Financial Statements
Property, Plant and Equipment Disclosure [Text Block]	8. Property and equipment, net consists of the following: Estimated Useful Life (in years) September 30, December 31, Satellites and other equipment 3 - 5 $ 68,369 $ 54,370 Satellites under construction Not applicable 16,032 22,194 Leasehold improvements 5 - 10 7,601 6,433 Other property and equipment 3 - 10 4,227 4,146 Total property and equipment 96,229 87,143 Less: Accumulated depreciation (53,501 ) (39,162 ) Property and equipment, net $ 42,728 $ 47,981 Information related to the Company’s property and equipment and operating lease ROU assets by geography is as follows: September 30, December 31, Uruguay $ 37,991 $ 43,134 Argentina 930 1,346 Spain 828 729 Netherlands 11,820 9,471 Other countries 490 1,472 Total (1) (2) (3) $ 52,059 $ 56,152 ( 1 Non-current assets include property and equipment, net and operating lease right-of-use assets. ( 2 Presentation in the table is based on the geographic location of the entity that holds the assets. ( 3 We do not	8. Property and equipment, net consists of the following: December 31, Estimated Useful Life (in years) 2022 2021 Satellites in orbit 3 $ 54,370 $ 43,716 Satellites under construction Not applicable 22,194 10,558 Leasehold improvements 5 - 10 6,433 769 Other property and equipment 3 - 10 4,146 2,138 Total property and equipment 87,143 57,181 Less: Accumulated depreciation (39,162 ) (24,651 ) Property and equipment, net $ 47,981 $ 32,530 Provisions for depreciation are based on estimated useful lives of the assets using the straight-line method. Information related to our property and equipment and operating lease ROU assets by geography is as follows: December 31, 2022 2021 Uruguay $ 43,134 $ 33,208 Argentina 1,346 1,250 Spain 729 791 Netherlands 9,471 — Other countries 1,472 236 Total (1) (2) (3) $ 56,152 $ 35,485 ( 1 Non-current assets include property and equipment, net and operating lease right-of-use assets. ( 2 The presentation in the table above is based on the geographic location of the entity that holds the assets. ( 3 We do not

Note 9 - Additional Financial S

Note 9 - Additional Financial Statement Information	9 Months Ended	12 Months Ended
	Sep. 30, 2023	Dec. 31, 2022
Notes to Financial Statements
Additional Financial Information Disclosure [Text Block]	9. Prepaid Expenses and Other Current Assets September 30, December 31, 2023 2022 Prepaid expenses and other current assets Prepaid expenses $ 2,604 $ 1,767 Advances to suppliers 228 588 Other current assets 413 843 Total $ 3,245 $ 3,198 Accrued Expenses and Other Liabilities September 30, December 31, 2023 2022 Accrued expenses and other liabilities Provisions 66 71 Payroll and benefits payable 2,111 3,289 Other taxes payable 5,373 3,128 Other 430 451 Total $ 7,980 $ 6,939 Total current $ 7,481 $ 6,417 Total non-current $ 499 $ 522 Finance Costs, net Three Months Ended September 30, Nine Months Ended September 30, 2023 2022 2023 2022 Finance income (expense), net Interest expense $ — $ (9 ) $ (3 ) $ (1,597 ) Redeemable Series X preferred stock dividends — — — (97 ) Other finance costs (38 ) (29 ) (103 ) (99 ) Interest income 427 419 1,577 568 Total $ 389 $ 381 $ 1,471 $ (1,225 )	9. Prepaid Expenses and Other Current Assets December 31, 2022 2021 Prepaid expenses and other current assets Prepaid expenses $ 1,767 $ 1,153 Advances to suppliers 588 829 Other current assets 843 713 Total $ 3,198 $ 2,695 Accrued Expenses and Other Liabilities December 31, 2022 2021 Accrued expenses and other liabilities Accrued professional fees related to Merger (1) $ — $ 16,263 Provisions 71 2,934 Payroll and benefits payable 3,289 2,545 Other taxes payable 3,128 2,045 Other 451 2,200 Total $ 6,939 $ 25,987 Total current $ 6,417 $ 23,435 Total non-current $ 522 $ 2,552 ( 1 Refer to Note 4 Finance Costs, Net Year Ended December 31, 2022 2021 2020 Finance costs, net Interest expense $ (1,596 ) $ (8,729 ) $ (43 ) Redeemable Series X preferred stock dividends (97 ) (974 ) — Other finance costs (123 ) (71 ) — Interest income 1,164 36 78 Total $ (652 ) $ (9,738 ) $ 35

Note 10 - Income Tax

Note 10 - Income Tax	9 Months Ended	12 Months Ended
	Sep. 30, 2023	Dec. 31, 2022
Notes to Financial Statements
Income Tax Disclosure [Text Block]	10. The Company is incorporated in the BVI. The BVI does not The components of income tax expense were as follows: Three Months Ended September 30, Nine Months Ended September 30, 2023 2022 2023 2022 Loss before income tax $ (13,550 ) $ (11,840 ) $ (41,277 ) $ (17,818 ) Provision for income tax 4,069 2,983 $ 6,193 $ 5,126 Effective tax rate (30.0 %) (25.2 %) (15.0 %) (28.8 %) Our effective tax rate for the nine September 30, 2023 0%. 740 270 30 36 Accounting for Income Taxes not nine September 30, 2023 2022. The Company recognizes uncertain income tax positions when it is not not September 30, 2023, A reconciliation of the beginning and ending amounts of our gross unrecognized tax benefits is as follows: Nine Months Ended September 30, 2023 Balance at January 1, 2023 $ 3,889 Increases (decreases) in tax positions related to prior periods (1,974 ) Balance at September 30, 2023 $ 1,915 The Company believes that it is reasonably possible that a decrease of up to $0.2 million in unrecognized tax benefits related to foreign exposures may	10. We are incorporated in the BVI. See Item 10.E, December 31, 2022, 2021 2020 Year Ended December 31, 2022 2021 2020 Current $ 2,972 $ 1,387 $ 186 Deferred 1,601 (1,619 ) (38 ) Total provision for (benefit from) income tax $ 4,573 $ (232 ) $ 148 We maintain the exception under ASC 740 270 30 36 Accounting for Income Taxes not As of December 31, 2022, A reconciliation of the beginning and ending amounts of our gross unrecognized tax benefits is as follows. Year Ended December 31, 2022 Balance at January 1 $ — Increases (decreases) in tax positions related to the current period — Increases (decreases) in tax positions related to prior periods 3,889 Increases (decreases) related to prior year tax positions as a result of lapse of statute — Balance at December 31 $ 3,889 We did not 2021 2020. The BVI does not December 31, 2022, 2021 2020: Year Ended December 31, 2022 2021 2020 Loss before income tax $ (32,068 ) $ (96,537 ) $ (21,381 ) Provision for (benefit from) income tax at weighted-average statutory rates — — — U.S. state and local income tax, net of federal benefit (3 ) 5 (4 ) U.S. foreign-derived intangible income deduction (141 ) (200 ) — Argentina Tax Inflation Adjustment 239 (381 ) (198 ) Change in valuation allowances 4,283 3,648 1,198 Uncertain tax positions 2,293 — — Change in carryforward attributes (1,740 ) — — Effect of rates different than statutory (423 ) (3,300 ) (828 ) Tax credits (112 ) — — Other 177 (4 ) (20 ) Total $ 4,573 $ (232 ) $ 148 The change in the effective tax rate from December 31, 2021 December 31, 2022 three Deferred tax assets and liabilities as of December 31, 2022 2021 December 31, 2022 2021 Deferred income tax assets: Stock-based compensation $ 3,023 $ 2,053 Bad debt expense 415 407 Deferred financing costs 806 — Other 193 419 Net operating loss carryforwards 1,365 6,245 Total deferred income tax assets 5,802 9,124 Valuation allowance (5,802 ) (7,484 ) Total deferred income tax assets (liabilities), net $ — $ 1,640 The assessment of the realizability of the deferred income tax assets is based on all available positive and negative evidence. Such evidence includes, but is not not Below is a summary of our estimated loss and tax credit carryforwards at December 31, 2022. may 382 383. Net Operating Loss Expiration Gross Amount Carried Forward Net Amount Recognized as of December 31, 2022 Argentina December 31, 2023 - December 31, 2027 $ 7,864 $ — Netherlands Indefinite 2,856 — China December 31, 2026 - December 31, 2027 2,258 — United States Indefinite 280 — Uruguay December 31, 2026 - December 31, 2027 19 — As of December 31, 2022 2021, In the normal course of business, we are subject to examination by taxing authorities. Tax years vary by jurisdiction, ranging from 2017 2022

Note 11 - Stockholders' Equity

Note 11 - Stockholders' Equity	9 Months Ended	12 Months Ended
	Sep. 30, 2023	Dec. 31, 2022
Notes to Financial Statements
Equity [Text Block]	11. Equity Reverse Recapitalization The Condensed Consolidated Statements of Redeemable Preferred Stock and Stockholders’ Equity reflect the Merger and reverse recapitalization as of January 2022 4 Preferred Stock Prior to the Merger, the Company’s authorized and issued preferred stock consisted of the following: Authorized Shares (prior to Merger) Issued and Outstanding Shares (as of December 31, 2021) Series A preferred stock 4,723,330 2,547,330 Series B preferred stock 3,117,915 1,392,131 Series B-1 preferred stock 899,153 672,524 Total preferred stock 8,740,398 4,611,985 In connection with the Merger, all shares of preferred stock were converted to shares of Class A ordinary shares. Preferred Stockholder Transaction In March 2021, The Columbia Warrant was initially recognized as a liability. The fair value of the Columbia Warrant was reclassified to additional paid-in capital in connection with the Merger. Common Stock We are authorized to issue unlimited Class A ordinary shares with a par value of $0.0001 per share. Holders of Class A ordinary shares are entitled to one September 30, 2023, In addition, we are authorized to issue unlimited shares of Class B ordinary shares with a par value of $0.0001 per share. Holders of Class B ordinary shares are entitled to 1.472467906 Holders of Class B ordinary shares have a number of votes per share equal to the number of votes controlled by the Liberty Investor. Class B ordinary shares will automatically convert to Class A ordinary shares at the five Treasury Stock On February 14, 2022, may We repurchased 516,123 Class A ordinary shares for $2.7 million during the nine September 30, 2022. not nine September 30, 2023. Hannover Holdings Transaction We repurchased 51,700 Class A ordinary shares, 134,735 shares of Series A preferred stock, and 15,082 shares of Series B- 1	11. Equity (Deficit) Reverse Recapitalization The Consolidated Statements of Redeemable Preferred Stock and Stockholders’ Equity (Deficit) reflect the Merger and reverse recapitalization as of January 2022 4 Preferred Stock Prior to the Merger, our authorized and issued preferred stock consisted of the following: Authorized Shares (prior to Merger) Issued and Outstanding Shares (as of December 31, 2021) Series A preferred stock 4,723,330 2,547,330 Series B preferred stock 3,117,915 1,392,131 Series B-1 preferred stock 899,153 672,524 Total preferred stock 8,740,398 4,611,985 In connection with the Merger, all shares of preferred stock were converted to shares of Class A ordinary shares. Preferred Stockholder Transaction In March 2021, 17 The Columbia Warrant was initially recognized as a liability. The fair value of the Columbia Warrant was reclassified to additional paid-in capital in connection with the Merger. See Note 6 Common Stock Our registration statement was filed on May 2, 2022 May 9, 2022. We are authorized to issue unlimited Class A ordinary shares with a par value of $0.0001 per share. Holders of Class A ordinary shares are entitled to one December 31, 2022, In addition, we are authorized to issue unlimited Class B ordinary shares with a par value of $0.0001 per share. Holders of Class B ordinary shares are entitled to 1.472467906 Holders of Class B ordinary shares have a number of votes per share equal to the number of votes controlled by the Liberty Investor. Class B ordinary shares will automatically convert to Class A ordinary shares at the five Treasury Stock On February 14, 2022, may We repurchased 516,123 Class A ordinary shares for $2.7 million during the year ended December 31, 2022. Hannover Holdings Transaction We repurchased 51,700 Class A ordinary shares, 134,735 shares of Series A preferred stock, and 15,082 shares of Series B- 1

Note 12 - Stock-based Compensat

Note 12 - Stock-based Compensation	9 Months Ended	12 Months Ended
	Sep. 30, 2023	Dec. 31, 2022
Notes to Financial Statements
Share-Based Payment Arrangement [Text Block]	12. Our employees, including senior executives, receive incentives in the form of stock options and RSUs, whereby employees render services as consideration for equity instruments (equity-settled transactions). On the Closing Date, we established the Equity Incentive Plan, under which RSUs were issued. The Equity Incentive Plan provides for grant of options, stock appreciation rights, restricted stock awards, RSUs, shares granted as a bonus or in lieu of another award, dividend equivalents, or other stock-based awards or performance awards at the discretion of a board-elected committee. We also maintain our 2015 “2015 four December 31, 2022, no 2015 nine September 30, 2023 2022. A summary of stock option activity for the nine September 30, 2023 Number Weighted- Average Exercise Price Weighted- Average Remaining Contractual Term (years) Intrinsic Value (in thousands) Balance as of December 31, 2022 6,067,313 $ 1.83 2.07 Forfeited (425,178 ) 3.98 Exercised (186,307 ) 1.13 Expired (177,430 ) 2.27 Outstanding at September 30, 2023 5,278,398 $ 1.61 1.78 $ 1,041 Exercisable at September 30, 2023 4,594,898 $ 1.40 1.71 $ 1,000 As further detailed in Note 4 no nine September 30, 2023 2022. A summary of RSU activity for the nine September 30, 2023 Number of RSUs Intrinsic value (in thousands) Outstanding unvested RSUs at December 31, 2022 1,459,280 Granted during the year 3,369,167 Forfeited during the year (559,809 ) Vested during the year (494,287 ) Outstanding unvested RSUs at September 30, 2023 3,774,351 $ 4,416 The weighted-average grant-date price of RSUs at September 30, 2023 As of September 30, 2023, Stock-based Compensation Expense Total employee and non-employee stock-based compensation expense for the nine September 30, 2023 2022 Three Months Ended September 30, Nine Months Ended September 30, 2023 2022 2023 2022 General and administrative expenses $ 884 $ 554 $ 2,714 $ 2,240 Research and development expenses 312 781 933 1,753 Other operating expenses 218 804 607 2,631 Total $ 1,414 $ 2,139 $ 4,254 $ 6,624	12. Our employees, including senior executives, receive incentives in the form of stock options and RSUs, whereby employees render services as consideration for equity instruments (equity-settled transactions). On the Closing Date, we established the Equity Incentive Plan, under which RSUs were issued during the year ended December 31, 2022. 2015 “2015 four December 31, 2022, no 2015 December 31, 2022. A summary of stock option activity for the year ended December 31, 2022 Number Weighted-Average Exercise Price Weighted-Average Remaining Contractual Term (years) Intrinsic Value (in thousands) Balance as of December 31, 2021 6,864,563 $ 2.05 2.36 Granted — — Forfeited (574,299 ) 4.56 Exercised (102,825 ) 1.12 Expired (120,126 ) 2.60 Outstanding at December 31, 2022 6,067,313 $ 1.83 2.07 $ 10,818 Exercisable at December 31, 2022 4,449,152 $ 1.31 1.92 $ 8,832 The total intrinsic value of options exercised during the years ended December 31, 2022, 2021 2020 The following table lists the inputs used under the Black-Scholes model for stock-option awards during the years ended December 31, 2022, 2021, 2020, Year Ended December 31, 2022 2021 2020 Weighted-average fair value of options at the measurement date (grant date) $ — $23.36 $6.31 Dividend yield (%) — — — Expected volatility (%) — % 61 - 72 59 - 61 Risk-free interest rate (%) — % 0.5 - 1.4 0.4 - 0.5 Weighted average share price $ — $6.79 $2.75 As further detailed in Note 4 no December 31, 2022, 2021, 2020. A summary of RSU activity for the year ended December 31, 2022 Number Intrinsic Value (in thousands) Outstanding unvested RSUs at December 31, 2021 — Granted during the year 1,640,496 Forfeited during the year (60,823 ) Vested during the year (120,393 ) Expired during the year — Outstanding unvested RSUs at December 31, 2022 1,459,280 $ 1,940 The weighted-average exercise price of RSUs at December 31, 2022 As of December 31, 2022, Stock-based Compensation Expense Total employee and non-employee stock-based compensation expense for the years ended December 31, 2022, 2021, 2020 Year Ended December 31, 2022 2021 2020 General and administrative expenses $ 2,406 $ 5,274 $ 1,235 Research and development 3,631 1,968 382 Other operating expenses 2,331 3,639 115 Total $ 8,368 $ 10,881 $ 1,732

Note 13 - Redeemable Preferred

Note 13 - Redeemable Preferred Stock	9 Months Ended	12 Months Ended
	Sep. 30, 2023	Dec. 31, 2022
Notes to Financial Statements
Redeemable Preferred Stock [Text Block]	13. Reverse Recapitalization The redeemable Series X X X Upon the closing of the Merger (“Closing”), we cancelled and converted all 2,033,230 shares of issued and outstanding redeemable Series X As of September 30, 2023, X	13. Reverse Recapitalization The redeemable Series X X X Upon Closing, we canceled and converted all 2,033,230 shares of issued and outstanding redeemable Series X As of December 31, 2022, X

Note 14 - Net Loss Per Share

Note 14 - Net Loss Per Share	9 Months Ended	12 Months Ended
	Sep. 30, 2023	Dec. 31, 2022
Notes to Financial Statements
Earnings Per Share [Text Block]	14. The weighted-average number of shares of common stock outstanding prior to the Merger have been retroactively adjusted by the Exchange Ratio of 3.3028 (“Exchange Ratio”) to give effect to the reverse recapitalization treatment of the Merger. Shares of common stock issued as a result of redeemable Series X Diluted loss per share considers the impact of potentially dilutive securities. We identified financial instruments that qualify as potential common shares: (i) the share-based options awards described in Note 12 6 7 2022, The Columbia Warrant was dilutive due to the change in fair value of financial instruments during the nine September 30, 2022. Basic and diluted net loss per share attributable to common stockholders is calculated as follows: Three Months Ended September Nine Months Ended September 2023 2022 2023 2022 Net loss attributable to common stockholders $ (17,619 ) $ (14,823 ) $ (47,470 ) $ (22,944 ) Basic weighted-average common shares outstanding 89,739,310 89,002,430 89,476,065 81,221,550 Basic net loss per share for the period attributable to common stockholders $ (0.20 ) $ (0.17 ) $ (0.53 ) $ (0.28 ) Effect of dilutive securities: Net loss attributable to common stockholders $ (17,619 ) $ (14,823 ) $ (47,470 ) $ (22,944 ) Adjustment to numerator - Change in fair value of Columbia Warrant liability — (18,635 ) $ — $ (18,635 ) Dilutive numerator $ (17,619 ) $ (33,458 ) $ (47,470 ) $ (41,579 ) Columbia Warrant — 1,410,657 — 1,410,657 Diluted weighted-average common shares 89,739,310 90,413,087 89,476,065 82,632,207 Diluted net loss per share for the period attributable to common stockholders $ (0.20 ) $ (0.37 ) $ (0.53 ) $ (0.50 ) 1 4	14. The weighted-average number of shares of common stock outstanding prior to the Merger have been retroactively adjusted by the Exchange Ratio of 3.3028 (“Exchange Ratio”) to give effect to the reverse recapitalization treatment of the Merger. Shares of common stock issued as a result of redeemable Series X Diluted loss per share considers the impact of potentially dilutive securities. We identified financial instruments that qualify as potential common shares: (i) the share-based options awards described in Note 12 6 7 The Columbia Warrant was dilutive due to the change in fair value of financial instruments during the years ended December 31, 2022 2021. Basic and diluted net loss per share attributable to common stockholders is calculated as follows: Year Ended December 31, 2022 2021 2020 Net loss attributable to common stockholders $ (36,641 ) $ (96,305 ) $ (21,529 ) Basic weighted-average common shares outstanding (1) 83,188,276 16,655,634 16,029,826 Basic loss per share for the period attributable to common stockholders $ (0.44 ) $ (5.78 ) $ (1.34 ) Effect of dilutive securities: Adjustment to numerator - Change in fair value of Columbia Warrant liability $ (18,635 ) $ — $ — Dilutive numerator $ (55,276 ) $ (96,305 ) $ (21,529 ) Columbia Warrant 609,873 — — Diluted weighted-average common shares outstanding 83,798,149 16,655,634 16,029,826 Diluted loss per share for the period attributable to common stockholders $ (0.66 ) $ (5.78 ) $ (1.34 ) 1 4 Additionally, the following securities were not Year Ended December 31, 2022 2021 2020 Warrants 49,184,868 15,931,360 — Sponsor earnout shares 1,775,962 — — Stock options 6,067,313 6,864,563 4,694,314 Restricted stock units 1,459,280 — — Redeemable convertible preferred stock — 6,645,215 8,740,398 Total 58,487,423 29,441,138 13,434,712

Note 15 - Fair Value Measuremen

Note 15 - Fair Value Measurement and Financial Instruments	9 Months Ended	12 Months Ended
	Sep. 30, 2023	Dec. 31, 2022
Notes to Financial Statements
Fair Value Disclosures [Text Block]	15. The following tables provide the fair value measurement hierarchy of the Company’s assets and liabilities: As of September 30, 2023 Fair value measurement using Financial instruments Quoted prices in active markets (Level 1) Significant observable inputs (Level 2) Significant unobservable inputs (Level 3) $8.63 Warrants liability $ 704 $ — $ — PIPE Warrant liability — — 59 Liberty Warrants and Liberty Advisory Fee Warrant liability — — 1,182 Total Warrant Liabilities $ 704 $ — $ 1,241 Sponsor Earnout Liability $ — $ — $ 223 As of December 31, 2022 Fair value measurement using Financial instruments Quoted prices in active markets (Level 1) Significant observable inputs (Level 2) Significant unobservable inputs (Level 3) $8.63 Warrants liability $ 1,833 $ — $ — PIPE Warrant liability — — 311 Liberty Warrants and Liberty Advisory Fee Warrant liability — — 6,191 Total Warrant Liabilities $ 1,833 $ — $ 6,502 Sponsor Earnout Liability $ — $ — $ 1,353 The following methods and assumptions were used to estimate the fair values: • The carrying values of cash and cash equivalents, restricted cash, accounts receivable, prepaid expenses and other current assets, accounts payable, and accrued expenses and other liabilities are considered to approximate their fair values due to the short term nature of these items. • The fair values of the PIPE Warrant, the Liberty Warrants and Liberty Advisory Fee Warrant have been estimated using the Black-Scholes model. Significant unobservable inputs include: ◦ Time to expiry - 3.4 years ◦ Volatility - 67% ◦ Risk free rate of return: 4.8% • The fair values of the Sponsor Earnout has been estimated using the Monte Carlo model. Significant unobservable inputs include: ◦ Time to expiry - 3.3 years ◦ Volatility - 67% ◦ Risk free rate of return: 4.8% • The fair values of the $8.63 • The carrying value of operating lease liabilities is calculated as the present value of lease payments, discounted at its incremental borrowing rate at the lease commencement date. We consider that the incremental borrowing rate remained unchanged, therefore the carrying amount of operating lease liabilities approximates their fair value. • Changes in the fair value of Level 3 three September 30, 2023 2022 Liberty Warrants and Liberty Advisory Fee Warrant PIPE Warrant Columbia Warrant Sponsor Earnout Forfeiture Earnout Cantor Loan At June 30, 2022 $ 15,377 $ 952 $ — $ 3,111 $ — $ — Issues — — — — — — Remeasurement (gain)/loss (4,026 ) (415 ) — (537 ) — — Write-off of deferred costs — — — — — — Settlements — — — — — — At September 30, 2022 $ 11,351 $ 537 $ — $ 2,574 $ — $ — At June 30, 2023 $ 2,339 $ 109 $ — $ 504 $ — $ — Remeasurement (gain)/loss (1,157 ) (50 ) — (281 ) — — At September 30, 2023 $ 1,182 $ 59 $ — $ 223 $ — $ — • Changes in the fair value of Level 3 nine September 30, 2023 2022 Liberty Warrants and Liberty Advisory Fee Warrant PIPE Warrant Columbia Warrant Sponsor Earnout Forfeiture Earnout Cantor Loan At January 1, 2022 $ — $ — $ 143,237 $ — $ — $ 7,522 Issues 30,853 1,312 — 8,022 6,135 — Remeasurement (gain)/loss (1) (19,502 ) (775 ) (18,635 ) (5,448 ) (5,130 ) 489 Write-off of deferred costs — — 203 — — — Settlements (2) — — (124,805 ) — (1,005 ) (8,011 ) At September 30, 2022 $ 11,351 $ 537 $ — $ 2,574 $ — $ — At January 1, 2023 $ 6,191 $ 311 $ — $ 1,353 $ — $ — Remeasurement (gain)/loss (1) (5,009 ) (252 ) — (1,130 ) — — At September 30, 2023 $ 1,182 $ 59 $ — $ 223 $ — $ — ( 1 Recognized in the Condensed Consolidated Statements of Operations and Comprehensive Loss for the nine September 30, 2023 2022, ( 2 These liabilities were settled in connection with the Merger. See Note 4 There were no 1 2 nine September 30, 2023 2022.	15. The following tables provide the fair value measurement hierarchy of our assets and liabilities: As of December 31, 2022 Fair value measurement using Financial instruments Quoted prices Significant Significant $8.63 Warrants liability $ 1,833 $ — $ — PIPE Warrant liability — — 311 Liberty Warrants and Liberty Advisory Fee Warrant liability — — 6,191 Total Warrant Liabilities $ 1,833 $ — $ 6,502 Sponsor Earnout liability $ — $ — $ 1,353 As of December 31, 2021 Fair value measurement using Financial instruments Quoted prices Significant Significant Liabilities measured at fair value Cantor Loan $ — $ — $ 7,522 Columbia Warrant liability — — 143,237 Liabilities for which fair values are disclosed Notes $ — $ 180,356 $ — Promissory notes — 40,925 — The following methods and assumptions were used to estimate the fair values: • The carrying values of cash and cash equivalents, restricted cash, accounts receivable, prepaid expenses and other current assets, accounts payable, and accrued expenses and other liabilities are considered to approximate their fair values due to the short-term nature of these items. • The fair values of the PIPE Warrant, the Liberty Warrants and Liberty Advisory Fee Warrant, and the Columbia Warrant have been estimated using the Black-Scholes model. • The fair value of the Sponsor Earnout has been estimated using the Monte Carlo model. • The fair values of the $8.63 Warrants were determined using the quoted prices in the active warrant market. • The carrying value of operating lease liabilities is calculated as the present value of lease payments, discounted at its incremental borrowing rate at the lease commencement date. We consider that the incremental borrowing rate remained unchanged, therefore the carrying amount of operating lease liabilities approximates its fair value. • The fair value of the Cantor Loan was determined by using the “with” method. At each measurement date, we valued the Cantor Loan with the make-whole premium. The difference between the aggregate fair value of the Cantor Loan and the unpaid principal balance was $22 thousand at December 31, 2021. • The fair value of the Notes debt is determined by using the “with” and “without” method. As of each measurement date, we first Changes in the fair value of Level 3 December 31, 2022 2021 Liberty Warrants and Liberty Advisory Fee Warrant PIPE Warrant Columbia Warrant Sponsor Earnout Forfeiture Earnout Cantor Loan At January 1, 2021 $ — $ — $ — $ — $ — $ — Issues — — 161,432 — — 7,513 Remeasurement (gain)/loss (1) — — (17,992 ) — — 9 Amortization of deferred costs — — (203 ) — — — At December 31, 2021 — — 143,237 — — 7,522 Issues 30,853 1,312 — 8,022 6,135 — Remeasurement (gain)/loss (1) (24,662 ) (1,001 ) (18,635 ) (6,669 ) (5,130 ) 488 Write-off of deferred costs — — 203 — — — Settlements (2) — — (124,805 ) — (1,005 ) (8,010 ) At December 31, 2022 $ 6,191 $ 311 $ — $ 1,353 $ — $ — ( 1 Recognized in the Consolidated Statements of Operations and Comprehensive Loss for the years ended December 31, 2022 2021, ( 2 These liabilities were settled in connection with the Merger. See Note 4 There were no 1 2 December 31, 2022 2021.

Note 16 - Related Parties

Note 16 - Related Parties	9 Months Ended	12 Months Ended
	Sep. 30, 2023	Dec. 31, 2022
Notes to Financial Statements
Related Party Transactions Disclosure [Text Block]	16. We had convertible notes with certain related parties that were settled in connection with the Merger. See Note 4 The following table provides the associated finance costs as follows: Three Months Ended September 30, Nine Months Ended September 30, 2023 2022 2023 2022 Convertible notes from related parties Interest expense on amounts owed to related parties $ — $ — $ — $ 44 There are no See description of transactions with CF&Co and Liberty Investment as part of the Merger Transaction described in Note 4 We made purchases totaling $1.4 million from our equity method investee, OS, in the nine September 30, 2023 September 30, 2023.	16. We had convertible notes with certain related parties at December 31, 2021. 4 December 31, 2022 2021 2020 Convertible notes debt from related parties Amounts owed to related parties $ — $ 13,028 $ — Interest expense $ 554 $ 620 $ 591 There are no See description of transactions with CF&Co and Liberty Investment as part of the Merger transaction described in Note 4 We made purchases totaling $456 from our equity method investee, OS, during the period beginning on the investment date to December 31, 2022. 21

Note 17 - Debt

Note 17 - Debt	12 Months Ended
	Dec. 31, 2022
Notes to Financial Statements
Debt Disclosure [Text Block]	17. There was no December 31, 2022. December 31, 2021 December 31, 2018 Convertible Notes $ 19,862 2019 Convertible Notes 27,498 2020 Convertible Notes 15,294 Cantor Loan 7,522 Columbia Loan 38,297 Total debt 108,473 Less deferred financing costs — Total debt less deferred financing fees 108,473 Less: Current portion — Total non-current debt, net of deferred financing fees $ 108,473 Convertible Notes In April 2021, 2018 2019 2018 2019 April September 2021, April 2022, December 31, 2021. On January 25, 2022, 4 Cantor Loan In December 2021, Pursuant to the Promissory Note Waiver Letter, the Company repaid the Cantor Loan, including all principal and interest, by the issuance of 788,021 Class A ordinary shares. Such repayment occurred on the Closing Date. The Promissory Note Waiver Letter included a provision where in the event the VWAP is less than $10.00 per Class A ordinary share, CF&Co. will be entitled to receive a certain number of additional Class A ordinary shares (the “Cantor Loan Additional Shares”), up to a maximum of 197,005 Cantor Loan Additional Shares (if the Adjustment Period VWAP, as defined in the Promissory Note Waiver Letter, is less than or equal to $8.00 per share). We extinguished the remaining Cantor Loan liability through the issuance of 26,050 Cantor Loan Additional Shares on May 9, 2022 Columbia Loan On March 8, 2021, 1 no December 31, 2022

Note 18 - Leases

Note 18 - Leases	12 Months Ended
	Dec. 31, 2022
Notes to Financial Statements
Lessee, Operating Leases [Text Block]	18. We have operating leases for property and equipment. Lease terms range from two Changes in our operating lease ROU assets carrying amounts were as follows: December 31, 2022 2021 Balance as of beginning of period $ 2,955 $ 1,403 Lease expense (1,701 ) (494 ) Foreign exchange differences 115 (48 ) Additions 7,171 2,119 Disposals (322 ) — Transfers (47 ) (25 ) Balance as of end of period $ 8,171 $ 2,955 Changes in our operating lease liabilities carrying amounts were as follows: December 31, 2022 2021 Balance as of beginning of period $ 3,068 $ 1,415 Additions to operating lease liabilities 7,171 2,119 Lease expense 314 54 Foreign exchange differences (293 ) (48 ) Disposals (329 ) — Payments (1,692 ) (472 ) Balance as of end of period $ 8,239 $ 3,068 Total current $ 2,176 $ 985 Total non-current 6,063 2,083 We recognized in the Consolidated Statements of Operations and Comprehensive Loss the following expenses related to our operating leases for the years ended December 31, 2022, 2021 2020: Year Ended December 31, 2022 2021 2020 Right-of-use assets $ 1,701 $ 494 $ 247 Operating lease liabilities 314 54 51 Total lease expense $ 2,015 $ 548 $ 298 The amounts of future undiscounted cash flows related to the lease payments over the lease term and the reconciliation to the present value of the operating lease liabilities at December 31, 2022 Operating leases Years Ended 2023 $ 2,484 2024 2,235 2025 824 2026 603 2027 and thereafter 3,166 Total remaining lease payments 9,312 Less imputed interest (1,073 ) Present value of lease liability $ 8,239 Total current $ 2,176 Total non-current $ 6,063 The weighted-average remaining years for the operating leases are 5.66.

Note 19 - Adoption of U.S. GAAP

Note 19 - Adoption of U.S. GAAP	9 Months Ended	12 Months Ended
	Sep. 30, 2023	Dec. 31, 2022
Notes to Financial Statements
Accounting Standards Update and Change in Accounting Principle [Text Block]	3. ASU ) Accounting Standard Recently Adopted In June 2016, No. 2016 13, 2016 13” 2016 13 January 1, 2023. not	3. ASU ) Accounting Standards Recently Adopted In May 2021, 2021 04, Earnings per Share (Topic 260 470 50 718 s Own Equity (Subtopic 815 40 December 15, 2021, January 1, 2022. not In January 2020, 2020 01, Investments Equity Securities (Topic 321 Equity Method and Joint Ventures (Topic 323 815 Clarifying the Interactions between Topic 321, 323, 815 December 15, 2021, January 1, 2022. not In December 2019, No. 2019 12, Income Taxes (Topic 740 2019 12” 2019 12 2019 12 December 15, 2021, December 15, 2022, January 1, 2022. not Accounting Standards Not In June 2016, No. 2016 13, Credit Losses - Measurement of Credit Losses on Financial Instruments 2016 13” 2016 13 January 1, 2023 not
Revision of Prior Period, Adjustment [Member]
Notes to Financial Statements
Accounting Standards Update and Change in Accounting Principle [Text Block]		19. Reconciliation of the Consolidated Statement of Operations and Comprehensive Loss for the year ended December 31, 2021: Year Ended December 31, 2021 IFRS Adjustments/ Note U.S. GAAP Revenue $ 4,247 $ — $ 4,247 Costs and expenses Cost of sales 1,876 — 1,876 General administrative expenses 36,649 (9 ) a, c 36,640 Research and development 9,640 (4 ) b 9,636 Depreciation expense 10,825 (97 ) b 10,728 Other operating expenses, net 14,002 — 14,002 Total costs and expenses 72,992 (110 ) 72,882 Operating loss (68,745 ) 110 (68,635 ) Other income (expense), net Finance costs, net (11,769 ) 2,031 c, d (9,738 ) Change in fair value of financial instruments (42,102 ) 60,085 d 17,983 Gain (loss) on extinguishment of debt 3,576 (40,792 ) d (37,216 ) Other income (expense), net 1,067 2 c 1,069 Total other income (expense), net (49,228 ) 21,326 (27,902 ) Loss before income tax (117,973 ) 21,436 (96,537 ) Income tax 232 — 232 Net loss available to common stockholders $ (117,741 ) $ 21,436 $ (96,305 ) Other comprehensive loss Foreign currency translation loss, net of tax (86 ) — (86 ) Comprehensive loss $ (117,827 ) $ 21,436 $ (96,391 ) Basic loss for the period attributable to common stockholders $ (7.07 ) $ 1.29 e $ (5.78 ) Basic weighted-average common shares outstanding 16,655,634 — e 16,655,634 Diluted loss for the period attributable to common stockholders $ (7.07 ) $ 1.29 e $ (5.78 ) Diluted weighted-average common shares outstanding 16,655,634 — e 16,655,634 Reconciliation of the Consolidated Statement of Operations and Comprehensive Loss for the year ended December 31, 2020: Year Ended December 31, 2020 IFRS Adjustments/ Note U.S. GAAP Revenue $ — $ — $ — Costs and expenses Cost of sales — — — General administrative expenses 8,127 (124 ) a, c 8,003 Research and development 5,878 46 a, b 5,924 Depreciation expense 3,182 (151 ) b 3,031 Other operating expenses, net 5,476 (27 ) a, b 5,449 Total costs and expenses 22,663 (256 ) 22,407 Operating loss (22,663 ) 256 (22,407 ) Other income (expense), net Finance costs, net (22 ) 57 c, d 35 Change in fair value of financial instruments (84,224 ) 93,861 d 9,637 Gain (loss) on extinguishment of debt (7,466 ) (1,774 ) d (9,240 ) Other income (expense), net 597 (3 ) c 594 Total other income (expense), net (91,115 ) 92,141 1,026 Loss before income tax (113,778 ) 92,397 (21,381 ) Income tax (148 ) — (148 ) Net loss available to common stockholders $ (113,926 ) $ 92,397 $ (21,529 ) Other comprehensive loss Foreign currency translation loss, net of tax — — — Comprehensive loss $ (113,926 ) $ 92,397 $ (21,529 ) Basic loss for the period attributable to common stockholders $ (7.11 ) $ 5.76 e $ (1.34 ) Basic weighted-average common shares outstanding 16,029,826 — e 16,029,826 Diluted loss for the period attributable to common stockholders $ (7.11 ) $ 5.76 e $ (1.34 ) Diluted weighted-average common shares outstanding 16,029,826 — e 16,029,826 Reconciliation of the Consolidated Balance Sheet as of December 31, 2021: IFRS Adjustments / Note U.S. GAAP ASSETS Current assets Cash and cash equivalents $ 8,533 $ — $ 8,533 Accounts receivable 1,196 — 1,196 Prepaid expenses and other current assets 2,695 — 2,695 Total current assets 12,424 — 12,424 Property and equipment, net 33,586 (1,056 ) b 32,530 Operating lease right-of-use assets 2,663 292 c 2,955 Deferred income tax assets 1,640 — 1,640 Other non-current assets 369 — 369 Total assets $ 50,682 $ (764 ) $ 49,918 LIABILITIES, REDEEMABLE PREFERRED STOCK AND STOCKHOLDERS EQUITY (DEFICIT) Current liabilities Accounts payable $ 6,650 $ — $ 6,650 Debt 246,189 (137,716 ) d 108,473 Warrant liabilities — 143,237 d 143,237 Operating lease liabilities 891 94 c 985 Contract liabilities 935 — 935 Accrued expenses and other liabilities 23,435 — 23,435 Total current liabilities 278,100 5,615 283,715 Operating lease liabilities 1,908 175 c 2,083 Contract liabilities 1,000 — 1,000 Other non-current liabilities 2,552 — 2,552 Total liabilities 283,560 5,790 289,350 Redeemable preferred stock — 21,306 d 21,306 Stockholders’ equity (deficit) Treasury stock (170,949 ) — (170,949 ) Additional paid-in capital 235,909 (139,438 ) a, d 96,471 Accumulated other comprehensive loss (86 ) — (86 ) Accumulated deficit (297,752 ) 111,578 (186,174 ) Total stockholders’ equity (deficit) (232,878 ) (27,860 ) (260,738 ) Total liabilities, redeemable preferred stock and stockholders’ equity (deficit) $ 50,682 $ (764 ) $ 49,918 a. Stock-based compensation Certain awards granted by us have a service inception date preceding the grant date. Under IFRS, this resulted in the recognition of stock-based compensation expense prior to the grant date. Under U.S. GAAP, the stock-based compensation expense shall not The impact of this change before considering the tax effect is as follows: Year Ended December 31, (Consolidated Statement of Operations and Comprehensive Loss) 2021 2020 General and administrative expenses $ (80 ) $ (136 ) Research and development — (89 ) Other operating expenses — (27 ) Increase (decrease) to loss before income tax $ (80 ) $ (252 ) (Consolidated Balance Sheet) December 31, Additional paid-in-capital $ 542 Adjustment to accumulated deficit (542 ) Total liabilities, redeemable preferred stock and stockholders’ equity (deficit) $ — b. Research and development Under IFRS, certain development expenditures may The impact of this change before considering the tax effect is as follows: Year Ended December 31, (Consolidated Statement of Operations and Comprehensive Loss) 2021 2020 Research and development $ (4 ) $ 135 Depreciation expense (97 ) (151 ) Other operating expenses — — Increase (decrease) to loss before income tax $ (101 ) $ (16 ) (Consolidated Balance Sheet) December 31, Property and equipment, net $ (1,056 ) Total assets $ (1,056 ) Adjustment to accumulated deficit $ (1,056 ) Total liabilities, redeemable preferred stock and stockholders’ equity (deficit) $ (1,056 ) c. Leases Under IFRS, all recognized leases are accounted for similarly to finance leases. Under U.S. GAAP, there is a dual classification on-balance sheet lease accounting model for lessees: finance and operating leases. Operating leases create a straight-line expense, and no The impact of this change before considering the tax effect is as follows: Year Ended December 31, (Consolidated Statement of Operations and Comprehensive Loss) 2021 2020 General and administrative expenses $ 71 $ 12 Less: Finance costs, net (49 ) (57 ) Less: Other income, net (2 ) 3 Increase (decrease) to loss before income tax $ 20 $ (42 ) (Consolidated Balance Sheet) December 31, Operating lease right-of-use assets $ 292 Total assets $ 292 Operating lease liabilities $ 94 Non-current operating lease liabilities 175 Adjustment to accumulated deficit 23 Total liabilities, redeemable preferred stock and stockholders’ equity (deficit) $ 292 d. Financial instruments Under IFRS, the redeemable Series X not Under IFRS, it was determined that the redeemable Series X X Under IFRS, it was determined that the Columbia Warrant should be classified as equity since settlement would only occur by exchanging a fixed amount of cash for a fixed number of our own equity instruments. Changes in fair value are not Additionally, the resulting gain (loss) on extinguishment of the amended convertible notes differed under IFRS versus U.S. GAAP. The impact of this change before considering the tax effect is as follows: Year Ended December 31, (Consolidated Statements of Operations and Comprehensive Loss) 2021 2020 Less: Finance costs, net $ (1,982 ) $ — Less: Change in fair value of financial instruments (60,085 ) (93,861 ) Less: Gain (Loss) on extinguishment of debt 40,792 1,774 Increase (decrease) to loss before income tax $ (21,275 ) $ (92,087 ) (Consolidated Balance Sheet) December 31, Debt $ (137,716 ) Redeemable Series X preferred stock 21,306 Warrant liability 143,237 Additional paid-in capital (139,980 ) Adjustment to accumulated deficit 113,153 Total liabilities, redeemable preferred stock and stockholders’ equity (deficit) $ — e. Net loss per share The change in net loss in the adoption of U.S. GAAP as described in items a-d above impacted net loss per share as follows: Year Ended December 31, 2021 2020 Net loss attributable to common stockholders $ (96,305 ) $ (21,529 ) Basic weighted-average common shares outstanding (1) 16,655,634 16,029,826 Basic loss per share for the period attributable to common stockholders $ (5.78 ) $ (1.34 ) Dilutive numerator $ (96,305 ) $ (21,529 ) Diluted weighted-average common shares outstanding 16,655,634 16,029,826 Diluted loss per share for the period attributable to common stockholders $ (5.78 ) $ (1.34 ) ( 1 4

Note 20 - Commitments and Conti

Note 20 - Commitments and Contingencies	9 Months Ended	12 Months Ended
	Sep. 30, 2023	Dec. 31, 2022
Notes to Financial Statements
Commitments and Contingencies Disclosure [Text Block]	17. Contingencies We may September 30, 2023 December 31, 2022, not	20. Contingencies We may December 31, 2022 December 31, 2021, not

Note 21 - Equity Method Investm

Note 21 - Equity Method Investment	12 Months Ended
	Dec. 31, 2022
Notes to Financial Statements
Equity Method Investments and Joint Ventures Disclosure [Text Block]	21. On May 6, 2022, September 30, 2022.

Note 22 - Subsequent Events

Note 22 - Subsequent Events	12 Months Ended
	Dec. 31, 2022
Notes to Financial Statements
Subsequent Events [Text Block]	22. On March 8, 2023, 1.1

Note 1 - Nature of the Busine_2

Note 1 - Nature of the Business and Basis of Presentation 1	9 Months Ended	12 Months Ended
	Sep. 30, 2023	Dec. 31, 2022
Notes to Financial Statements
Business Description and Basis of Presentation [Text Block]	1. Nature of the Business On January 25, 2022 ( July 5, 2021 ( 1 2 Nettar was, prior to the transaction, the holding company of the Satellogic group and was incorporated on October 7, 2014 173 D8 VG1110. References to “Nettar” contained herein refer to Nettar Group Inc. prior to the mergers, and references to “the Company,” “we,” “our,” “us” or “Satellogic” refer to Satellogic Inc. prior to the mergers and to the combined company following the mergers. Through our subsidiaries, we invest in the software, hardware, and optics of the aerospace industry focusing on satellite and image analytics technologies. Our strategy is to build a planetary scale analytics platform based on a proprietary satellite constellation with the capability to generate insights from images and information, with focus on multi-temporal analysis and high frequency of revisits. We also intend to leverage our ability to quickly build and launch high quality, sub-meter satellites at a low cost by selling satellites to certain key customers. Basis of Presentation The accompanying unaudited interim condensed consolidated financial statements have been prepared in accordance with generally accepted accounting principles in the United States (“U.S. GAAP”) and the rules and regulations of the U.S. Securities and Exchange Commission (“SEC”). The Company conducts business through one operating segment. The accompanying Condensed Consolidated Financial Statements include our accounts and those of our wholly owned subsidiaries. All intercompany accounts and transactions have been eliminated in consolidation. The Condensed Consolidated Financial Statements are presented in United States dollars (hereinafter “U.S. dollars” or “$”). The accompanying Condensed Consolidated Financial Statements are unaudited and reflect all adjustments of a normal, recurring nature that are, in the opinion of management, necessary for a fair presentation of the interim period financial statements. The results of operations for these interim periods are not Emerging Growth Company We are an “emerging growth company,” as defined in Section 2 1933, 2012 not not 1934, not may not Going Concern and Liquidity The accompanying unaudited condensed consolidated financial statements have been prepared assuming we will continue as a going concern. The going concern basis of presentation assumes that we will continue in operation one Pursuant to the requirements of ASC Topic 205 40, one not not not 1 one 2 one We have evaluated whether there are any conditions and events, considered in the aggregate, that raise substantial doubt about our ability to continue as a going concern over the next twelve September 2024. nine September 30, 2023. September 30, 2023, not may second third 2024 In order for us to proceed and reach larger scale revenue generation, we will need to raise additional funds through the issuance of additional equity, debt or both. Until such time that we can generate revenue sufficient to achieve profitability, we expect to finance our operations through equity or debt financings, which may not may may may no As a result of these uncertainties, and notwithstanding our plans and efforts to date, there is substantial doubt about our ability to continue as a going concern for one	1. Nature of the Business On January 25, 2022 ( July 5, 2021 ( 1 2 Nettar was, prior to the transaction, the holding company of the Satellogic group and was incorporated on October 7, 2014, 173 D8 VG1110. References to “Nettar” contained herein refer to Nettar Group Inc. prior to the mergers, and references to “the Company,” “we,” “our,” “us” or “Satellogic” refer to Satellogic Inc. prior to the mergers and to the combined company following the mergers. Through our subsidiaries, we invest in the software, hardware, and optics of the aerospace industry focusing on satellite and image analytics technologies. Our strategy is to build a planetary scale analytics platform based on a proprietary satellite constellation with the capability to generate insights from images and information, with focus on multi-temporal analysis and high frequency of revisits. We also intend to leverage our ability to quickly build and launch high quality, sub-meter satellites at a low cost by selling satellites to certain key customers. Basis of Presentation The accompanying Consolidated Financial Statements as of December 31, 2022 2021 December 31, 2022, 2021 2020 The accompanying Consolidated Financial Statements include our accounts and those of our wholly owned subsidiaries. All intercompany accounts and transactions, including the intercompany portion of transactions with equity method investees, have been eliminated in consolidation. The Consolidated Financial Statements are presented in United States dollars (hereinafter “U.S. dollars” or “$”). Historically the consolidated financial statements were prepared in accordance with International Financial Reporting Standards (“IFRS”) as issued by the International Accounting Standards Board. For the Consolidated Financial Statements, we have prepared our consolidated financial statements in accordance with U.S. GAAP. The change from reporting in IFRS to U.S. GAAP was treated as a change in accounting standard, whereby we retrospectively applied the change to all prior reporting periods contained in these Consolidated Financial Statements. Where the initial adoption of U.S. GAAP resulted in a material change in an asset or liability, the adjustment was reported to the opening balance of accumulated deficit and additional paid-in capital as of January 1, 2020. 19 Certain prior year amounts have been reclassified to conform to the current year presentation. Emerging Growth Company We are an “emerging growth company,” as defined in Section 2 1933, 2012 not not 1934, not may not Liquidity Since our formation, we have devoted substantial effort and capital resources to the development of our satellite constellation and image technologies. As of December 31, 2022, December 31, 2022, December 31, 2022, We anticipate losses and negative operating cash flows to continue, primarily as a result of our satellite constellation expansion as we obtain adequate sources of funding through revenue growth. We believe we will have sufficient funding for at least the next 12 Failure to generate revenue growth with sufficient positive cash flows from operations or to raise additional funding in the longer term may

Note 2 - Summary of Significa_2

Note 2 - Summary of Significant Accounting Policies 1	9 Months Ended	12 Months Ended
	Sep. 30, 2023	Dec. 31, 2022
Notes to Financial Statements
Significant Accounting Policies [Text Block]	2. Use of Estimates The preparation of the Condensed Consolidated Financial Statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent liabilities at the date of the financial statements, and the reported amounts of revenue and expenses during the reporting period. Significant estimates and assumptions reflected in these Condensed Consolidated Financial Statements include, but are not may Revenue Recognition We recognize revenue in accordance with Topic 606, Revenue from contracts with customers. five Our main revenue stream is from services. We recognize as revenues, the amount of the transaction price that is allocated to the respective performance obligation when or as the performance obligation is satisfied. Revenue is recognized ratably over the subscription period or at the point in time upon delivery. Our satellite imagery can be delivered to customers in two The nature of our contracts does not not We evaluate contracts with a minimum purchase commitment to determine whether we expect to be entitled to a breakage amount. We consider the requirements on constraining estimates variable consideration. The following factors are evaluated when assessing the increased likelihood of a significant revenue reversal: (i) the amount of consideration is highly susceptible to factors outside our influence or control (e.g., volatility in a market, judgment of action of third not We exclude amounts collected on behalf of third Contract liabilities consist of payments received from customers, or such consideration that is contractually due, in advance of providing the product or performing services. We generally do not not may Fair Value Measurement Certain assets and liabilities are carried at fair value in accordance with U.S. GAAP. Valuation techniques used to measure fair value requires us to utilize observable and unobservable inputs. The hierarchy gives the highest priority to quoted prices in active markets for identical assets or liabilities (Level 1 3 one three first two • Level 1: • Level 2: • Level 3: Assets and liabilities recognized at fair value on a recurring basis in the Condensed Consolidated Financial Statements are re-assessed at the end of each reporting period to determine whether any transfers have occurred between levels in the hierarchy. For fair value disclosures, classes of assets and liabilities are based on the nature, characteristics and risks of the asset or liability and the level of the fair value hierarchy. Credit risk management Credit risk is the risk that a counterparty fails to discharge an obligation to us. We are exposed to credit risk from financial assets including cash, cash equivalents and restricted cash held at banks, trade and other receivables. The credit risk is managed based on our credit risk management policies and procedures. Credit risk of any entity doing business with us is systematically analyzed, including aspects of a qualitative nature. The measurement and assessment of our total exposure to credit risk covers all financial instruments involving any counterparty risk. The credit risk in respect of cash balances held with banks and deposits with banks are managed via diversification of bank deposits and are only with major reputable financial institutions. As our risk exposure is mainly influenced by the individual characteristics of each customer, we continuously analyze the creditworthiness of significant debtors. Accounts receivable are non-interest bearing and generally on terms of 30 90 September 30, 2023 two December 31, 2022, one Two customers accounted for more than 10% of our revenue totaling $0.9 million for the three September 30, 2023 one three September 30, 2022. nine September 30, 2023 nine September 30, 2022. The Company contracts with certain third Impairment of Assets We assess potential impairments to long-lived assets whenever events or changes in circumstances indicate that the carrying amount may not September 30, 2023 not Estimates of future cash flows are highly subjective judgments based on management’s experience and knowledge of the Company's operations. These estimates can be significantly impacted by many factors, including changes in global economic conditions, operating costs, obsolescence of technology and competition. If estimates or underlying assumptions change in the future, we may Equity Method Investments We account for equity investments in which we have significant influence, but not may not September 30, 2023. Stock-Based Compensation We measure and recognize all stock-based compensation expense based on estimated fair values for all stock-based awards made to employees and non-employees. Compensation cost is recognized over the requisite service period for each separate tranche, as though each tranche of the award is, in substance, a separate award. The expense calculation includes estimated forfeiture rates, which have been developed based upon historical experience. The fair values for stock options are calculated using the Black-Scholes option pricing model using the following inputs: Expected term - The simplified method is used to calculate the expected term. Expected volatility - We determine the expected stock price volatility based on the historical volatilities of guideline companies from comparable industries. Expected dividend yield - We do not not Risk-free interest rate - We base our interest rate on a treasury instrument for which the term is commensurate with the maximum expected life of the stock options. The fair values for restricted stock units ("RSUs") with service-based vesting conditions are calculated based upon our closing stock price on the date of the grant. Foreign Currencies The financial position and results of operations of certain of our foreign subsidiaries are measured using the local currency as the functional currency. Revenues and expenses of these subsidiaries have been translated into U.S. dollars at average exchange rates prevailing during the period. Assets and liabilities of these subsidiaries have been translated at the exchange rates as of the balance sheet date. Translation gains and losses are recorded in accumulated other comprehensive loss. Aggregate foreign currency gains and losses, such as those resulting from the settlement of receivables or payables, foreign currency contracts and short-term intercompany advances in a currency other than the relevant subsidiary’s functional currency, are recorded currently in the Condensed Consolidated Statements of Operations and Comprehensive Loss (included in other income, net) and resulted in gains of $1.8 million and $1.1 million during the three September 30, 2023 2022, nine September 30, 2023 2022, Leases We determine if a contract is a lease or contains a lease at inception. On the lease commencement date, we recognize a right-of-use (“ROU”) asset and lease liability related to operating type leases. The cost of ROU assets includes the amount of lease liabilities recognized, initial direct costs incurred, and lease payments made at or before the commencement date less any lease incentives received. Operating lease liabilities are recorded based on the present value of the future lease fixed payments. In determining the present value of future lease payments, we use our incremental borrowing rate applicable to the economic environment and the duration of the lease based on the information available at the commencement date as the majority of leases do not 12 not We remeasure and reallocate the consideration in a lease when there is a modification of the lease that is not We account for lease agreements with contractually required lease and non-lease components on a combined basis. Lease payments made for cancellable leases, variable amounts that are not 12 For the periods presented, the Company does not For the three September 30, 2023 2022, nine September 30, 2023 2022, September 30, 2023 December 31, 2022 nine September 30, 2023. Accounts Receivable and Allowance for Credit Losses Trade accounts receivable are stated at the amount owed by the customer, net of allowances for estimated credit losses, discounts, returns and rebates. We measure the allowance for credit losses based on the estimated loss. In calculating an allowance for credit losses, we use our historical experience, external indicators and an aging method. We assess impairment of trade accounts receivable on a collective basis as they possess shared credit risk characteristics, which have been grouped based on customer industry type. The Company also considers account size in its groupings and the days past due in its analysis. Accounts are written off against the allowance account when they are determined to be no nine September 30, 2023 2022: Nine Months Ended September 30, 2023 2022 Allowance for credit losses as of beginning of period $ 3,237 $ 1,794 Provision 80 1,736 Allowance for credit losses as of end of period $ 3,317 $ 3,530 Cash, Cash Equivalents and Restricted Cash Cash and cash equivalents include deposits in banks and short-term (original maturities of three three Restricted cash, including amounts in Other non-current assets, represents amounts pledged as guarantees for sales and lease agreements as contractually required. September 30, December 31, Cash and cash equivalents $ 30,971 $ 76,528 Restricted cash — 126 Restricted cash included in Other non-current assets 1,151 1,138 Total cash, cash equivalents and restricted cash $ 32,122 $ 77,792	2. Use of Estimates The preparation of the Consolidated Financial Statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent liabilities at the date of the financial statements, and the reported amounts of revenue and expenses during the reporting period. Significant estimates and assumptions reflected in these Consolidated Financial Statements include, but are not may Revenue Recognition We recognize revenue in accordance with Topic 606 Revenue from contracts with customers. five Our main revenue stream is from services. We recognize as revenues the amount of the transaction price that is allocated to the respective performance obligation when or as the performance obligation is satisfied. Generally, our performance obligations are transferred to customers at a point in time, typically upon delivery. Our satellite imagery can be delivered to customers in two The nature of our contracts does not not We evaluate contracts with a minimum purchase commitment to determine whether we expect to be entitled to a breakage amount. We consider the requirements on constraining estimates variable consideration. The following factors are evaluated when assessing the increased likelihood of a significant revenue reversal: (i) the amount of consideration is highly susceptible to factors outside our influence or control ( e.g., third not We exclude amounts collected on behalf of third Contract liabilities consist of payments received from customers, or such consideration that is contractually due, in advance of providing the product or performing services. We generally do not not may Fair Value Measurement Certain assets and liabilities are carried at fair value in accordance with U.S. GAAP. Valuation techniques used to measure fair value requires us to utilize observable and unobservable inputs. The hierarchy gives the highest priority to quoted prices in active markets for identical assets or liabilities (Level 1 3 one three first two • Level 1: • Level 2: • Level 3: Assets and liabilities recognized at fair value on a recurring basis in the Consolidated Financial Statements are re-assessed at the end of each reporting period to determine whether any transfers have occurred between levels in the hierarchy. For fair value disclosures, classes of assets and liabilities are based on the nature, characteristics and risks of the asset or liability and the level of the fair value hierarchy. Credit risk management Credit risk is the risk that a counterparty fails to discharge an obligation to us. We are exposed to credit risk from financial assets including cash, cash equivalents and restricted cash held at banks, trade and other receivables. The credit risk is managed based on our credit risk management policies and procedures. Credit risk of any entity doing business with us is systematically analyzed, including aspects of a qualitative nature. The measurement and assessment of our total exposure to credit risk covers all financial instruments involving any counterparty risk. The credit risk in respect of cash balances held with banks and deposits with banks are managed via diversification of bank deposits and are only with major reputable financial institutions. As our risk exposure is mainly influenced by the individual characteristics of each customer, we continuously analyze the creditworthiness of significant debtors. Accounts receivable are non-interest bearing and generally on terms of 30 90 Impairment of Assets We assess potential impairments to long-lived assets whenever events or changes in circumstances indicate that the carrying amount may not December 31, 2022, 2021 2020 not Estimates of future cash flows are highly subjective judgments based on management’s experience and knowledge of the Company's operations. These estimates can be significantly impacted by many factors, including changes in global economic conditions, operating costs, obsolescence of technology and competition. If estimates or underlying assumptions change in the future, we may Equity Method Investments We account for equity investments in which we have significant influence, but not may not December 31, 2022. not 2021 2020. Stock-Based Compensation We measure and recognize all stock-based compensation expense based on estimated fair values for all stock-based awards made to employees and non-employees. Compensation cost is recognized over the requisite service period for each separate tranche, as though each tranche of the award is, in substance, a separate award. The expense calculation includes estimated forfeiture rates, which have been developed based upon historical experience. The fair values for stock options are calculated using the Black-Scholes option pricing model using the following inputs: Expected term - Expected volatility - Expected dividend yield - not not Risk-free interest rate - The fair values for restricted stock units ("RSUs") with service-based vesting conditions are calculated based upon our closing stock price on the date of the grant. Foreign Currencies The financial position and results of operations of certain of our foreign subsidiaries are measured using the local currency as the functional currency. Revenues and expenses of these subsidiaries have been translated into U.S. dollars at average exchange rates prevailing during the period. Assets and liabilities of these subsidiaries have been translated at the exchange rates as of the balance sheet date. Translation gains and losses are recorded in accumulated other comprehensive loss. Aggregate foreign currency gains and losses, such as those resulting from the settlement of receivables or payables, foreign currency contracts and short-term intercompany advances in a currency other than the relevant subsidiary’s functional currency, are recorded currently in the Consolidated Statements of Operations and Comprehensive Loss (included in other income, net) and resulted in gains of $1,576, $1,022, and $594 during the years ended December 31, 2022, 2021, 2020, Leases We determine if a contract is a lease or contains a lease at inception. On the lease commencement date, we recognize a right-of-use (“ROU”) asset and lease liability related to operating type leases. The cost of ROU assets includes the amount of lease liabilities recognized, initial direct costs incurred, and lease payments made at or before the commencement date less any lease incentives received. Operating lease liabilities are recorded based on the present value of the future lease fixed payments. In determining the present value of future lease payments, we use our incremental borrowing rate applicable to the economic environment and the duration of the lease based on the information available at the commencement date as the majority of leases do not 12 not We remeasure and reallocate the consideration in a lease when there is a modification of the lease that is not We account for lease agreements with contractually required lease and non-lease components on a combined basis. Lease payments made for cancellable leases, variable amounts that are not 12 For the periods presented, we do not Accounts Receivable and Allowance for Doubtful Accounts Trade accounts receivable are stated at the amount owed by the customer, net of allowances for estimated doubtful accounts, discounts, returns and rebates. We measure the allowance for doubtful accounts based on the estimated loss. In calculating an allowance for doubtful accounts, we use our historical experience, external indicators and an aging method. We assess impairment of trade accounts receivable on a collective basis as they possess shared credit risk characteristics which have been grouped based on the days past due. Accounts are written off against the allowance account when they are determined to be no December 31, 2022 2021: December 31, 2022 2021 Allowance for doubtful accounts as of beginning of period $ 1,794 $ — Provision 1,736 1,794 Write-offs — — Foreign exchange and other (293 ) — Allowance for doubtful accounts as of end of period $ 3,237 $ 1,794 Cash, Cash Equivalents and Restricted Cash Cash and cash equivalents include deposits in banks and short-term (original maturities of three three Restricted cash, including amounts in Other non-current assets, represents amounts pledged as guarantees for sales and lease agreements as contractually required. December 31, 2022 2021 Cash and cash equivalents $ 76,528 $ 8,533 Restricted cash 126 — Restricted cash included in Other non-current assets 1,138 — Total cash, cash equivalents and restricted cash $ 77,792 $ 8,533 Cash Flow Information Year Ended December 31, 2022 2021 2020 Cash paid during the period for: Income tax, net of refunds $ 758 $ 96 $ 59 Interest $ 3,520 $ 49,283 $ 27,286

Note 3 - Accounting Standards_2

Note 3 - Accounting Standards Updates (ASU) 1	9 Months Ended	12 Months Ended
	Sep. 30, 2023	Dec. 31, 2022
Notes to Financial Statements
Accounting Standards Update and Change in Accounting Principle [Text Block]	3. ASU ) Accounting Standard Recently Adopted In June 2016, No. 2016 13, 2016 13” 2016 13 January 1, 2023. not	3. ASU ) Accounting Standards Recently Adopted In May 2021, 2021 04, Earnings per Share (Topic 260 470 50 718 s Own Equity (Subtopic 815 40 December 15, 2021, January 1, 2022. not In January 2020, 2020 01, Investments Equity Securities (Topic 321 Equity Method and Joint Ventures (Topic 323 815 Clarifying the Interactions between Topic 321, 323, 815 December 15, 2021, January 1, 2022. not In December 2019, No. 2019 12, Income Taxes (Topic 740 2019 12” 2019 12 2019 12 December 15, 2021, December 15, 2022, January 1, 2022. not Accounting Standards Not In June 2016, No. 2016 13, Credit Losses - Measurement of Credit Losses on Financial Instruments 2016 13” 2016 13 January 1, 2023 not

Note 4 - Reverse Recapitaliza_2

Note 4 - Reverse Recapitalization 1	9 Months Ended	12 Months Ended
	Sep. 30, 2023	Dec. 31, 2022
Notes to Financial Statements
Reverse Recapitalization Disclosure [Text Block]	4. On January 25, 2022 no The transaction resulted in net cash proceeds of $168 million, after transaction expenses and debt repayment, through the contribution of cash held in CF V’s trust account, net of redemptions by CF V’s public stockholders, and a concurrent private placement offering led by SoftBank’s SBLA Advisers Corp. and Cantor Fitzgerald & Co. (“CF&Co.”), among other institutional investors, and the Liberty Investment, as defined and described further below. On the Closing Date, the Company consummated the Merger contemplated by the Merger Agreement, including the following: Private Placement ( PIPE ) Investment Pursuant to the relevant subscription agreement, the Company issued 5,816,770 Class A ordinary shares and a non-redeemable warrant (“PIPE Warrant”) to purchase 2,500,000 Class A ordinary shares to a PIPE investor at an exercise price of $20.00 per share, for an aggregate purchase price of $58.2 million. Forward Purchase Agreement In July 2021, Cantor Loan Satellogic and Cantor Fitzgerald Securities (“CF Securities”) entered into a Secured Promissory Note, dated December 23, 2021 ( January 18, 2022, Redeemable Series X Per the transaction, the 2,033,230 outstanding shares of redeemable Series X Liberty Investment On January 18, 2022, “$10.00 “$15.00 $10.00 February 10, 2022 ( An advisory fee is payable by Satellogic in exchange for advisory services to be provided to Satellogic from time to time until a Cessation Event (as defined in the Liberty Subscription Agreement). The advisory fee includes a warrant to purchase 2,500,000 of Satellogic’s Class A ordinary shares at an exercise price of $10.00 per share (the “Liberty Advisory Fee Warrant”), which was issued at the Liberty Closing, and for so long as a Cessation Event has not not five three 18 The Liberty Advisory Fee Warrant became exercisable as of and from February 10, 2023, fifth February 10, 2027). Transaction Fees On January 18, 2022, Company Stockholders In connection with the Merger Transaction: • the ordinary shares and preferred shares of Nettar that were issued and outstanding immediately prior to the Merger were automatically cancelled and ceased to exist in exchange for Satellogic’s Class A ordinary shares, as determined in accordance with the Merger Agreement; • all Convertible Notes of Nettar converted into Nettar Preferred Shares which were exchanged for shares of Satellogic’s Class A ordinary shares as determined in the Merger Agreement; • all options to purchase ordinary shares of Nettar were assumed by the Company and became options to purchase Satellogic’s Class A ordinary shares as determined in accordance with the Merger Agreement; • the Columbia Warrant (as defined below) outstanding immediately prior to the Merger became exercisable for that number of Satellogic’s Class A ordinary shares as determined in accordance with the Merger Agreement. The following table illustrates the shares issued to our stockholders after giving effect to the 3.3028 Exchange Ratio in accordance with the transactions contemplated by the Merger Agreement as of the Closing Date and the issuance of shares pursuant to the transactions described above: Company stockholders Shares Class A stockholders immediately prior to merger 17,215,336 Series A preferred stockholders 7,968,316 Series B preferred stockholders 4,597,928 Series B-1 preferred stockholders 2,171,399 2018 convertible noteholders 5,581,416 2019 convertible noteholders 7,846,333 2020 convertible noteholders 4,553,205 Redeemable Series X preferred stockholders 2,140,340 Liberty investors 20,000,000 PIPE investors 5,816,770 Shares issued for Cantor loan repayment 788,021 Shares issued to Sponsor under Forward Purchase Securities Agreement 1,250,000 Issuance of shares for transaction fees 2,058,229 CF V shares 6,837,354 88,824,647	4. On January 25, 2022, no The transaction resulted in net cash proceeds of $168 million, after transaction expenses and debt repayment, through the contribution of cash held in CF V’s trust account, net of redemptions by CF V’s public stockholders, and a concurrent private placement offering led by SoftBank’s SBLA Advisers Corp. and Cantor Fitzgerald & Co. (“CF&Co.”), among other institutional investors, and the Liberty Investment, as defined and described further below. On the Closing Date, the Company consummated the Merger contemplated by the Merger Agreement, including the following: Private Placement ( PIPE ) Investment Pursuant to the relevant subscription agreement, Satellogic issued 5,816,770 Class A ordinary shares and a non-redeemable warrant (“PIPE Warrant”) to purchase 2,500,000 Class A ordinary shares to a PIPE investor at an exercise price of $20.00 per share, for an aggregate purchase price of $58.2 million. Forward Purchase Agreement In July 2021, Cantor Loan Satellogic and Cantor Fitzgerald Securities (“CF Securities”) entered into a Secured Promissory Note, dated December 23, 2021 ( January 18, 2022, Redeemable Series X Per the transaction, the 2,033,230 outstanding shares of redeemable Series X Liberty Investment On January 18, 2022, “$10.00 “$15.00 $10.00 February 10, 2022 ( An advisory fee is payable by Satellogic in exchange for advisory services to be provided to Satellogic from time to time until a Cessation Event (as defined in the Liberty Subscription Agreement). The advisory fee includes a warrant to purchase 2,500,000 of Satellogic’s Class A ordinary shares at an exercise price of $10.00 per share (the “Liberty Advisory Fee Warrant”), which was issued at the Liberty Closing, and for so long as a Cessation Event has not not five three 18 The Liberty Advisory Fee Warrant became exercisable as of and from February 10, 2023, fifth February 10, 2027). Transaction Fees On January 18, 2022, Company Stockholders In connection with the Merger transaction: • the common stock and preferred stock of Nettar that were issued and outstanding immediately prior to the Merger were automatically canceled and ceased to exist in exchange for Satellogic’s Class A ordinary shares, as determined in accordance with the Merger Agreement; • all Convertible Notes of Nettar converted into Nettar Preferred Shares which were exchanged for shares of Satellogic’s Class A ordinary shares as determined in the Merger Agreement; • all options to purchase common stock of Nettar were assumed by the Company and became options to purchase Satellogic’s Class A ordinary shares as determined in accordance with the Merger Agreement; • the Columbia Warrant (as defined below) outstanding immediately prior to the Merger became exercisable for that number of Satellogic’s Class A ordinary shares as determined in accordance with the Merger Agreement. The following table illustrates the shares issued to our stockholders after giving effect to the 3.3028 Exchange Ratio in accordance with the transactions contemplated by the Merger Agreement as of the Closing Date and the issuance of shares pursuant to the transactions described above: Company stockholders Shares Class A stockholders immediately prior to merger 17,215,336 Series A preferred stockholders 7,968,316 Series B preferred stockholders 4,597,928 Series B-1 preferred stockholders 2,171,399 2018 convertible noteholders 5,581,416 2019 convertible noteholders 7,846,333 2020 convertible noteholders 4,553,205 Redeemable Series X preferred stockholders 2,140,340 Liberty investors 20,000,000 PIPE investors 5,816,770 Shares issued for Cantor loan repayment 788,021 Shares issued to Sponsor under Forward Purchase Securities Agreement 1,250,000 Issuance of shares for transaction fees 2,058,229 CF V shares 6,837,354 88,824,647

Note 5 - Revenue from Contrac_2

Note 5 - Revenue from Contracts with Customers 1	9 Months Ended	12 Months Ended
	Sep. 30, 2023	Dec. 31, 2022
Notes to Financial Statements
Revenue from Contract with Customer [Text Block]	5. As described below, during the three September 30, 2023 2022, nine September 30, 2023 2022, Three Months Ended September 30, Nine Months Ended September 30, 2023 2022 2023 2022 Revenue by timing Over time $ 413 $ — $ 1,236 $ 1,524 Point-in time 783 2,158 3,144 3,022 Total revenue $ 1,196 $ 2,158 $ 4,380 $ 4,546 Information about the Company’s revenue by geography is as follows: Three Months Ended September 30, Nine Months Ended September 30, 2023 2022 2023 2022 Revenue by geography (1) (2) Asia Pacific $ 82 $ 232 $ 351 $ 1,946 Europe 513 43 1,506 80 North America 588 1,817 2,467 2,435 South America 13 66 56 85 Total revenue $ 1,196 $ 2,158 $ 4,380 $ 4,546 ( 1 Revenue by geography is based on the geographical location of the customer. ( 2 Certain comparative figures have been reclassified to conform to the current year presentation. Contract liabilities and Remaining Performance Obligations Our contract liabilities consist of payments received from customers, or such consideration contractually due, in advance of providing the relevant satellite imagery or related service. Amounts included in Contract liabilities are as follows: September 30, December 31, 2023 2022 Non-current $ 1,000 $ 1,000 Current 3,286 1,941 Total $ 4,286 $ 2,941 During the nine September 30, 2023, December 31, 2022. nine September 30, 2022, December 31, 2021. A contract’s transaction price is allocated to each distinct performance obligation and recognized as revenue when, or as, the performance obligation is satisfied. The following table represents the total transaction price for the remaining performance obligations as of September 30, 2023 12 Within 1 Year Years 2 Years 3 Thereafter Remaining performance obligations $ 6,852 $ 5,648 $ 5,005 $ 1,000	5. During the year ended December 31, 2022, December 31, 2021, not 2020. Information about our revenue by geography is as follows: Year Ended December 31, 2022 2021 Revenue by geography (1) Asia Pacific $ 1,531 $ 3,988 North America 3,438 201 Other 1,043 58 Total revenue $ 6,012 $ 4,247 ( 1 Revenue by geography is based on the geographical location of the customer. Two December 31, 2022. December 31, 2021. Contract Liabilities and Remaining Performance Obligations Our contract liabilities consist of payments received from customers, or such consideration contractually due, in advance of providing the relevant satellite imagery or related service. Amounts included in Contract liabilities are as follows: December 31, 2022 2021 Non-current $ 1,000 $ 1,000 Current 1,941 935 Total $ 2,941 $ 1,935 During the year ended December 31, 2022, December 31, 2021. December 31, 2021, December 31, 2020. A contract’s transaction price is allocated to each distinct performance obligation and recognized as revenue when, or as, the performance obligation is satisfied. The following table represents the total transaction price for the remaining performance obligations as of December 31, 2022 12 Within 1 Year Years 1-2 Years 2-3 Thereafter Remaining performance obligations $ 6,422 $ 11,296 $ 3,860 $ —

Note 6 - Warrant Liabilities 1

Note 6 - Warrant Liabilities 1	9 Months Ended	12 Months Ended
	Sep. 30, 2023	Dec. 31, 2022
Notes to Financial Statements
Warrant Liabilities Disclosure [Text Block]	6. Liberty Warrants and Liberty Advisory Fee Warrant PIPE Warrant $8.63 Warrants Total Warrants As of December 31, 2022 $ 6,191 $ 311 $ 1,833 $ 8,335 Warrants issued $ — $ — $ — $ — Change in fair value of financial instruments (5,009 ) (252 ) (1,129 ) (6,390 ) As of September 30, 2023 $ 1,182 $ 59 $ 704 $ 1,945 Liberty Warrants and Liberty Advisory Fee Warrant The Liberty Warrants and the Liberty Advisory Fee Warrant were initially recognized as a liability with a fair value of $30.9 million. The Liberty Warrants and the Liberty Advisory Fee Warrant remain unexercised and were remeasured to fair value of $1.2 million as of September 30, 2023. PIPE Warrant The PIPE Warrant was initially recognized as a liability with a fair value of $1.3 million. The PIPE Warrant remains unexercised and was remeasured to fair value of $59 thousand as of September 30, 2023. $8.63 Warrants In connection with the Merger, we entered into an Assignment, Assumption and Amendment Agreement (the “Amended Warrant Agreement”), dated January 25, 2022 January 28, 2021. Pursuant to the Existing Warrant Agreement we issued Public Warrants to purchase 8,333,333 Class A ordinary shares and 200,000 Private Placement Warrants. Additionally, we agreed to issue the Forward Purchase Warrant to purchase 333,333 Class A ordinary shares pursuant to the Amended and Restated Forward Purchase Agreement (together, with the Public Warrants and the Private Placement Warrants, the “$8.63 All of the $8.63 Warrants are governed by the Existing Warrant Agreement. The $8.63 Warrants became exercisable 30 February 25, 2022, five January 25, 2027), The $8.63 Warrants were initially recognized as a liability with a fair value of $4.9 million. On April 1, 2022, January 28, 2021, January 25, 2022, Public Warrants to purchase 613,111 shares of Class A ordinary shares were exercised during the nine September 30, 2022.	6. Liberty Warrants and Liberty Advisory Fee Warrant PIPE Warrant Columbia Warrant $8.63 Warrants Total Warrant Liabilities As of December 31, 2021 $ — $ — $ 143,237 $ — $ 143,237 Warrants issued $ 30,853 $ 1,312 $ — $ 4,872 $ 37,037 Change in fair value of financial instruments (24,662 ) (1,001 ) (18,635 ) (2,702 ) (47,000 ) Write-off of deferred costs — — 203 — 203 Settlements — — — (337 ) (337 ) Reclassification to equity — — (124,805 ) — (124,805 ) As of December 31, 2022 $ 6,191 $ 311 $ — $ 1,833 $ 8,335 Liberty Warrants and Liberty Advisory Fee Warrant The Liberty Warrants and the Liberty Advisory Fee Warrant were initially recognized as a liability with a fair value of $30.9 million. The Liberty Warrants and the Liberty Advisory Fee Warrant remain unexercised and were remeasured to fair value of $6.2 million as of December 31, 2022. PIPE Warrant The PIPE Warrant was initially recognized as a liability with a fair value of $1.3 million. The PIPE Warrant remains unexercised and was remeasured to fair value of $0.3 million as of December 31, 2022. Columbia Warrant In March 2021, The Columbia Warrant is exercisable the earlier of 25 years from the effective date or the date in which the warrant is exercised in full. The Columbia Warrant was initially recognized on March 8, 2021 December 31, 2021. December 31, 2022. $8.63 Warrants In connection with the Merger, we entered into an Assignment, Assumption and Amendment Agreement (the “Amended Warrant Agreement”), dated January 25, 2022, January 28, 2021. Pursuant to the Existing Warrant Agreement, we issued Public Warrants to purchase 8,333,333 Class A ordinary shares and 200,000 private placement Warrants. Additionally, we agreed to issue the Forward Purchase Warrant to purchase 333,333 Class A ordinary shares pursuant to the Amended and Restated Forward Purchase Agreement (together, with the Public Warrants and the private placement Warrants, the “$8.63 All of the $8.63 Warrants are governed by the Existing Warrant Agreement. The $8.63 Warrants became exercisable 30 February 25, 2022, five January 25, 2027), The $8.63 Warrants were initially recognized as a liability with a fair value of $4.9 million. On April 1, 2022, January 28, 2021, January 25, 2022, Public Warrants to purchase 613,111 Class A ordinary shares were exercised during the year ended December 31, 2022.

Note 7 - Earnout Liabilities 1

Note 7 - Earnout Liabilities 1	9 Months Ended	12 Months Ended
	Sep. 30, 2023	Dec. 31, 2022
Notes to Financial Statements
Earnout Liability [Text Block]	7. Sponsor Earnout As of December 31, 2022 $ 1,353 Change in fair value of financial instruments (1,130 ) As of September 30, 2023 $ 223 Sponsor Earnout Pursuant to that certain Sponsor Support Agreement, dated as of July 5, 2021, five not 30% no 10 20 not nine September 30, 2023. not The estimated fair value of the Sponsor Earnout liability is based on a Monte Carlo simulation valuation model using a distribution of potential outcomes on a semi-annual basis over the earnout period, using the most reliable information available. Assumptions used in the valuation are as follows: September 30, 2023 December 31, 2022 Expected term (in years) 3.32 4.07 Dividend yield (%) — % — % Expected volatility 67.3 % 50.4 % Risk-free interest rate 4.8 % 4.1 % Expected number of shares 1,775,962 1,775,962 Forfeiture Earnout In connection with the closing of the Merger (the “Closing”), we delivered 310,127 shares of our Class A ordinary shares to an escrow account (“Forfeiture Escrow Shares”). The Forfeiture Escrow Shares were held in escrow for a 30 five 10 20 not The shares were forfeited because the VWAP was below $10.00. The Forfeiture Earnout was initially recognized as a liability with a fair value of $6.1 million. The liability was remeasured to a fair value of $1.0 million at the end of the adjustment period and reclassified as an equity instrument.	7. Sponsor Earnout Forfeiture Earnout Total Earnout Liabilities As of December 31, 2021 $ — $ — $ — Additions $ 8,022 $ 6,135 $ 14,157 Change in fair value of financial instruments (6,669 ) (5,130 ) (11,799 ) Reclassification to equity — (1,005 ) (1,005 ) As of December 31, 2022 $ 1,353 $ — $ 1,353 Sponsor Earnout Pursuant to that certain Sponsor Support Agreement, dated as of July 5, 2021, five not 30% no 10 20 not December 31, 2022. not The estimated fair value of the Sponsor Earnout liability is based on a Monte Carlo simulation valuation model using a distribution of potential outcomes on a semi-annual basis over the earnout period, using the most reliable information available. Assumptions used in the valuation are as follows: January 25, December 31, 2022 2022 Expected term (in years) 5.00 4.07 Dividend yield (%) — — Expected volatility 30 % 50.4 % Risk-free interest rate 1.6 % 4.1 % Expected number of shares 1,842,759 1,775,962 Forfeiture Earnout In connection with the closing of the Merger (the “Closing”), we delivered 310,127 shares of our Class A ordinary shares to an escrow account (“Forfeiture Escrow Shares”). The Forfeiture Escrow Shares were held in escrow for a 30 five 10 20 not The shares were forfeited because the VWAP was below $10.00. The Forfeiture Earnout was initially recognized as a liability with a fair value of $6.1 million. The liability was remeasured to a fair value of $1.0 million at the end of the adjustment period and reclassified as an equity instrument. SATELLOGIC INC. Notes to Consolidated Financial Statements (in thousands of U.S. dollars, except share and per share information, unless otherwise stated)

Note 8 - Property and Equipme_2

Note 8 - Property and Equipment 1	9 Months Ended	12 Months Ended
	Sep. 30, 2023	Dec. 31, 2022
Notes to Financial Statements
Property, Plant and Equipment Disclosure [Text Block]	8. Property and equipment, net consists of the following: Estimated Useful Life (in years) September 30, December 31, Satellites and other equipment 3 - 5 $ 68,369 $ 54,370 Satellites under construction Not applicable 16,032 22,194 Leasehold improvements 5 - 10 7,601 6,433 Other property and equipment 3 - 10 4,227 4,146 Total property and equipment 96,229 87,143 Less: Accumulated depreciation (53,501 ) (39,162 ) Property and equipment, net $ 42,728 $ 47,981 Information related to the Company’s property and equipment and operating lease ROU assets by geography is as follows: September 30, December 31, Uruguay $ 37,991 $ 43,134 Argentina 930 1,346 Spain 828 729 Netherlands 11,820 9,471 Other countries 490 1,472 Total (1) (2) (3) $ 52,059 $ 56,152 ( 1 Non-current assets include property and equipment, net and operating lease right-of-use assets. ( 2 Presentation in the table is based on the geographic location of the entity that holds the assets. ( 3 We do not	8. Property and equipment, net consists of the following: December 31, Estimated Useful Life (in years) 2022 2021 Satellites in orbit 3 $ 54,370 $ 43,716 Satellites under construction Not applicable 22,194 10,558 Leasehold improvements 5 - 10 6,433 769 Other property and equipment 3 - 10 4,146 2,138 Total property and equipment 87,143 57,181 Less: Accumulated depreciation (39,162 ) (24,651 ) Property and equipment, net $ 47,981 $ 32,530 Provisions for depreciation are based on estimated useful lives of the assets using the straight-line method. Information related to our property and equipment and operating lease ROU assets by geography is as follows: December 31, 2022 2021 Uruguay $ 43,134 $ 33,208 Argentina 1,346 1,250 Spain 729 791 Netherlands 9,471 — Other countries 1,472 236 Total (1) (2) (3) $ 56,152 $ 35,485 ( 1 Non-current assets include property and equipment, net and operating lease right-of-use assets. ( 2 The presentation in the table above is based on the geographic location of the entity that holds the assets. ( 3 We do not

Note 9 - Additional Financial_2

Note 9 - Additional Financial Statement Information 1	9 Months Ended	12 Months Ended
	Sep. 30, 2023	Dec. 31, 2022
Notes to Financial Statements
Additional Financial Information Disclosure [Text Block]	9. Prepaid Expenses and Other Current Assets September 30, December 31, 2023 2022 Prepaid expenses and other current assets Prepaid expenses $ 2,604 $ 1,767 Advances to suppliers 228 588 Other current assets 413 843 Total $ 3,245 $ 3,198 Accrued Expenses and Other Liabilities September 30, December 31, 2023 2022 Accrued expenses and other liabilities Provisions 66 71 Payroll and benefits payable 2,111 3,289 Other taxes payable 5,373 3,128 Other 430 451 Total $ 7,980 $ 6,939 Total current $ 7,481 $ 6,417 Total non-current $ 499 $ 522 Finance Costs, net Three Months Ended September 30, Nine Months Ended September 30, 2023 2022 2023 2022 Finance income (expense), net Interest expense $ — $ (9 ) $ (3 ) $ (1,597 ) Redeemable Series X preferred stock dividends — — — (97 ) Other finance costs (38 ) (29 ) (103 ) (99 ) Interest income 427 419 1,577 568 Total $ 389 $ 381 $ 1,471 $ (1,225 )	9. Prepaid Expenses and Other Current Assets December 31, 2022 2021 Prepaid expenses and other current assets Prepaid expenses $ 1,767 $ 1,153 Advances to suppliers 588 829 Other current assets 843 713 Total $ 3,198 $ 2,695 Accrued Expenses and Other Liabilities December 31, 2022 2021 Accrued expenses and other liabilities Accrued professional fees related to Merger (1) $ — $ 16,263 Provisions 71 2,934 Payroll and benefits payable 3,289 2,545 Other taxes payable 3,128 2,045 Other 451 2,200 Total $ 6,939 $ 25,987 Total current $ 6,417 $ 23,435 Total non-current $ 522 $ 2,552 ( 1 Refer to Note 4 Finance Costs, Net Year Ended December 31, 2022 2021 2020 Finance costs, net Interest expense $ (1,596 ) $ (8,729 ) $ (43 ) Redeemable Series X preferred stock dividends (97 ) (974 ) — Other finance costs (123 ) (71 ) — Interest income 1,164 36 78 Total $ (652 ) $ (9,738 ) $ 35

Note 10 - Income Tax 1

Note 10 - Income Tax 1	9 Months Ended	12 Months Ended
	Sep. 30, 2023	Dec. 31, 2022
Notes to Financial Statements
Income Tax Disclosure [Text Block]	10. The Company is incorporated in the BVI. The BVI does not The components of income tax expense were as follows: Three Months Ended September 30, Nine Months Ended September 30, 2023 2022 2023 2022 Loss before income tax $ (13,550 ) $ (11,840 ) $ (41,277 ) $ (17,818 ) Provision for income tax 4,069 2,983 $ 6,193 $ 5,126 Effective tax rate (30.0 %) (25.2 %) (15.0 %) (28.8 %) Our effective tax rate for the nine September 30, 2023 0%. 740 270 30 36 Accounting for Income Taxes not nine September 30, 2023 2022. The Company recognizes uncertain income tax positions when it is not not September 30, 2023, A reconciliation of the beginning and ending amounts of our gross unrecognized tax benefits is as follows: Nine Months Ended September 30, 2023 Balance at January 1, 2023 $ 3,889 Increases (decreases) in tax positions related to prior periods (1,974 ) Balance at September 30, 2023 $ 1,915 The Company believes that it is reasonably possible that a decrease of up to $0.2 million in unrecognized tax benefits related to foreign exposures may	10. We are incorporated in the BVI. See Item 10.E, December 31, 2022, 2021 2020 Year Ended December 31, 2022 2021 2020 Current $ 2,972 $ 1,387 $ 186 Deferred 1,601 (1,619 ) (38 ) Total provision for (benefit from) income tax $ 4,573 $ (232 ) $ 148 We maintain the exception under ASC 740 270 30 36 Accounting for Income Taxes not As of December 31, 2022, A reconciliation of the beginning and ending amounts of our gross unrecognized tax benefits is as follows. Year Ended December 31, 2022 Balance at January 1 $ — Increases (decreases) in tax positions related to the current period — Increases (decreases) in tax positions related to prior periods 3,889 Increases (decreases) related to prior year tax positions as a result of lapse of statute — Balance at December 31 $ 3,889 We did not 2021 2020. The BVI does not December 31, 2022, 2021 2020: Year Ended December 31, 2022 2021 2020 Loss before income tax $ (32,068 ) $ (96,537 ) $ (21,381 ) Provision for (benefit from) income tax at weighted-average statutory rates — — — U.S. state and local income tax, net of federal benefit (3 ) 5 (4 ) U.S. foreign-derived intangible income deduction (141 ) (200 ) — Argentina Tax Inflation Adjustment 239 (381 ) (198 ) Change in valuation allowances 4,283 3,648 1,198 Uncertain tax positions 2,293 — — Change in carryforward attributes (1,740 ) — — Effect of rates different than statutory (423 ) (3,300 ) (828 ) Tax credits (112 ) — — Other 177 (4 ) (20 ) Total $ 4,573 $ (232 ) $ 148 The change in the effective tax rate from December 31, 2021 December 31, 2022 three Deferred tax assets and liabilities as of December 31, 2022 2021 December 31, 2022 2021 Deferred income tax assets: Stock-based compensation $ 3,023 $ 2,053 Bad debt expense 415 407 Deferred financing costs 806 — Other 193 419 Net operating loss carryforwards 1,365 6,245 Total deferred income tax assets 5,802 9,124 Valuation allowance (5,802 ) (7,484 ) Total deferred income tax assets (liabilities), net $ — $ 1,640 The assessment of the realizability of the deferred income tax assets is based on all available positive and negative evidence. Such evidence includes, but is not not Below is a summary of our estimated loss and tax credit carryforwards at December 31, 2022. may 382 383. Net Operating Loss Expiration Gross Amount Carried Forward Net Amount Recognized as of December 31, 2022 Argentina December 31, 2023 - December 31, 2027 $ 7,864 $ — Netherlands Indefinite 2,856 — China December 31, 2026 - December 31, 2027 2,258 — United States Indefinite 280 — Uruguay December 31, 2026 - December 31, 2027 19 — As of December 31, 2022 2021, In the normal course of business, we are subject to examination by taxing authorities. Tax years vary by jurisdiction, ranging from 2017 2022

Note 11 - Stockholders' Equity

Note 11 - Stockholders' Equity 1	9 Months Ended	12 Months Ended
	Sep. 30, 2023	Dec. 31, 2022
Notes to Financial Statements
Equity [Text Block]	11. Equity Reverse Recapitalization The Condensed Consolidated Statements of Redeemable Preferred Stock and Stockholders’ Equity reflect the Merger and reverse recapitalization as of January 2022 4 Preferred Stock Prior to the Merger, the Company’s authorized and issued preferred stock consisted of the following: Authorized Shares (prior to Merger) Issued and Outstanding Shares (as of December 31, 2021) Series A preferred stock 4,723,330 2,547,330 Series B preferred stock 3,117,915 1,392,131 Series B-1 preferred stock 899,153 672,524 Total preferred stock 8,740,398 4,611,985 In connection with the Merger, all shares of preferred stock were converted to shares of Class A ordinary shares. Preferred Stockholder Transaction In March 2021, The Columbia Warrant was initially recognized as a liability. The fair value of the Columbia Warrant was reclassified to additional paid-in capital in connection with the Merger. Common Stock We are authorized to issue unlimited Class A ordinary shares with a par value of $0.0001 per share. Holders of Class A ordinary shares are entitled to one September 30, 2023, In addition, we are authorized to issue unlimited shares of Class B ordinary shares with a par value of $0.0001 per share. Holders of Class B ordinary shares are entitled to 1.472467906 Holders of Class B ordinary shares have a number of votes per share equal to the number of votes controlled by the Liberty Investor. Class B ordinary shares will automatically convert to Class A ordinary shares at the five Treasury Stock On February 14, 2022, may We repurchased 516,123 Class A ordinary shares for $2.7 million during the nine September 30, 2022. not nine September 30, 2023. Hannover Holdings Transaction We repurchased 51,700 Class A ordinary shares, 134,735 shares of Series A preferred stock, and 15,082 shares of Series B- 1	11. Equity (Deficit) Reverse Recapitalization The Consolidated Statements of Redeemable Preferred Stock and Stockholders’ Equity (Deficit) reflect the Merger and reverse recapitalization as of January 2022 4 Preferred Stock Prior to the Merger, our authorized and issued preferred stock consisted of the following: Authorized Shares (prior to Merger) Issued and Outstanding Shares (as of December 31, 2021) Series A preferred stock 4,723,330 2,547,330 Series B preferred stock 3,117,915 1,392,131 Series B-1 preferred stock 899,153 672,524 Total preferred stock 8,740,398 4,611,985 In connection with the Merger, all shares of preferred stock were converted to shares of Class A ordinary shares. Preferred Stockholder Transaction In March 2021, 17 The Columbia Warrant was initially recognized as a liability. The fair value of the Columbia Warrant was reclassified to additional paid-in capital in connection with the Merger. See Note 6 Common Stock Our registration statement was filed on May 2, 2022 May 9, 2022. We are authorized to issue unlimited Class A ordinary shares with a par value of $0.0001 per share. Holders of Class A ordinary shares are entitled to one December 31, 2022, In addition, we are authorized to issue unlimited Class B ordinary shares with a par value of $0.0001 per share. Holders of Class B ordinary shares are entitled to 1.472467906 Holders of Class B ordinary shares have a number of votes per share equal to the number of votes controlled by the Liberty Investor. Class B ordinary shares will automatically convert to Class A ordinary shares at the five Treasury Stock On February 14, 2022, may We repurchased 516,123 Class A ordinary shares for $2.7 million during the year ended December 31, 2022. Hannover Holdings Transaction We repurchased 51,700 Class A ordinary shares, 134,735 shares of Series A preferred stock, and 15,082 shares of Series B- 1

Note 12 - Stock-based Compens_2

Note 12 - Stock-based Compensation 1	9 Months Ended	12 Months Ended
	Sep. 30, 2023	Dec. 31, 2022
Notes to Financial Statements
Share-Based Payment Arrangement [Text Block]	12. Our employees, including senior executives, receive incentives in the form of stock options and RSUs, whereby employees render services as consideration for equity instruments (equity-settled transactions). On the Closing Date, we established the Equity Incentive Plan, under which RSUs were issued. The Equity Incentive Plan provides for grant of options, stock appreciation rights, restricted stock awards, RSUs, shares granted as a bonus or in lieu of another award, dividend equivalents, or other stock-based awards or performance awards at the discretion of a board-elected committee. We also maintain our 2015 “2015 four December 31, 2022, no 2015 nine September 30, 2023 2022. A summary of stock option activity for the nine September 30, 2023 Number Weighted- Average Exercise Price Weighted- Average Remaining Contractual Term (years) Intrinsic Value (in thousands) Balance as of December 31, 2022 6,067,313 $ 1.83 2.07 Forfeited (425,178 ) 3.98 Exercised (186,307 ) 1.13 Expired (177,430 ) 2.27 Outstanding at September 30, 2023 5,278,398 $ 1.61 1.78 $ 1,041 Exercisable at September 30, 2023 4,594,898 $ 1.40 1.71 $ 1,000 As further detailed in Note 4 no nine September 30, 2023 2022. A summary of RSU activity for the nine September 30, 2023 Number of RSUs Intrinsic value (in thousands) Outstanding unvested RSUs at December 31, 2022 1,459,280 Granted during the year 3,369,167 Forfeited during the year (559,809 ) Vested during the year (494,287 ) Outstanding unvested RSUs at September 30, 2023 3,774,351 $ 4,416 The weighted-average grant-date price of RSUs at September 30, 2023 As of September 30, 2023, Stock-based Compensation Expense Total employee and non-employee stock-based compensation expense for the nine September 30, 2023 2022 Three Months Ended September 30, Nine Months Ended September 30, 2023 2022 2023 2022 General and administrative expenses $ 884 $ 554 $ 2,714 $ 2,240 Research and development expenses 312 781 933 1,753 Other operating expenses 218 804 607 2,631 Total $ 1,414 $ 2,139 $ 4,254 $ 6,624	12. Our employees, including senior executives, receive incentives in the form of stock options and RSUs, whereby employees render services as consideration for equity instruments (equity-settled transactions). On the Closing Date, we established the Equity Incentive Plan, under which RSUs were issued during the year ended December 31, 2022. 2015 “2015 four December 31, 2022, no 2015 December 31, 2022. A summary of stock option activity for the year ended December 31, 2022 Number Weighted-Average Exercise Price Weighted-Average Remaining Contractual Term (years) Intrinsic Value (in thousands) Balance as of December 31, 2021 6,864,563 $ 2.05 2.36 Granted — — Forfeited (574,299 ) 4.56 Exercised (102,825 ) 1.12 Expired (120,126 ) 2.60 Outstanding at December 31, 2022 6,067,313 $ 1.83 2.07 $ 10,818 Exercisable at December 31, 2022 4,449,152 $ 1.31 1.92 $ 8,832 The total intrinsic value of options exercised during the years ended December 31, 2022, 2021 2020 The following table lists the inputs used under the Black-Scholes model for stock-option awards during the years ended December 31, 2022, 2021, 2020, Year Ended December 31, 2022 2021 2020 Weighted-average fair value of options at the measurement date (grant date) $ — $23.36 $6.31 Dividend yield (%) — — — Expected volatility (%) — % 61 - 72 59 - 61 Risk-free interest rate (%) — % 0.5 - 1.4 0.4 - 0.5 Weighted average share price $ — $6.79 $2.75 As further detailed in Note 4 no December 31, 2022, 2021, 2020. A summary of RSU activity for the year ended December 31, 2022 Number Intrinsic Value (in thousands) Outstanding unvested RSUs at December 31, 2021 — Granted during the year 1,640,496 Forfeited during the year (60,823 ) Vested during the year (120,393 ) Expired during the year — Outstanding unvested RSUs at December 31, 2022 1,459,280 $ 1,940 The weighted-average exercise price of RSUs at December 31, 2022 As of December 31, 2022, Stock-based Compensation Expense Total employee and non-employee stock-based compensation expense for the years ended December 31, 2022, 2021, 2020 Year Ended December 31, 2022 2021 2020 General and administrative expenses $ 2,406 $ 5,274 $ 1,235 Research and development 3,631 1,968 382 Other operating expenses 2,331 3,639 115 Total $ 8,368 $ 10,881 $ 1,732

Note 13 - Redeemable Preferre_2

Note 13 - Redeemable Preferred Stock 1	9 Months Ended	12 Months Ended
	Sep. 30, 2023	Dec. 31, 2022
Notes to Financial Statements
Redeemable Preferred Stock [Text Block]	13. Reverse Recapitalization The redeemable Series X X X Upon the closing of the Merger (“Closing”), we cancelled and converted all 2,033,230 shares of issued and outstanding redeemable Series X As of September 30, 2023, X	13. Reverse Recapitalization The redeemable Series X X X Upon Closing, we canceled and converted all 2,033,230 shares of issued and outstanding redeemable Series X As of December 31, 2022, X

Note 14 - Net Loss Per Share 1

Note 14 - Net Loss Per Share 1	9 Months Ended	12 Months Ended
	Sep. 30, 2023	Dec. 31, 2022
Notes to Financial Statements
Earnings Per Share [Text Block]	14. The weighted-average number of shares of common stock outstanding prior to the Merger have been retroactively adjusted by the Exchange Ratio of 3.3028 (“Exchange Ratio”) to give effect to the reverse recapitalization treatment of the Merger. Shares of common stock issued as a result of redeemable Series X Diluted loss per share considers the impact of potentially dilutive securities. We identified financial instruments that qualify as potential common shares: (i) the share-based options awards described in Note 12 6 7 2022, The Columbia Warrant was dilutive due to the change in fair value of financial instruments during the nine September 30, 2022. Basic and diluted net loss per share attributable to common stockholders is calculated as follows: Three Months Ended September Nine Months Ended September 2023 2022 2023 2022 Net loss attributable to common stockholders $ (17,619 ) $ (14,823 ) $ (47,470 ) $ (22,944 ) Basic weighted-average common shares outstanding 89,739,310 89,002,430 89,476,065 81,221,550 Basic net loss per share for the period attributable to common stockholders $ (0.20 ) $ (0.17 ) $ (0.53 ) $ (0.28 ) Effect of dilutive securities: Net loss attributable to common stockholders $ (17,619 ) $ (14,823 ) $ (47,470 ) $ (22,944 ) Adjustment to numerator - Change in fair value of Columbia Warrant liability — (18,635 ) $ — $ (18,635 ) Dilutive numerator $ (17,619 ) $ (33,458 ) $ (47,470 ) $ (41,579 ) Columbia Warrant — 1,410,657 — 1,410,657 Diluted weighted-average common shares 89,739,310 90,413,087 89,476,065 82,632,207 Diluted net loss per share for the period attributable to common stockholders $ (0.20 ) $ (0.37 ) $ (0.53 ) $ (0.50 ) 1 4	14. The weighted-average number of shares of common stock outstanding prior to the Merger have been retroactively adjusted by the Exchange Ratio of 3.3028 (“Exchange Ratio”) to give effect to the reverse recapitalization treatment of the Merger. Shares of common stock issued as a result of redeemable Series X Diluted loss per share considers the impact of potentially dilutive securities. We identified financial instruments that qualify as potential common shares: (i) the share-based options awards described in Note 12 6 7 The Columbia Warrant was dilutive due to the change in fair value of financial instruments during the years ended December 31, 2022 2021. Basic and diluted net loss per share attributable to common stockholders is calculated as follows: Year Ended December 31, 2022 2021 2020 Net loss attributable to common stockholders $ (36,641 ) $ (96,305 ) $ (21,529 ) Basic weighted-average common shares outstanding (1) 83,188,276 16,655,634 16,029,826 Basic loss per share for the period attributable to common stockholders $ (0.44 ) $ (5.78 ) $ (1.34 ) Effect of dilutive securities: Adjustment to numerator - Change in fair value of Columbia Warrant liability $ (18,635 ) $ — $ — Dilutive numerator $ (55,276 ) $ (96,305 ) $ (21,529 ) Columbia Warrant 609,873 — — Diluted weighted-average common shares outstanding 83,798,149 16,655,634 16,029,826 Diluted loss per share for the period attributable to common stockholders $ (0.66 ) $ (5.78 ) $ (1.34 ) 1 4 Additionally, the following securities were not Year Ended December 31, 2022 2021 2020 Warrants 49,184,868 15,931,360 — Sponsor earnout shares 1,775,962 — — Stock options 6,067,313 6,864,563 4,694,314 Restricted stock units 1,459,280 — — Redeemable convertible preferred stock — 6,645,215 8,740,398 Total 58,487,423 29,441,138 13,434,712

Note 15 - Fair Value Measurem_2

Note 15 - Fair Value Measurement and Financial Instruments 1	9 Months Ended	12 Months Ended
	Sep. 30, 2023	Dec. 31, 2022
Notes to Financial Statements
Fair Value Disclosures [Text Block]	15. The following tables provide the fair value measurement hierarchy of the Company’s assets and liabilities: As of September 30, 2023 Fair value measurement using Financial instruments Quoted prices in active markets (Level 1) Significant observable inputs (Level 2) Significant unobservable inputs (Level 3) $8.63 Warrants liability $ 704 $ — $ — PIPE Warrant liability — — 59 Liberty Warrants and Liberty Advisory Fee Warrant liability — — 1,182 Total Warrant Liabilities $ 704 $ — $ 1,241 Sponsor Earnout Liability $ — $ — $ 223 As of December 31, 2022 Fair value measurement using Financial instruments Quoted prices in active markets (Level 1) Significant observable inputs (Level 2) Significant unobservable inputs (Level 3) $8.63 Warrants liability $ 1,833 $ — $ — PIPE Warrant liability — — 311 Liberty Warrants and Liberty Advisory Fee Warrant liability — — 6,191 Total Warrant Liabilities $ 1,833 $ — $ 6,502 Sponsor Earnout Liability $ — $ — $ 1,353 The following methods and assumptions were used to estimate the fair values: • The carrying values of cash and cash equivalents, restricted cash, accounts receivable, prepaid expenses and other current assets, accounts payable, and accrued expenses and other liabilities are considered to approximate their fair values due to the short term nature of these items. • The fair values of the PIPE Warrant, the Liberty Warrants and Liberty Advisory Fee Warrant have been estimated using the Black-Scholes model. Significant unobservable inputs include: ◦ Time to expiry - 3.4 years ◦ Volatility - 67% ◦ Risk free rate of return: 4.8% • The fair values of the Sponsor Earnout has been estimated using the Monte Carlo model. Significant unobservable inputs include: ◦ Time to expiry - 3.3 years ◦ Volatility - 67% ◦ Risk free rate of return: 4.8% • The fair values of the $8.63 • The carrying value of operating lease liabilities is calculated as the present value of lease payments, discounted at its incremental borrowing rate at the lease commencement date. We consider that the incremental borrowing rate remained unchanged, therefore the carrying amount of operating lease liabilities approximates their fair value. • Changes in the fair value of Level 3 three September 30, 2023 2022 Liberty Warrants and Liberty Advisory Fee Warrant PIPE Warrant Columbia Warrant Sponsor Earnout Forfeiture Earnout Cantor Loan At June 30, 2022 $ 15,377 $ 952 $ — $ 3,111 $ — $ — Issues — — — — — — Remeasurement (gain)/loss (4,026 ) (415 ) — (537 ) — — Write-off of deferred costs — — — — — — Settlements — — — — — — At September 30, 2022 $ 11,351 $ 537 $ — $ 2,574 $ — $ — At June 30, 2023 $ 2,339 $ 109 $ — $ 504 $ — $ — Remeasurement (gain)/loss (1,157 ) (50 ) — (281 ) — — At September 30, 2023 $ 1,182 $ 59 $ — $ 223 $ — $ — • Changes in the fair value of Level 3 nine September 30, 2023 2022 Liberty Warrants and Liberty Advisory Fee Warrant PIPE Warrant Columbia Warrant Sponsor Earnout Forfeiture Earnout Cantor Loan At January 1, 2022 $ — $ — $ 143,237 $ — $ — $ 7,522 Issues 30,853 1,312 — 8,022 6,135 — Remeasurement (gain)/loss (1) (19,502 ) (775 ) (18,635 ) (5,448 ) (5,130 ) 489 Write-off of deferred costs — — 203 — — — Settlements (2) — — (124,805 ) — (1,005 ) (8,011 ) At September 30, 2022 $ 11,351 $ 537 $ — $ 2,574 $ — $ — At January 1, 2023 $ 6,191 $ 311 $ — $ 1,353 $ — $ — Remeasurement (gain)/loss (1) (5,009 ) (252 ) — (1,130 ) — — At September 30, 2023 $ 1,182 $ 59 $ — $ 223 $ — $ — ( 1 Recognized in the Condensed Consolidated Statements of Operations and Comprehensive Loss for the nine September 30, 2023 2022, ( 2 These liabilities were settled in connection with the Merger. See Note 4 There were no 1 2 nine September 30, 2023 2022.	15. The following tables provide the fair value measurement hierarchy of our assets and liabilities: As of December 31, 2022 Fair value measurement using Financial instruments Quoted prices Significant Significant $8.63 Warrants liability $ 1,833 $ — $ — PIPE Warrant liability — — 311 Liberty Warrants and Liberty Advisory Fee Warrant liability — — 6,191 Total Warrant Liabilities $ 1,833 $ — $ 6,502 Sponsor Earnout liability $ — $ — $ 1,353 As of December 31, 2021 Fair value measurement using Financial instruments Quoted prices Significant Significant Liabilities measured at fair value Cantor Loan $ — $ — $ 7,522 Columbia Warrant liability — — 143,237 Liabilities for which fair values are disclosed Notes $ — $ 180,356 $ — Promissory notes — 40,925 — The following methods and assumptions were used to estimate the fair values: • The carrying values of cash and cash equivalents, restricted cash, accounts receivable, prepaid expenses and other current assets, accounts payable, and accrued expenses and other liabilities are considered to approximate their fair values due to the short-term nature of these items. • The fair values of the PIPE Warrant, the Liberty Warrants and Liberty Advisory Fee Warrant, and the Columbia Warrant have been estimated using the Black-Scholes model. • The fair value of the Sponsor Earnout has been estimated using the Monte Carlo model. • The fair values of the $8.63 Warrants were determined using the quoted prices in the active warrant market. • The carrying value of operating lease liabilities is calculated as the present value of lease payments, discounted at its incremental borrowing rate at the lease commencement date. We consider that the incremental borrowing rate remained unchanged, therefore the carrying amount of operating lease liabilities approximates its fair value. • The fair value of the Cantor Loan was determined by using the “with” method. At each measurement date, we valued the Cantor Loan with the make-whole premium. The difference between the aggregate fair value of the Cantor Loan and the unpaid principal balance was $22 thousand at December 31, 2021. • The fair value of the Notes debt is determined by using the “with” and “without” method. As of each measurement date, we first Changes in the fair value of Level 3 December 31, 2022 2021 Liberty Warrants and Liberty Advisory Fee Warrant PIPE Warrant Columbia Warrant Sponsor Earnout Forfeiture Earnout Cantor Loan At January 1, 2021 $ — $ — $ — $ — $ — $ — Issues — — 161,432 — — 7,513 Remeasurement (gain)/loss (1) — — (17,992 ) — — 9 Amortization of deferred costs — — (203 ) — — — At December 31, 2021 — — 143,237 — — 7,522 Issues 30,853 1,312 — 8,022 6,135 — Remeasurement (gain)/loss (1) (24,662 ) (1,001 ) (18,635 ) (6,669 ) (5,130 ) 488 Write-off of deferred costs — — 203 — — — Settlements (2) — — (124,805 ) — (1,005 ) (8,010 ) At December 31, 2022 $ 6,191 $ 311 $ — $ 1,353 $ — $ — ( 1 Recognized in the Consolidated Statements of Operations and Comprehensive Loss for the years ended December 31, 2022 2021, ( 2 These liabilities were settled in connection with the Merger. See Note 4 There were no 1 2 December 31, 2022 2021.

Note 16 - Related Parties 1

Note 16 - Related Parties 1	9 Months Ended	12 Months Ended
	Sep. 30, 2023	Dec. 31, 2022
Notes to Financial Statements
Related Party Transactions Disclosure [Text Block]	16. We had convertible notes with certain related parties that were settled in connection with the Merger. See Note 4 The following table provides the associated finance costs as follows: Three Months Ended September 30, Nine Months Ended September 30, 2023 2022 2023 2022 Convertible notes from related parties Interest expense on amounts owed to related parties $ — $ — $ — $ 44 There are no See description of transactions with CF&Co and Liberty Investment as part of the Merger Transaction described in Note 4 We made purchases totaling $1.4 million from our equity method investee, OS, in the nine September 30, 2023 September 30, 2023.	16. We had convertible notes with certain related parties at December 31, 2021. 4 December 31, 2022 2021 2020 Convertible notes debt from related parties Amounts owed to related parties $ — $ 13,028 $ — Interest expense $ 554 $ 620 $ 591 There are no See description of transactions with CF&Co and Liberty Investment as part of the Merger transaction described in Note 4 We made purchases totaling $456 from our equity method investee, OS, during the period beginning on the investment date to December 31, 2022. 21

Note 17 - Commitments and Conti

Note 17 - Commitments and Contingencies	9 Months Ended	12 Months Ended
	Sep. 30, 2023	Dec. 31, 2022
Notes to Financial Statements
Commitments and Contingencies Disclosure [Text Block]	17. Contingencies We may September 30, 2023 December 31, 2022, not	20. Contingencies We may December 31, 2022 December 31, 2021, not

Significant Accounting Policies

Significant Accounting Policies (Policies)	9 Months Ended	12 Months Ended
	Sep. 30, 2023	Dec. 31, 2022
Accounting Policies [Abstract]
Use of Estimates, Policy [Policy Text Block]	Use of Estimates The preparation of the Condensed Consolidated Financial Statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent liabilities at the date of the financial statements, and the reported amounts of revenue and expenses during the reporting period. Significant estimates and assumptions reflected in these Condensed Consolidated Financial Statements include, but are not may	Use of Estimates The preparation of the Consolidated Financial Statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent liabilities at the date of the financial statements, and the reported amounts of revenue and expenses during the reporting period. Significant estimates and assumptions reflected in these Consolidated Financial Statements include, but are not may
Revenue from Contract with Customer [Policy Text Block]	Revenue Recognition We recognize revenue in accordance with Topic 606, Revenue from contracts with customers. five Our main revenue stream is from services. We recognize as revenues, the amount of the transaction price that is allocated to the respective performance obligation when or as the performance obligation is satisfied. Revenue is recognized ratably over the subscription period or at the point in time upon delivery. Our satellite imagery can be delivered to customers in two The nature of our contracts does not not We evaluate contracts with a minimum purchase commitment to determine whether we expect to be entitled to a breakage amount. We consider the requirements on constraining estimates variable consideration. The following factors are evaluated when assessing the increased likelihood of a significant revenue reversal: (i) the amount of consideration is highly susceptible to factors outside our influence or control (e.g., volatility in a market, judgment of action of third not We exclude amounts collected on behalf of third Contract liabilities consist of payments received from customers, or such consideration that is contractually due, in advance of providing the product or performing services. We generally do not not may	Revenue Recognition We recognize revenue in accordance with Topic 606 Revenue from contracts with customers. five Our main revenue stream is from services. We recognize as revenues the amount of the transaction price that is allocated to the respective performance obligation when or as the performance obligation is satisfied. Generally, our performance obligations are transferred to customers at a point in time, typically upon delivery. Our satellite imagery can be delivered to customers in two The nature of our contracts does not not We evaluate contracts with a minimum purchase commitment to determine whether we expect to be entitled to a breakage amount. We consider the requirements on constraining estimates variable consideration. The following factors are evaluated when assessing the increased likelihood of a significant revenue reversal: (i) the amount of consideration is highly susceptible to factors outside our influence or control ( e.g., third not We exclude amounts collected on behalf of third Contract liabilities consist of payments received from customers, or such consideration that is contractually due, in advance of providing the product or performing services. We generally do not not may
Fair Value Measurement, Policy [Policy Text Block]	Fair Value Measurement Certain assets and liabilities are carried at fair value in accordance with U.S. GAAP. Valuation techniques used to measure fair value requires us to utilize observable and unobservable inputs. The hierarchy gives the highest priority to quoted prices in active markets for identical assets or liabilities (Level 1 3 one three first two • Level 1: • Level 2: • Level 3: Assets and liabilities recognized at fair value on a recurring basis in the Condensed Consolidated Financial Statements are re-assessed at the end of each reporting period to determine whether any transfers have occurred between levels in the hierarchy. For fair value disclosures, classes of assets and liabilities are based on the nature, characteristics and risks of the asset or liability and the level of the fair value hierarchy.	Fair Value Measurement Certain assets and liabilities are carried at fair value in accordance with U.S. GAAP. Valuation techniques used to measure fair value requires us to utilize observable and unobservable inputs. The hierarchy gives the highest priority to quoted prices in active markets for identical assets or liabilities (Level 1 3 one three first two • Level 1: • Level 2: • Level 3: Assets and liabilities recognized at fair value on a recurring basis in the Consolidated Financial Statements are re-assessed at the end of each reporting period to determine whether any transfers have occurred between levels in the hierarchy. For fair value disclosures, classes of assets and liabilities are based on the nature, characteristics and risks of the asset or liability and the level of the fair value hierarchy.
Concentration Risk, Credit Risk, Policy [Policy Text Block]	Credit risk management Credit risk is the risk that a counterparty fails to discharge an obligation to us. We are exposed to credit risk from financial assets including cash, cash equivalents and restricted cash held at banks, trade and other receivables. The credit risk is managed based on our credit risk management policies and procedures. Credit risk of any entity doing business with us is systematically analyzed, including aspects of a qualitative nature. The measurement and assessment of our total exposure to credit risk covers all financial instruments involving any counterparty risk. The credit risk in respect of cash balances held with banks and deposits with banks are managed via diversification of bank deposits and are only with major reputable financial institutions. As our risk exposure is mainly influenced by the individual characteristics of each customer, we continuously analyze the creditworthiness of significant debtors. Accounts receivable are non-interest bearing and generally on terms of 30 90 September 30, 2023 two December 31, 2022, one Two customers accounted for more than 10% of our revenue totaling $0.9 million for the three September 30, 2023 one three September 30, 2022. nine September 30, 2023 nine September 30, 2022. The Company contracts with certain third	Credit risk management Credit risk is the risk that a counterparty fails to discharge an obligation to us. We are exposed to credit risk from financial assets including cash, cash equivalents and restricted cash held at banks, trade and other receivables. The credit risk is managed based on our credit risk management policies and procedures. Credit risk of any entity doing business with us is systematically analyzed, including aspects of a qualitative nature. The measurement and assessment of our total exposure to credit risk covers all financial instruments involving any counterparty risk. The credit risk in respect of cash balances held with banks and deposits with banks are managed via diversification of bank deposits and are only with major reputable financial institutions. As our risk exposure is mainly influenced by the individual characteristics of each customer, we continuously analyze the creditworthiness of significant debtors. Accounts receivable are non-interest bearing and generally on terms of 30 90
Impairment or Disposal of Long-Lived Assets, Policy [Policy Text Block]	Impairment of Assets We assess potential impairments to long-lived assets whenever events or changes in circumstances indicate that the carrying amount may not September 30, 2023 not Estimates of future cash flows are highly subjective judgments based on management’s experience and knowledge of the Company's operations. These estimates can be significantly impacted by many factors, including changes in global economic conditions, operating costs, obsolescence of technology and competition. If estimates or underlying assumptions change in the future, we may	Impairment of Assets We assess potential impairments to long-lived assets whenever events or changes in circumstances indicate that the carrying amount may not December 31, 2022, 2021 2020 not Estimates of future cash flows are highly subjective judgments based on management’s experience and knowledge of the Company's operations. These estimates can be significantly impacted by many factors, including changes in global economic conditions, operating costs, obsolescence of technology and competition. If estimates or underlying assumptions change in the future, we may
Equity Method Investments [Policy Text Block]	Equity Method Investments We account for equity investments in which we have significant influence, but not may not September 30, 2023.	Equity Method Investments We account for equity investments in which we have significant influence, but not may not December 31, 2022. not 2021 2020.
Share-Based Payment Arrangement [Policy Text Block]	Stock-Based Compensation We measure and recognize all stock-based compensation expense based on estimated fair values for all stock-based awards made to employees and non-employees. Compensation cost is recognized over the requisite service period for each separate tranche, as though each tranche of the award is, in substance, a separate award. The expense calculation includes estimated forfeiture rates, which have been developed based upon historical experience. The fair values for stock options are calculated using the Black-Scholes option pricing model using the following inputs: Expected term - The simplified method is used to calculate the expected term. Expected volatility - We determine the expected stock price volatility based on the historical volatilities of guideline companies from comparable industries. Expected dividend yield - We do not not Risk-free interest rate - We base our interest rate on a treasury instrument for which the term is commensurate with the maximum expected life of the stock options. The fair values for restricted stock units ("RSUs") with service-based vesting conditions are calculated based upon our closing stock price on the date of the grant.	Stock-Based Compensation We measure and recognize all stock-based compensation expense based on estimated fair values for all stock-based awards made to employees and non-employees. Compensation cost is recognized over the requisite service period for each separate tranche, as though each tranche of the award is, in substance, a separate award. The expense calculation includes estimated forfeiture rates, which have been developed based upon historical experience. The fair values for stock options are calculated using the Black-Scholes option pricing model using the following inputs: Expected term - Expected volatility - Expected dividend yield - not not Risk-free interest rate - The fair values for restricted stock units ("RSUs") with service-based vesting conditions are calculated based upon our closing stock price on the date of the grant.
Foreign Currency Transactions and Translations Policy [Policy Text Block]	Foreign Currencies The financial position and results of operations of certain of our foreign subsidiaries are measured using the local currency as the functional currency. Revenues and expenses of these subsidiaries have been translated into U.S. dollars at average exchange rates prevailing during the period. Assets and liabilities of these subsidiaries have been translated at the exchange rates as of the balance sheet date. Translation gains and losses are recorded in accumulated other comprehensive loss. Aggregate foreign currency gains and losses, such as those resulting from the settlement of receivables or payables, foreign currency contracts and short-term intercompany advances in a currency other than the relevant subsidiary’s functional currency, are recorded currently in the Condensed Consolidated Statements of Operations and Comprehensive Loss (included in other income, net) and resulted in gains of $1.8 million and $1.1 million during the three September 30, 2023 2022, nine September 30, 2023 2022,	Foreign Currencies The financial position and results of operations of certain of our foreign subsidiaries are measured using the local currency as the functional currency. Revenues and expenses of these subsidiaries have been translated into U.S. dollars at average exchange rates prevailing during the period. Assets and liabilities of these subsidiaries have been translated at the exchange rates as of the balance sheet date. Translation gains and losses are recorded in accumulated other comprehensive loss. Aggregate foreign currency gains and losses, such as those resulting from the settlement of receivables or payables, foreign currency contracts and short-term intercompany advances in a currency other than the relevant subsidiary’s functional currency, are recorded currently in the Consolidated Statements of Operations and Comprehensive Loss (included in other income, net) and resulted in gains of $1,576, $1,022, and $594 during the years ended December 31, 2022, 2021, 2020,
Lessee, Leases [Policy Text Block]	Leases We determine if a contract is a lease or contains a lease at inception. On the lease commencement date, we recognize a right-of-use (“ROU”) asset and lease liability related to operating type leases. The cost of ROU assets includes the amount of lease liabilities recognized, initial direct costs incurred, and lease payments made at or before the commencement date less any lease incentives received. Operating lease liabilities are recorded based on the present value of the future lease fixed payments. In determining the present value of future lease payments, we use our incremental borrowing rate applicable to the economic environment and the duration of the lease based on the information available at the commencement date as the majority of leases do not 12 not We remeasure and reallocate the consideration in a lease when there is a modification of the lease that is not We account for lease agreements with contractually required lease and non-lease components on a combined basis. Lease payments made for cancellable leases, variable amounts that are not 12 For the periods presented, the Company does not For the three September 30, 2023 2022, nine September 30, 2023 2022, September 30, 2023 December 31, 2022 nine September 30, 2023.	Leases We determine if a contract is a lease or contains a lease at inception. On the lease commencement date, we recognize a right-of-use (“ROU”) asset and lease liability related to operating type leases. The cost of ROU assets includes the amount of lease liabilities recognized, initial direct costs incurred, and lease payments made at or before the commencement date less any lease incentives received. Operating lease liabilities are recorded based on the present value of the future lease fixed payments. In determining the present value of future lease payments, we use our incremental borrowing rate applicable to the economic environment and the duration of the lease based on the information available at the commencement date as the majority of leases do not 12 not We remeasure and reallocate the consideration in a lease when there is a modification of the lease that is not We account for lease agreements with contractually required lease and non-lease components on a combined basis. Lease payments made for cancellable leases, variable amounts that are not 12 For the periods presented, we do not
Accounts Receivable [Policy Text Block]	Accounts Receivable and Allowance for Credit Losses Trade accounts receivable are stated at the amount owed by the customer, net of allowances for estimated credit losses, discounts, returns and rebates. We measure the allowance for credit losses based on the estimated loss. In calculating an allowance for credit losses, we use our historical experience, external indicators and an aging method. We assess impairment of trade accounts receivable on a collective basis as they possess shared credit risk characteristics, which have been grouped based on customer industry type. The Company also considers account size in its groupings and the days past due in its analysis. Accounts are written off against the allowance account when they are determined to be no nine September 30, 2023 2022: Nine Months Ended September 30, 2023 2022 Allowance for credit losses as of beginning of period $ 3,237 $ 1,794 Provision 80 1,736 Allowance for credit losses as of end of period $ 3,317 $ 3,530	Accounts Receivable and Allowance for Doubtful Accounts Trade accounts receivable are stated at the amount owed by the customer, net of allowances for estimated doubtful accounts, discounts, returns and rebates. We measure the allowance for doubtful accounts based on the estimated loss. In calculating an allowance for doubtful accounts, we use our historical experience, external indicators and an aging method. We assess impairment of trade accounts receivable on a collective basis as they possess shared credit risk characteristics which have been grouped based on the days past due. Accounts are written off against the allowance account when they are determined to be no December 31, 2022 2021: December 31, 2022 2021 Allowance for doubtful accounts as of beginning of period $ 1,794 $ — Provision 1,736 1,794 Write-offs — — Foreign exchange and other (293 ) — Allowance for doubtful accounts as of end of period $ 3,237 $ 1,794
Cash and Cash Equivalents, Restricted Cash and Cash Equivalents, Policy [Policy Text Block]	Cash, Cash Equivalents and Restricted Cash Cash and cash equivalents include deposits in banks and short-term (original maturities of three three Restricted cash, including amounts in Other non-current assets, represents amounts pledged as guarantees for sales and lease agreements as contractually required. September 30, December 31, Cash and cash equivalents $ 30,971 $ 76,528 Restricted cash — 126 Restricted cash included in Other non-current assets 1,151 1,138 Total cash, cash equivalents and restricted cash $ 32,122 $ 77,792	Cash, Cash Equivalents and Restricted Cash Cash and cash equivalents include deposits in banks and short-term (original maturities of three three Restricted cash, including amounts in Other non-current assets, represents amounts pledged as guarantees for sales and lease agreements as contractually required. December 31, 2022 2021 Cash and cash equivalents $ 76,528 $ 8,533 Restricted cash 126 — Restricted cash included in Other non-current assets 1,138 — Total cash, cash equivalents and restricted cash $ 77,792 $ 8,533 Cash Flow Information Year Ended December 31, 2022 2021 2020 Cash paid during the period for: Income tax, net of refunds $ 758 $ 96 $ 59 Interest $ 3,520 $ 49,283 $ 27,286

Note 2 - Summary of Significa_3

Note 2 - Summary of Significant Accounting Policies (Tables)	9 Months Ended	12 Months Ended
	Sep. 30, 2023	Dec. 31, 2022
Notes Tables
Accounts Receivable, Allowance for Credit Loss [Table Text Block]	Nine Months Ended September 30, 2023 2022 Allowance for credit losses as of beginning of period $ 3,237 $ 1,794 Provision 80 1,736 Allowance for credit losses as of end of period $ 3,317 $ 3,530	December 31, 2022 2021 Allowance for doubtful accounts as of beginning of period $ 1,794 $ — Provision 1,736 1,794 Write-offs — — Foreign exchange and other (293 ) — Allowance for doubtful accounts as of end of period $ 3,237 $ 1,794
Schedule of Cash and Cash Equivalents [Table Text Block]	September 30, December 31, Cash and cash equivalents $ 30,971 $ 76,528 Restricted cash — 126 Restricted cash included in Other non-current assets 1,151 1,138 Total cash, cash equivalents and restricted cash $ 32,122 $ 77,792	December 31, 2022 2021 Cash and cash equivalents $ 76,528 $ 8,533 Restricted cash 126 — Restricted cash included in Other non-current assets 1,138 — Total cash, cash equivalents and restricted cash $ 77,792 $ 8,533
Schedule of Cash Flow, Supplemental Disclosures [Table Text Block]		Year Ended December 31, 2022 2021 2020 Cash paid during the period for: Income tax, net of refunds $ 758 $ 96 $ 59 Interest $ 3,520 $ 49,283 $ 27,286

Note 4 - Reverse Recapitaliza_3

Note 4 - Reverse Recapitalization (Tables)	9 Months Ended	12 Months Ended
	Sep. 30, 2023	Dec. 31, 2022
Notes Tables
Schedule Of Reverse Recapitalization [Table Text Block]	Company stockholders Shares Class A stockholders immediately prior to merger 17,215,336 Series A preferred stockholders 7,968,316 Series B preferred stockholders 4,597,928 Series B-1 preferred stockholders 2,171,399 2018 convertible noteholders 5,581,416 2019 convertible noteholders 7,846,333 2020 convertible noteholders 4,553,205 Redeemable Series X preferred stockholders 2,140,340 Liberty investors 20,000,000 PIPE investors 5,816,770 Shares issued for Cantor loan repayment 788,021 Shares issued to Sponsor under Forward Purchase Securities Agreement 1,250,000 Issuance of shares for transaction fees 2,058,229 CF V shares 6,837,354 88,824,647	Company stockholders Shares Class A stockholders immediately prior to merger 17,215,336 Series A preferred stockholders 7,968,316 Series B preferred stockholders 4,597,928 Series B-1 preferred stockholders 2,171,399 2018 convertible noteholders 5,581,416 2019 convertible noteholders 7,846,333 2020 convertible noteholders 4,553,205 Redeemable Series X preferred stockholders 2,140,340 Liberty investors 20,000,000 PIPE investors 5,816,770 Shares issued for Cantor loan repayment 788,021 Shares issued to Sponsor under Forward Purchase Securities Agreement 1,250,000 Issuance of shares for transaction fees 2,058,229 CF V shares 6,837,354 88,824,647

Note 5 - Revenue from Contrac_3

Note 5 - Revenue from Contracts with Customers (Tables)	9 Months Ended	12 Months Ended
	Sep. 30, 2023	Dec. 31, 2022
Notes Tables
Disaggregation of Revenue [Table Text Block]	Three Months Ended September 30, Nine Months Ended September 30, 2023 2022 2023 2022 Revenue by timing Over time $ 413 $ — $ 1,236 $ 1,524 Point-in time 783 2,158 3,144 3,022 Total revenue $ 1,196 $ 2,158 $ 4,380 $ 4,546 Three Months Ended September 30, Nine Months Ended September 30, 2023 2022 2023 2022 Revenue by geography (1) (2) Asia Pacific $ 82 $ 232 $ 351 $ 1,946 Europe 513 43 1,506 80 North America 588 1,817 2,467 2,435 South America 13 66 56 85 Total revenue $ 1,196 $ 2,158 $ 4,380 $ 4,546	Year Ended December 31, 2022 2021 Revenue by geography (1) Asia Pacific $ 1,531 $ 3,988 North America 3,438 201 Other 1,043 58 Total revenue $ 6,012 $ 4,247
Contract with Customer, Contract Asset, Contract Liability, and Receivable [Table Text Block]	September 30, December 31, 2023 2022 Non-current $ 1,000 $ 1,000 Current 3,286 1,941 Total $ 4,286 $ 2,941	December 31, 2022 2021 Non-current $ 1,000 $ 1,000 Current 1,941 935 Total $ 2,941 $ 1,935
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Table Text Block]	Within 1 Year Years 2 Years 3 Thereafter Remaining performance obligations $ 6,852 $ 5,648 $ 5,005 $ 1,000	Within 1 Year Years 1-2 Years 2-3 Thereafter Remaining performance obligations $ 6,422 $ 11,296 $ 3,860 $ —

Note 6 - Warrant Liabilities (T

Note 6 - Warrant Liabilities (Tables)	9 Months Ended	12 Months Ended
	Sep. 30, 2023	Dec. 31, 2022
Notes Tables
Schedule Of Warrant Liability [Table Text Block]	Liberty Warrants and Liberty Advisory Fee Warrant PIPE Warrant $8.63 Warrants Total Warrants As of December 31, 2022 $ 6,191 $ 311 $ 1,833 $ 8,335 Warrants issued $ — $ — $ — $ — Change in fair value of financial instruments (5,009 ) (252 ) (1,129 ) (6,390 ) As of September 30, 2023 $ 1,182 $ 59 $ 704 $ 1,945	Liberty Warrants and Liberty Advisory Fee Warrant PIPE Warrant Columbia Warrant $8.63 Warrants Total Warrant Liabilities As of December 31, 2021 $ — $ — $ 143,237 $ — $ 143,237 Warrants issued $ 30,853 $ 1,312 $ — $ 4,872 $ 37,037 Change in fair value of financial instruments (24,662 ) (1,001 ) (18,635 ) (2,702 ) (47,000 ) Write-off of deferred costs — — 203 — 203 Settlements — — — (337 ) (337 ) Reclassification to equity — — (124,805 ) — (124,805 ) As of December 31, 2022 $ 6,191 $ 311 $ — $ 1,833 $ 8,335

Note 7 - Earnout Liabilities (T

Note 7 - Earnout Liabilities (Tables)	9 Months Ended	12 Months Ended
	Sep. 30, 2023	Dec. 31, 2022
Notes Tables
Schedule of Earnout Liability [Table Text Block]	Sponsor Earnout As of December 31, 2022 $ 1,353 Change in fair value of financial instruments (1,130 ) As of September 30, 2023 $ 223	Sponsor Earnout Forfeiture Earnout Total Earnout Liabilities As of December 31, 2021 $ — $ — $ — Additions $ 8,022 $ 6,135 $ 14,157 Change in fair value of financial instruments (6,669 ) (5,130 ) (11,799 ) Reclassification to equity — (1,005 ) (1,005 ) As of December 31, 2022 $ 1,353 $ — $ 1,353
Fair Value Measurement Inputs and Valuation Techniques [Table Text Block]	September 30, 2023 December 31, 2022 Expected term (in years) 3.32 4.07 Dividend yield (%) — % — % Expected volatility 67.3 % 50.4 % Risk-free interest rate 4.8 % 4.1 % Expected number of shares 1,775,962 1,775,962	January 25, December 31, 2022 2022 Expected term (in years) 5.00 4.07 Dividend yield (%) — — Expected volatility 30 % 50.4 % Risk-free interest rate 1.6 % 4.1 % Expected number of shares 1,842,759 1,775,962

Note 8 - Property and Equipme_3

Note 8 - Property and Equipment (Tables)	9 Months Ended	12 Months Ended
	Sep. 30, 2023	Dec. 31, 2022
Notes Tables
Property, Plant and Equipment [Table Text Block]	Estimated Useful Life (in years) September 30, December 31, Satellites and other equipment 3 - 5 $ 68,369 $ 54,370 Satellites under construction Not applicable 16,032 22,194 Leasehold improvements 5 - 10 7,601 6,433 Other property and equipment 3 - 10 4,227 4,146 Total property and equipment 96,229 87,143 Less: Accumulated depreciation (53,501 ) (39,162 ) Property and equipment, net $ 42,728 $ 47,981 September 30, December 31, Uruguay $ 37,991 $ 43,134 Argentina 930 1,346 Spain 828 729 Netherlands 11,820 9,471 Other countries 490 1,472 Total (1) (2) (3) $ 52,059 $ 56,152	December 31, Estimated Useful Life (in years) 2022 2021 Satellites in orbit 3 $ 54,370 $ 43,716 Satellites under construction Not applicable 22,194 10,558 Leasehold improvements 5 - 10 6,433 769 Other property and equipment 3 - 10 4,146 2,138 Total property and equipment 87,143 57,181 Less: Accumulated depreciation (39,162 ) (24,651 ) Property and equipment, net $ 47,981 $ 32,530 December 31, 2022 2021 Uruguay $ 43,134 $ 33,208 Argentina 1,346 1,250 Spain 729 791 Netherlands 9,471 — Other countries 1,472 236 Total (1) (2) (3) $ 56,152 $ 35,485

Note 9 - Additional Financial_3

Note 9 - Additional Financial Statement Information (Tables)	9 Months Ended	12 Months Ended
	Sep. 30, 2023	Dec. 31, 2022
Notes Tables
Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Table Text Block]	September 30, December 31, 2023 2022 Prepaid expenses and other current assets Prepaid expenses $ 2,604 $ 1,767 Advances to suppliers 228 588 Other current assets 413 843 Total $ 3,245 $ 3,198	December 31, 2022 2021 Prepaid expenses and other current assets Prepaid expenses $ 1,767 $ 1,153 Advances to suppliers 588 829 Other current assets 843 713 Total $ 3,198 $ 2,695
Schedule of Accrued Liabilities [Table Text Block]	September 30, December 31, 2023 2022 Accrued expenses and other liabilities Provisions 66 71 Payroll and benefits payable 2,111 3,289 Other taxes payable 5,373 3,128 Other 430 451 Total $ 7,980 $ 6,939 Total current $ 7,481 $ 6,417 Total non-current $ 499 $ 522	December 31, 2022 2021 Accrued expenses and other liabilities Accrued professional fees related to Merger (1) $ — $ 16,263 Provisions 71 2,934 Payroll and benefits payable 3,289 2,545 Other taxes payable 3,128 2,045 Other 451 2,200 Total $ 6,939 $ 25,987 Total current $ 6,417 $ 23,435 Total non-current $ 522 $ 2,552
Schedule of Finance Costs, Net and Other Financial Income (Expense) [Table Text Block]	Three Months Ended September 30, Nine Months Ended September 30, 2023 2022 2023 2022 Finance income (expense), net Interest expense $ — $ (9 ) $ (3 ) $ (1,597 ) Redeemable Series X preferred stock dividends — — — (97 ) Other finance costs (38 ) (29 ) (103 ) (99 ) Interest income 427 419 1,577 568 Total $ 389 $ 381 $ 1,471 $ (1,225 )	Year Ended December 31, 2022 2021 2020 Finance costs, net Interest expense $ (1,596 ) $ (8,729 ) $ (43 ) Redeemable Series X preferred stock dividends (97 ) (974 ) — Other finance costs (123 ) (71 ) — Interest income 1,164 36 78 Total $ (652 ) $ (9,738 ) $ 35

Note 10 - Income Tax (Tables)

Note 10 - Income Tax (Tables)	9 Months Ended	12 Months Ended
	Sep. 30, 2023	Dec. 31, 2022
Notes Tables
Schedule of Components of Income Tax Expense (Benefit) [Table Text Block]	Three Months Ended September 30, Nine Months Ended September 30, 2023 2022 2023 2022 Loss before income tax $ (13,550 ) $ (11,840 ) $ (41,277 ) $ (17,818 ) Provision for income tax 4,069 2,983 $ 6,193 $ 5,126 Effective tax rate (30.0 %) (25.2 %) (15.0 %) (28.8 %)	Year Ended December 31, 2022 2021 2020 Current $ 2,972 $ 1,387 $ 186 Deferred 1,601 (1,619 ) (38 ) Total provision for (benefit from) income tax $ 4,573 $ (232 ) $ 148
Schedule of Unrecognized Tax Benefits Roll Forward [Table Text Block]	Nine Months Ended September 30, 2023 Balance at January 1, 2023 $ 3,889 Increases (decreases) in tax positions related to prior periods (1,974 ) Balance at September 30, 2023 $ 1,915	Year Ended December 31, 2022 Balance at January 1 $ — Increases (decreases) in tax positions related to the current period — Increases (decreases) in tax positions related to prior periods 3,889 Increases (decreases) related to prior year tax positions as a result of lapse of statute — Balance at December 31 $ 3,889
Schedule of Effective Income Tax Rate Reconciliation [Table Text Block]		Year Ended December 31, 2022 2021 2020 Loss before income tax $ (32,068 ) $ (96,537 ) $ (21,381 ) Provision for (benefit from) income tax at weighted-average statutory rates — — — U.S. state and local income tax, net of federal benefit (3 ) 5 (4 ) U.S. foreign-derived intangible income deduction (141 ) (200 ) — Argentina Tax Inflation Adjustment 239 (381 ) (198 ) Change in valuation allowances 4,283 3,648 1,198 Uncertain tax positions 2,293 — — Change in carryforward attributes (1,740 ) — — Effect of rates different than statutory (423 ) (3,300 ) (828 ) Tax credits (112 ) — — Other 177 (4 ) (20 ) Total $ 4,573 $ (232 ) $ 148
Schedule of Deferred Tax Assets and Liabilities [Table Text Block]		December 31, 2022 2021 Deferred income tax assets: Stock-based compensation $ 3,023 $ 2,053 Bad debt expense 415 407 Deferred financing costs 806 — Other 193 419 Net operating loss carryforwards 1,365 6,245 Total deferred income tax assets 5,802 9,124 Valuation allowance (5,802 ) (7,484 ) Total deferred income tax assets (liabilities), net $ — $ 1,640
Summary of Operating Loss Carryforwards [Table Text Block]		Net Operating Loss Expiration Gross Amount Carried Forward Net Amount Recognized as of December 31, 2022 Argentina December 31, 2023 - December 31, 2027 $ 7,864 $ — Netherlands Indefinite 2,856 — China December 31, 2026 - December 31, 2027 2,258 — United States Indefinite 280 — Uruguay December 31, 2026 - December 31, 2027 19 —

Note 11 - Stockholders' Equit_2

Note 11 - Stockholders' Equity (Tables)	9 Months Ended	12 Months Ended
	Sep. 30, 2023	Dec. 31, 2022
Notes Tables
Schedule of Stock by Class [Table Text Block]	Authorized Shares (prior to Merger) Issued and Outstanding Shares (as of December 31, 2021) Series A preferred stock 4,723,330 2,547,330 Series B preferred stock 3,117,915 1,392,131 Series B-1 preferred stock 899,153 672,524 Total preferred stock 8,740,398 4,611,985	Authorized Shares (prior to Merger) Issued and Outstanding Shares (as of December 31, 2021) Series A preferred stock 4,723,330 2,547,330 Series B preferred stock 3,117,915 1,392,131 Series B-1 preferred stock 899,153 672,524 Total preferred stock 8,740,398 4,611,985

Note 12 - Stock-based Compens_3

Note 12 - Stock-based Compensation (Tables)	9 Months Ended	12 Months Ended
	Sep. 30, 2023	Dec. 31, 2022
Notes Tables
Share-Based Payment Arrangement, Option, Activity [Table Text Block]	Number Weighted- Average Exercise Price Weighted- Average Remaining Contractual Term (years) Intrinsic Value (in thousands) Balance as of December 31, 2022 6,067,313 $ 1.83 2.07 Forfeited (425,178 ) 3.98 Exercised (186,307 ) 1.13 Expired (177,430 ) 2.27 Outstanding at September 30, 2023 5,278,398 $ 1.61 1.78 $ 1,041 Exercisable at September 30, 2023 4,594,898 $ 1.40 1.71 $ 1,000	Number Weighted-Average Exercise Price Weighted-Average Remaining Contractual Term (years) Intrinsic Value (in thousands) Balance as of December 31, 2021 6,864,563 $ 2.05 2.36 Granted — — Forfeited (574,299 ) 4.56 Exercised (102,825 ) 1.12 Expired (120,126 ) 2.60 Outstanding at December 31, 2022 6,067,313 $ 1.83 2.07 $ 10,818 Exercisable at December 31, 2022 4,449,152 $ 1.31 1.92 $ 8,832
Schedule of Share-Based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]		Year Ended December 31, 2022 2021 2020 Weighted-average fair value of options at the measurement date (grant date) $ — $23.36 $6.31 Dividend yield (%) — — — Expected volatility (%) — % 61 - 72 59 - 61 Risk-free interest rate (%) — % 0.5 - 1.4 0.4 - 0.5 Weighted average share price $ — $6.79 $2.75
Share-Based Payment Arrangement, Restricted Stock Unit, Activity [Table Text Block]	Number of RSUs Intrinsic value (in thousands) Outstanding unvested RSUs at December 31, 2022 1,459,280 Granted during the year 3,369,167 Forfeited during the year (559,809 ) Vested during the year (494,287 ) Outstanding unvested RSUs at September 30, 2023 3,774,351 $ 4,416	Number Intrinsic Value (in thousands) Outstanding unvested RSUs at December 31, 2021 — Granted during the year 1,640,496 Forfeited during the year (60,823 ) Vested during the year (120,393 ) Expired during the year — Outstanding unvested RSUs at December 31, 2022 1,459,280 $ 1,940
Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table Text Block]	Three Months Ended September 30, Nine Months Ended September 30, 2023 2022 2023 2022 General and administrative expenses $ 884 $ 554 $ 2,714 $ 2,240 Research and development expenses 312 781 933 1,753 Other operating expenses 218 804 607 2,631 Total $ 1,414 $ 2,139 $ 4,254 $ 6,624	Year Ended December 31, 2022 2021 2020 General and administrative expenses $ 2,406 $ 5,274 $ 1,235 Research and development 3,631 1,968 382 Other operating expenses 2,331 3,639 115 Total $ 8,368 $ 10,881 $ 1,732

Note 14 - Net Loss Per Share (T

Note 14 - Net Loss Per Share (Tables)	9 Months Ended	12 Months Ended
	Sep. 30, 2023	Dec. 31, 2022
Notes Tables
Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]	Three Months Ended September Nine Months Ended September 2023 2022 2023 2022 Net loss attributable to common stockholders $ (17,619 ) $ (14,823 ) $ (47,470 ) $ (22,944 ) Basic weighted-average common shares outstanding 89,739,310 89,002,430 89,476,065 81,221,550 Basic net loss per share for the period attributable to common stockholders $ (0.20 ) $ (0.17 ) $ (0.53 ) $ (0.28 ) Effect of dilutive securities: Net loss attributable to common stockholders $ (17,619 ) $ (14,823 ) $ (47,470 ) $ (22,944 ) Adjustment to numerator - Change in fair value of Columbia Warrant liability — (18,635 ) $ — $ (18,635 ) Dilutive numerator $ (17,619 ) $ (33,458 ) $ (47,470 ) $ (41,579 ) Columbia Warrant — 1,410,657 — 1,410,657 Diluted weighted-average common shares 89,739,310 90,413,087 89,476,065 82,632,207 Diluted net loss per share for the period attributable to common stockholders $ (0.20 ) $ (0.37 ) $ (0.53 ) $ (0.50 )	Year Ended December 31, 2022 2021 2020 Net loss attributable to common stockholders $ (36,641 ) $ (96,305 ) $ (21,529 ) Basic weighted-average common shares outstanding (1) 83,188,276 16,655,634 16,029,826 Basic loss per share for the period attributable to common stockholders $ (0.44 ) $ (5.78 ) $ (1.34 ) Effect of dilutive securities: Adjustment to numerator - Change in fair value of Columbia Warrant liability $ (18,635 ) $ — $ — Dilutive numerator $ (55,276 ) $ (96,305 ) $ (21,529 ) Columbia Warrant 609,873 — — Diluted weighted-average common shares outstanding 83,798,149 16,655,634 16,029,826 Diluted loss per share for the period attributable to common stockholders $ (0.66 ) $ (5.78 ) $ (1.34 )
Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block]		Year Ended December 31, 2022 2021 2020 Warrants 49,184,868 15,931,360 — Sponsor earnout shares 1,775,962 — — Stock options 6,067,313 6,864,563 4,694,314 Restricted stock units 1,459,280 — — Redeemable convertible preferred stock — 6,645,215 8,740,398 Total 58,487,423 29,441,138 13,434,712

Note 15 - Fair Value Measurem_3

Note 15 - Fair Value Measurement and Financial Instruments (Tables)	9 Months Ended	12 Months Ended
	Sep. 30, 2023	Dec. 31, 2022
Notes Tables
Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block]	As of September 30, 2023 Fair value measurement using Financial instruments Quoted prices in active markets (Level 1) Significant observable inputs (Level 2) Significant unobservable inputs (Level 3) $8.63 Warrants liability $ 704 $ — $ — PIPE Warrant liability — — 59 Liberty Warrants and Liberty Advisory Fee Warrant liability — — 1,182 Total Warrant Liabilities $ 704 $ — $ 1,241 Sponsor Earnout Liability $ — $ — $ 223 As of December 31, 2022 Fair value measurement using Financial instruments Quoted prices in active markets (Level 1) Significant observable inputs (Level 2) Significant unobservable inputs (Level 3) $8.63 Warrants liability $ 1,833 $ — $ — PIPE Warrant liability — — 311 Liberty Warrants and Liberty Advisory Fee Warrant liability — — 6,191 Total Warrant Liabilities $ 1,833 $ — $ 6,502 Sponsor Earnout Liability $ — $ — $ 1,353	As of December 31, 2022 Fair value measurement using Financial instruments Quoted prices Significant Significant $8.63 Warrants liability $ 1,833 $ — $ — PIPE Warrant liability — — 311 Liberty Warrants and Liberty Advisory Fee Warrant liability — — 6,191 Total Warrant Liabilities $ 1,833 $ — $ 6,502 Sponsor Earnout liability $ — $ — $ 1,353 As of December 31, 2021 Fair value measurement using Financial instruments Quoted prices Significant Significant Liabilities measured at fair value Cantor Loan $ — $ — $ 7,522 Columbia Warrant liability — — 143,237 Liabilities for which fair values are disclosed Notes $ — $ 180,356 $ — Promissory notes — 40,925 —
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block]	Liberty Warrants and Liberty Advisory Fee Warrant PIPE Warrant Columbia Warrant Sponsor Earnout Forfeiture Earnout Cantor Loan At June 30, 2022 $ 15,377 $ 952 $ — $ 3,111 $ — $ — Issues — — — — — — Remeasurement (gain)/loss (4,026 ) (415 ) — (537 ) — — Write-off of deferred costs — — — — — — Settlements — — — — — — At September 30, 2022 $ 11,351 $ 537 $ — $ 2,574 $ — $ — At June 30, 2023 $ 2,339 $ 109 $ — $ 504 $ — $ — Remeasurement (gain)/loss (1,157 ) (50 ) — (281 ) — — At September 30, 2023 $ 1,182 $ 59 $ — $ 223 $ — $ — Liberty Warrants and Liberty Advisory Fee Warrant PIPE Warrant Columbia Warrant Sponsor Earnout Forfeiture Earnout Cantor Loan At January 1, 2022 $ — $ — $ 143,237 $ — $ — $ 7,522 Issues 30,853 1,312 — 8,022 6,135 — Remeasurement (gain)/loss (1) (19,502 ) (775 ) (18,635 ) (5,448 ) (5,130 ) 489 Write-off of deferred costs — — 203 — — — Settlements (2) — — (124,805 ) — (1,005 ) (8,011 ) At September 30, 2022 $ 11,351 $ 537 $ — $ 2,574 $ — $ — At January 1, 2023 $ 6,191 $ 311 $ — $ 1,353 $ — $ — Remeasurement (gain)/loss (1) (5,009 ) (252 ) — (1,130 ) — — At September 30, 2023 $ 1,182 $ 59 $ — $ 223 $ — $ —	Liberty Warrants and Liberty Advisory Fee Warrant PIPE Warrant Columbia Warrant Sponsor Earnout Forfeiture Earnout Cantor Loan At January 1, 2021 $ — $ — $ — $ — $ — $ — Issues — — 161,432 — — 7,513 Remeasurement (gain)/loss (1) — — (17,992 ) — — 9 Amortization of deferred costs — — (203 ) — — — At December 31, 2021 — — 143,237 — — 7,522 Issues 30,853 1,312 — 8,022 6,135 — Remeasurement (gain)/loss (1) (24,662 ) (1,001 ) (18,635 ) (6,669 ) (5,130 ) 488 Write-off of deferred costs — — 203 — — — Settlements (2) — — (124,805 ) — (1,005 ) (8,010 ) At December 31, 2022 $ 6,191 $ 311 $ — $ 1,353 $ — $ —

Note 16 - Related Parties (Tabl

Note 16 - Related Parties (Tables)	9 Months Ended	12 Months Ended
	Sep. 30, 2023	Dec. 31, 2022
Notes Tables
Schedule of Related Party Transactions [Table Text Block]	Three Months Ended September 30, Nine Months Ended September 30, 2023 2022 2023 2022 Convertible notes from related parties Interest expense on amounts owed to related parties $ — $ — $ — $ 44	December 31, 2022 2021 2020 Convertible notes debt from related parties Amounts owed to related parties $ — $ 13,028 $ — Interest expense $ 554 $ 620 $ 591

Note 17 - Debt (Tables)

Note 17 - Debt (Tables)	12 Months Ended
	Dec. 31, 2022
Notes Tables
Schedule of Debt [Table Text Block]	December 31, 2018 Convertible Notes $ 19,862 2019 Convertible Notes 27,498 2020 Convertible Notes 15,294 Cantor Loan 7,522 Columbia Loan 38,297 Total debt 108,473 Less deferred financing costs — Total debt less deferred financing fees 108,473 Less: Current portion — Total non-current debt, net of deferred financing fees $ 108,473

Note 18 - Leases (Tables)

Note 18 - Leases (Tables)	12 Months Ended
	Dec. 31, 2022
Notes Tables
Schedule of Change in Right-of-Use Assets [Table Text Block]	December 31, 2022 2021 Balance as of beginning of period $ 2,955 $ 1,403 Lease expense (1,701 ) (494 ) Foreign exchange differences 115 (48 ) Additions 7,171 2,119 Disposals (322 ) — Transfers (47 ) (25 ) Balance as of end of period $ 8,171 $ 2,955
Schedule of Change in Lease Liabilities [Table Text Block]	December 31, 2022 2021 Balance as of beginning of period $ 3,068 $ 1,415 Additions to operating lease liabilities 7,171 2,119 Lease expense 314 54 Foreign exchange differences (293 ) (48 ) Disposals (329 ) — Payments (1,692 ) (472 ) Balance as of end of period $ 8,239 $ 3,068 Total current $ 2,176 $ 985 Total non-current 6,063 2,083
Lease, Cost [Table Text Block]	Year Ended December 31, 2022 2021 2020 Right-of-use assets $ 1,701 $ 494 $ 247 Operating lease liabilities 314 54 51 Total lease expense $ 2,015 $ 548 $ 298
Lessee, Operating Lease, Liability, to be Paid, Maturity [Table Text Block]	Operating leases Years Ended 2023 $ 2,484 2024 2,235 2025 824 2026 603 2027 and thereafter 3,166 Total remaining lease payments 9,312 Less imputed interest (1,073 ) Present value of lease liability $ 8,239 Total current $ 2,176 Total non-current $ 6,063

Note 19 - Adoption of U.S. GA_2

Note 19 - Adoption of U.S. GAAP (Tables)	12 Months Ended
	Dec. 31, 2022
Notes Tables
Accounting Standards Update and Change in Accounting Principle [Table Text Block]	Year Ended December 31, 2021 IFRS Adjustments/ Note U.S. GAAP Revenue $ 4,247 $ — $ 4,247 Costs and expenses Cost of sales 1,876 — 1,876 General administrative expenses 36,649 (9 ) a, c 36,640 Research and development 9,640 (4 ) b 9,636 Depreciation expense 10,825 (97 ) b 10,728 Other operating expenses, net 14,002 — 14,002 Total costs and expenses 72,992 (110 ) 72,882 Operating loss (68,745 ) 110 (68,635 ) Other income (expense), net Finance costs, net (11,769 ) 2,031 c, d (9,738 ) Change in fair value of financial instruments (42,102 ) 60,085 d 17,983 Gain (loss) on extinguishment of debt 3,576 (40,792 ) d (37,216 ) Other income (expense), net 1,067 2 c 1,069 Total other income (expense), net (49,228 ) 21,326 (27,902 ) Loss before income tax (117,973 ) 21,436 (96,537 ) Income tax 232 — 232 Net loss available to common stockholders $ (117,741 ) $ 21,436 $ (96,305 ) Other comprehensive loss Foreign currency translation loss, net of tax (86 ) — (86 ) Comprehensive loss $ (117,827 ) $ 21,436 $ (96,391 ) Basic loss for the period attributable to common stockholders $ (7.07 ) $ 1.29 e $ (5.78 ) Basic weighted-average common shares outstanding 16,655,634 — e 16,655,634 Diluted loss for the period attributable to common stockholders $ (7.07 ) $ 1.29 e $ (5.78 ) Diluted weighted-average common shares outstanding 16,655,634 — e 16,655,634 Year Ended December 31, 2020 IFRS Adjustments/ Note U.S. GAAP Revenue $ — $ — $ — Costs and expenses Cost of sales — — — General administrative expenses 8,127 (124 ) a, c 8,003 Research and development 5,878 46 a, b 5,924 Depreciation expense 3,182 (151 ) b 3,031 Other operating expenses, net 5,476 (27 ) a, b 5,449 Total costs and expenses 22,663 (256 ) 22,407 Operating loss (22,663 ) 256 (22,407 ) Other income (expense), net Finance costs, net (22 ) 57 c, d 35 Change in fair value of financial instruments (84,224 ) 93,861 d 9,637 Gain (loss) on extinguishment of debt (7,466 ) (1,774 ) d (9,240 ) Other income (expense), net 597 (3 ) c 594 Total other income (expense), net (91,115 ) 92,141 1,026 Loss before income tax (113,778 ) 92,397 (21,381 ) Income tax (148 ) — (148 ) Net loss available to common stockholders $ (113,926 ) $ 92,397 $ (21,529 ) Other comprehensive loss Foreign currency translation loss, net of tax — — — Comprehensive loss $ (113,926 ) $ 92,397 $ (21,529 ) Basic loss for the period attributable to common stockholders $ (7.11 ) $ 5.76 e $ (1.34 ) Basic weighted-average common shares outstanding 16,029,826 — e 16,029,826 Diluted loss for the period attributable to common stockholders $ (7.11 ) $ 5.76 e $ (1.34 ) Diluted weighted-average common shares outstanding 16,029,826 — e 16,029,826 IFRS Adjustments / Note U.S. GAAP ASSETS Current assets Cash and cash equivalents $ 8,533 $ — $ 8,533 Accounts receivable 1,196 — 1,196 Prepaid expenses and other current assets 2,695 — 2,695 Total current assets 12,424 — 12,424 Property and equipment, net 33,586 (1,056 ) b 32,530 Operating lease right-of-use assets 2,663 292 c 2,955 Deferred income tax assets 1,640 — 1,640 Other non-current assets 369 — 369 Total assets $ 50,682 $ (764 ) $ 49,918 LIABILITIES, REDEEMABLE PREFERRED STOCK AND STOCKHOLDERS EQUITY (DEFICIT) Current liabilities Accounts payable $ 6,650 $ — $ 6,650 Debt 246,189 (137,716 ) d 108,473 Warrant liabilities — 143,237 d 143,237 Operating lease liabilities 891 94 c 985 Contract liabilities 935 — 935 Accrued expenses and other liabilities 23,435 — 23,435 Total current liabilities 278,100 5,615 283,715 Operating lease liabilities 1,908 175 c 2,083 Contract liabilities 1,000 — 1,000 Other non-current liabilities 2,552 — 2,552 Total liabilities 283,560 5,790 289,350 Redeemable preferred stock — 21,306 d 21,306 Stockholders’ equity (deficit) Treasury stock (170,949 ) — (170,949 ) Additional paid-in capital 235,909 (139,438 ) a, d 96,471 Accumulated other comprehensive loss (86 ) — (86 ) Accumulated deficit (297,752 ) 111,578 (186,174 ) Total stockholders’ equity (deficit) (232,878 ) (27,860 ) (260,738 ) Total liabilities, redeemable preferred stock and stockholders’ equity (deficit) $ 50,682 $ (764 ) $ 49,918 Year Ended December 31, (Consolidated Statement of Operations and Comprehensive Loss) 2021 2020 General and administrative expenses $ (80 ) $ (136 ) Research and development — (89 ) Other operating expenses — (27 ) Increase (decrease) to loss before income tax $ (80 ) $ (252 ) (Consolidated Balance Sheet) December 31, Additional paid-in-capital $ 542 Adjustment to accumulated deficit (542 ) Total liabilities, redeemable preferred stock and stockholders’ equity (deficit) $ — Year Ended December 31, (Consolidated Statement of Operations and Comprehensive Loss) 2021 2020 Research and development $ (4 ) $ 135 Depreciation expense (97 ) (151 ) Other operating expenses — — Increase (decrease) to loss before income tax $ (101 ) $ (16 ) (Consolidated Balance Sheet) December 31, Property and equipment, net $ (1,056 ) Total assets $ (1,056 ) Adjustment to accumulated deficit $ (1,056 ) Total liabilities, redeemable preferred stock and stockholders’ equity (deficit) $ (1,056 ) Year Ended December 31, (Consolidated Statement of Operations and Comprehensive Loss) 2021 2020 General and administrative expenses $ 71 $ 12 Less: Finance costs, net (49 ) (57 ) Less: Other income, net (2 ) 3 Increase (decrease) to loss before income tax $ 20 $ (42 ) (Consolidated Balance Sheet) December 31, Operating lease right-of-use assets $ 292 Total assets $ 292 Operating lease liabilities $ 94 Non-current operating lease liabilities 175 Adjustment to accumulated deficit 23 Total liabilities, redeemable preferred stock and stockholders’ equity (deficit) $ 292 Year Ended December 31, (Consolidated Statements of Operations and Comprehensive Loss) 2021 2020 Less: Finance costs, net $ (1,982 ) $ — Less: Change in fair value of financial instruments (60,085 ) (93,861 ) Less: Gain (Loss) on extinguishment of debt 40,792 1,774 Increase (decrease) to loss before income tax $ (21,275 ) $ (92,087 ) (Consolidated Balance Sheet) December 31, Debt $ (137,716 ) Redeemable Series X preferred stock 21,306 Warrant liability 143,237 Additional paid-in capital (139,980 ) Adjustment to accumulated deficit 113,153 Total liabilities, redeemable preferred stock and stockholders’ equity (deficit) $ — Year Ended December 31, 2021 2020 Net loss attributable to common stockholders $ (96,305 ) $ (21,529 ) Basic weighted-average common shares outstanding (1) 16,655,634 16,029,826 Basic loss per share for the period attributable to common stockholders $ (5.78 ) $ (1.34 ) Dilutive numerator $ (96,305 ) $ (21,529 ) Diluted weighted-average common shares outstanding 16,655,634 16,029,826 Diluted loss per share for the period attributable to common stockholders $ (5.78 ) $ (1.34 )

Note 2 - Summary of Significa_4

Note 2 - Summary of Significant Accounting Policies 1 (Tables)	9 Months Ended	12 Months Ended
	Sep. 30, 2023	Dec. 31, 2022
Notes Tables
Accounts Receivable, Allowance for Credit Loss [Table Text Block]	Nine Months Ended September 30, 2023 2022 Allowance for credit losses as of beginning of period $ 3,237 $ 1,794 Provision 80 1,736 Allowance for credit losses as of end of period $ 3,317 $ 3,530	December 31, 2022 2021 Allowance for doubtful accounts as of beginning of period $ 1,794 $ — Provision 1,736 1,794 Write-offs — — Foreign exchange and other (293 ) — Allowance for doubtful accounts as of end of period $ 3,237 $ 1,794
Schedule of Cash and Cash Equivalents [Table Text Block]	September 30, December 31, Cash and cash equivalents $ 30,971 $ 76,528 Restricted cash — 126 Restricted cash included in Other non-current assets 1,151 1,138 Total cash, cash equivalents and restricted cash $ 32,122 $ 77,792	December 31, 2022 2021 Cash and cash equivalents $ 76,528 $ 8,533 Restricted cash 126 — Restricted cash included in Other non-current assets 1,138 — Total cash, cash equivalents and restricted cash $ 77,792 $ 8,533

Note 4 - Reverse Recapitaliza_4

Note 4 - Reverse Recapitalization 1 (Tables)	9 Months Ended	12 Months Ended
	Sep. 30, 2023	Dec. 31, 2022
Notes Tables
Schedule Of Reverse Recapitalization [Table Text Block]	Company stockholders Shares Class A stockholders immediately prior to merger 17,215,336 Series A preferred stockholders 7,968,316 Series B preferred stockholders 4,597,928 Series B-1 preferred stockholders 2,171,399 2018 convertible noteholders 5,581,416 2019 convertible noteholders 7,846,333 2020 convertible noteholders 4,553,205 Redeemable Series X preferred stockholders 2,140,340 Liberty investors 20,000,000 PIPE investors 5,816,770 Shares issued for Cantor loan repayment 788,021 Shares issued to Sponsor under Forward Purchase Securities Agreement 1,250,000 Issuance of shares for transaction fees 2,058,229 CF V shares 6,837,354 88,824,647	Company stockholders Shares Class A stockholders immediately prior to merger 17,215,336 Series A preferred stockholders 7,968,316 Series B preferred stockholders 4,597,928 Series B-1 preferred stockholders 2,171,399 2018 convertible noteholders 5,581,416 2019 convertible noteholders 7,846,333 2020 convertible noteholders 4,553,205 Redeemable Series X preferred stockholders 2,140,340 Liberty investors 20,000,000 PIPE investors 5,816,770 Shares issued for Cantor loan repayment 788,021 Shares issued to Sponsor under Forward Purchase Securities Agreement 1,250,000 Issuance of shares for transaction fees 2,058,229 CF V shares 6,837,354 88,824,647

Note 5 - Revenue from Contrac_4

Note 5 - Revenue from Contracts with Customers 1 (Tables)	9 Months Ended	12 Months Ended
	Sep. 30, 2023	Dec. 31, 2022
Notes Tables
Disaggregation of Revenue [Table Text Block]	Three Months Ended September 30, Nine Months Ended September 30, 2023 2022 2023 2022 Revenue by timing Over time $ 413 $ — $ 1,236 $ 1,524 Point-in time 783 2,158 3,144 3,022 Total revenue $ 1,196 $ 2,158 $ 4,380 $ 4,546 Three Months Ended September 30, Nine Months Ended September 30, 2023 2022 2023 2022 Revenue by geography (1) (2) Asia Pacific $ 82 $ 232 $ 351 $ 1,946 Europe 513 43 1,506 80 North America 588 1,817 2,467 2,435 South America 13 66 56 85 Total revenue $ 1,196 $ 2,158 $ 4,380 $ 4,546	Year Ended December 31, 2022 2021 Revenue by geography (1) Asia Pacific $ 1,531 $ 3,988 North America 3,438 201 Other 1,043 58 Total revenue $ 6,012 $ 4,247
Contract with Customer, Contract Asset, Contract Liability, and Receivable [Table Text Block]	September 30, December 31, 2023 2022 Non-current $ 1,000 $ 1,000 Current 3,286 1,941 Total $ 4,286 $ 2,941	December 31, 2022 2021 Non-current $ 1,000 $ 1,000 Current 1,941 935 Total $ 2,941 $ 1,935
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Table Text Block]	Within 1 Year Years 2 Years 3 Thereafter Remaining performance obligations $ 6,852 $ 5,648 $ 5,005 $ 1,000	Within 1 Year Years 1-2 Years 2-3 Thereafter Remaining performance obligations $ 6,422 $ 11,296 $ 3,860 $ —

Note 6 - Warrant Liabilities 1

Note 6 - Warrant Liabilities 1 (Tables)	9 Months Ended	12 Months Ended
	Sep. 30, 2023	Dec. 31, 2022
Notes Tables
Schedule Of Warrant Liability [Table Text Block]	Liberty Warrants and Liberty Advisory Fee Warrant PIPE Warrant $8.63 Warrants Total Warrants As of December 31, 2022 $ 6,191 $ 311 $ 1,833 $ 8,335 Warrants issued $ — $ — $ — $ — Change in fair value of financial instruments (5,009 ) (252 ) (1,129 ) (6,390 ) As of September 30, 2023 $ 1,182 $ 59 $ 704 $ 1,945	Liberty Warrants and Liberty Advisory Fee Warrant PIPE Warrant Columbia Warrant $8.63 Warrants Total Warrant Liabilities As of December 31, 2021 $ — $ — $ 143,237 $ — $ 143,237 Warrants issued $ 30,853 $ 1,312 $ — $ 4,872 $ 37,037 Change in fair value of financial instruments (24,662 ) (1,001 ) (18,635 ) (2,702 ) (47,000 ) Write-off of deferred costs — — 203 — 203 Settlements — — — (337 ) (337 ) Reclassification to equity — — (124,805 ) — (124,805 ) As of December 31, 2022 $ 6,191 $ 311 $ — $ 1,833 $ 8,335

Note 7 - Earnout Liabilities 1

Note 7 - Earnout Liabilities 1 (Tables)	9 Months Ended	12 Months Ended
	Sep. 30, 2023	Dec. 31, 2022
Notes Tables
Schedule of Earnout Liability [Table Text Block]	Sponsor Earnout As of December 31, 2022 $ 1,353 Change in fair value of financial instruments (1,130 ) As of September 30, 2023 $ 223	Sponsor Earnout Forfeiture Earnout Total Earnout Liabilities As of December 31, 2021 $ — $ — $ — Additions $ 8,022 $ 6,135 $ 14,157 Change in fair value of financial instruments (6,669 ) (5,130 ) (11,799 ) Reclassification to equity — (1,005 ) (1,005 ) As of December 31, 2022 $ 1,353 $ — $ 1,353
Fair Value Measurement Inputs and Valuation Techniques [Table Text Block]	September 30, 2023 December 31, 2022 Expected term (in years) 3.32 4.07 Dividend yield (%) — % — % Expected volatility 67.3 % 50.4 % Risk-free interest rate 4.8 % 4.1 % Expected number of shares 1,775,962 1,775,962	January 25, December 31, 2022 2022 Expected term (in years) 5.00 4.07 Dividend yield (%) — — Expected volatility 30 % 50.4 % Risk-free interest rate 1.6 % 4.1 % Expected number of shares 1,842,759 1,775,962

Note 8 - Property and Equipme_4

Note 8 - Property and Equipment 1 (Tables)	9 Months Ended	12 Months Ended
	Sep. 30, 2023	Dec. 31, 2022
Notes Tables
Property, Plant and Equipment [Table Text Block]	Estimated Useful Life (in years) September 30, December 31, Satellites and other equipment 3 - 5 $ 68,369 $ 54,370 Satellites under construction Not applicable 16,032 22,194 Leasehold improvements 5 - 10 7,601 6,433 Other property and equipment 3 - 10 4,227 4,146 Total property and equipment 96,229 87,143 Less: Accumulated depreciation (53,501 ) (39,162 ) Property and equipment, net $ 42,728 $ 47,981 September 30, December 31, Uruguay $ 37,991 $ 43,134 Argentina 930 1,346 Spain 828 729 Netherlands 11,820 9,471 Other countries 490 1,472 Total (1) (2) (3) $ 52,059 $ 56,152	December 31, Estimated Useful Life (in years) 2022 2021 Satellites in orbit 3 $ 54,370 $ 43,716 Satellites under construction Not applicable 22,194 10,558 Leasehold improvements 5 - 10 6,433 769 Other property and equipment 3 - 10 4,146 2,138 Total property and equipment 87,143 57,181 Less: Accumulated depreciation (39,162 ) (24,651 ) Property and equipment, net $ 47,981 $ 32,530 December 31, 2022 2021 Uruguay $ 43,134 $ 33,208 Argentina 1,346 1,250 Spain 729 791 Netherlands 9,471 — Other countries 1,472 236 Total (1) (2) (3) $ 56,152 $ 35,485

Note 9 - Additional Financial_4

Note 9 - Additional Financial Statement Information 1 (Tables)	9 Months Ended	12 Months Ended
	Sep. 30, 2023	Dec. 31, 2022
Notes Tables
Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Table Text Block]	September 30, December 31, 2023 2022 Prepaid expenses and other current assets Prepaid expenses $ 2,604 $ 1,767 Advances to suppliers 228 588 Other current assets 413 843 Total $ 3,245 $ 3,198	December 31, 2022 2021 Prepaid expenses and other current assets Prepaid expenses $ 1,767 $ 1,153 Advances to suppliers 588 829 Other current assets 843 713 Total $ 3,198 $ 2,695
Schedule of Accrued Liabilities [Table Text Block]	September 30, December 31, 2023 2022 Accrued expenses and other liabilities Provisions 66 71 Payroll and benefits payable 2,111 3,289 Other taxes payable 5,373 3,128 Other 430 451 Total $ 7,980 $ 6,939 Total current $ 7,481 $ 6,417 Total non-current $ 499 $ 522	December 31, 2022 2021 Accrued expenses and other liabilities Accrued professional fees related to Merger (1) $ — $ 16,263 Provisions 71 2,934 Payroll and benefits payable 3,289 2,545 Other taxes payable 3,128 2,045 Other 451 2,200 Total $ 6,939 $ 25,987 Total current $ 6,417 $ 23,435 Total non-current $ 522 $ 2,552
Schedule of Finance Costs, Net and Other Financial Income (Expense) [Table Text Block]	Three Months Ended September 30, Nine Months Ended September 30, 2023 2022 2023 2022 Finance income (expense), net Interest expense $ — $ (9 ) $ (3 ) $ (1,597 ) Redeemable Series X preferred stock dividends — — — (97 ) Other finance costs (38 ) (29 ) (103 ) (99 ) Interest income 427 419 1,577 568 Total $ 389 $ 381 $ 1,471 $ (1,225 )	Year Ended December 31, 2022 2021 2020 Finance costs, net Interest expense $ (1,596 ) $ (8,729 ) $ (43 ) Redeemable Series X preferred stock dividends (97 ) (974 ) — Other finance costs (123 ) (71 ) — Interest income 1,164 36 78 Total $ (652 ) $ (9,738 ) $ 35

Note 10 - Income Tax 1 (Tables)

Note 10 - Income Tax 1 (Tables)	9 Months Ended	12 Months Ended
	Sep. 30, 2023	Dec. 31, 2022
Notes Tables
Schedule of Components of Income Tax Expense (Benefit) [Table Text Block]	Three Months Ended September 30, Nine Months Ended September 30, 2023 2022 2023 2022 Loss before income tax $ (13,550 ) $ (11,840 ) $ (41,277 ) $ (17,818 ) Provision for income tax 4,069 2,983 $ 6,193 $ 5,126 Effective tax rate (30.0 %) (25.2 %) (15.0 %) (28.8 %)	Year Ended December 31, 2022 2021 2020 Current $ 2,972 $ 1,387 $ 186 Deferred 1,601 (1,619 ) (38 ) Total provision for (benefit from) income tax $ 4,573 $ (232 ) $ 148
Schedule of Unrecognized Tax Benefits Roll Forward [Table Text Block]	Nine Months Ended September 30, 2023 Balance at January 1, 2023 $ 3,889 Increases (decreases) in tax positions related to prior periods (1,974 ) Balance at September 30, 2023 $ 1,915	Year Ended December 31, 2022 Balance at January 1 $ — Increases (decreases) in tax positions related to the current period — Increases (decreases) in tax positions related to prior periods 3,889 Increases (decreases) related to prior year tax positions as a result of lapse of statute — Balance at December 31 $ 3,889

Note 11 - Stockholders' Equit_3

Note 11 - Stockholders' Equity 1 (Tables)	9 Months Ended	12 Months Ended
	Sep. 30, 2023	Dec. 31, 2022
Notes Tables
Schedule of Stock by Class [Table Text Block]	Authorized Shares (prior to Merger) Issued and Outstanding Shares (as of December 31, 2021) Series A preferred stock 4,723,330 2,547,330 Series B preferred stock 3,117,915 1,392,131 Series B-1 preferred stock 899,153 672,524 Total preferred stock 8,740,398 4,611,985	Authorized Shares (prior to Merger) Issued and Outstanding Shares (as of December 31, 2021) Series A preferred stock 4,723,330 2,547,330 Series B preferred stock 3,117,915 1,392,131 Series B-1 preferred stock 899,153 672,524 Total preferred stock 8,740,398 4,611,985

Note 12 - Stock-based Compens_4

Note 12 - Stock-based Compensation 1 (Tables)	9 Months Ended	12 Months Ended
	Sep. 30, 2023	Dec. 31, 2022
Notes Tables
Share-Based Payment Arrangement, Option, Activity [Table Text Block]	Number Weighted- Average Exercise Price Weighted- Average Remaining Contractual Term (years) Intrinsic Value (in thousands) Balance as of December 31, 2022 6,067,313 $ 1.83 2.07 Forfeited (425,178 ) 3.98 Exercised (186,307 ) 1.13 Expired (177,430 ) 2.27 Outstanding at September 30, 2023 5,278,398 $ 1.61 1.78 $ 1,041 Exercisable at September 30, 2023 4,594,898 $ 1.40 1.71 $ 1,000	Number Weighted-Average Exercise Price Weighted-Average Remaining Contractual Term (years) Intrinsic Value (in thousands) Balance as of December 31, 2021 6,864,563 $ 2.05 2.36 Granted — — Forfeited (574,299 ) 4.56 Exercised (102,825 ) 1.12 Expired (120,126 ) 2.60 Outstanding at December 31, 2022 6,067,313 $ 1.83 2.07 $ 10,818 Exercisable at December 31, 2022 4,449,152 $ 1.31 1.92 $ 8,832
Share-Based Payment Arrangement, Restricted Stock Unit, Activity [Table Text Block]	Number of RSUs Intrinsic value (in thousands) Outstanding unvested RSUs at December 31, 2022 1,459,280 Granted during the year 3,369,167 Forfeited during the year (559,809 ) Vested during the year (494,287 ) Outstanding unvested RSUs at September 30, 2023 3,774,351 $ 4,416	Number Intrinsic Value (in thousands) Outstanding unvested RSUs at December 31, 2021 — Granted during the year 1,640,496 Forfeited during the year (60,823 ) Vested during the year (120,393 ) Expired during the year — Outstanding unvested RSUs at December 31, 2022 1,459,280 $ 1,940
Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table Text Block]	Three Months Ended September 30, Nine Months Ended September 30, 2023 2022 2023 2022 General and administrative expenses $ 884 $ 554 $ 2,714 $ 2,240 Research and development expenses 312 781 933 1,753 Other operating expenses 218 804 607 2,631 Total $ 1,414 $ 2,139 $ 4,254 $ 6,624	Year Ended December 31, 2022 2021 2020 General and administrative expenses $ 2,406 $ 5,274 $ 1,235 Research and development 3,631 1,968 382 Other operating expenses 2,331 3,639 115 Total $ 8,368 $ 10,881 $ 1,732

Note 14 - Net Loss Per Share 1

Note 14 - Net Loss Per Share 1 (Tables)	9 Months Ended	12 Months Ended
	Sep. 30, 2023	Dec. 31, 2022
Notes Tables
Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]	Three Months Ended September Nine Months Ended September 2023 2022 2023 2022 Net loss attributable to common stockholders $ (17,619 ) $ (14,823 ) $ (47,470 ) $ (22,944 ) Basic weighted-average common shares outstanding 89,739,310 89,002,430 89,476,065 81,221,550 Basic net loss per share for the period attributable to common stockholders $ (0.20 ) $ (0.17 ) $ (0.53 ) $ (0.28 ) Effect of dilutive securities: Net loss attributable to common stockholders $ (17,619 ) $ (14,823 ) $ (47,470 ) $ (22,944 ) Adjustment to numerator - Change in fair value of Columbia Warrant liability — (18,635 ) $ — $ (18,635 ) Dilutive numerator $ (17,619 ) $ (33,458 ) $ (47,470 ) $ (41,579 ) Columbia Warrant — 1,410,657 — 1,410,657 Diluted weighted-average common shares 89,739,310 90,413,087 89,476,065 82,632,207 Diluted net loss per share for the period attributable to common stockholders $ (0.20 ) $ (0.37 ) $ (0.53 ) $ (0.50 )	Year Ended December 31, 2022 2021 2020 Net loss attributable to common stockholders $ (36,641 ) $ (96,305 ) $ (21,529 ) Basic weighted-average common shares outstanding (1) 83,188,276 16,655,634 16,029,826 Basic loss per share for the period attributable to common stockholders $ (0.44 ) $ (5.78 ) $ (1.34 ) Effect of dilutive securities: Adjustment to numerator - Change in fair value of Columbia Warrant liability $ (18,635 ) $ — $ — Dilutive numerator $ (55,276 ) $ (96,305 ) $ (21,529 ) Columbia Warrant 609,873 — — Diluted weighted-average common shares outstanding 83,798,149 16,655,634 16,029,826 Diluted loss per share for the period attributable to common stockholders $ (0.66 ) $ (5.78 ) $ (1.34 )

Note 15 - Fair Value Measurem_4

Note 15 - Fair Value Measurement and Financial Instruments 1 (Tables)	9 Months Ended	12 Months Ended
	Sep. 30, 2023	Dec. 31, 2022
Notes Tables
Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block]	As of September 30, 2023 Fair value measurement using Financial instruments Quoted prices in active markets (Level 1) Significant observable inputs (Level 2) Significant unobservable inputs (Level 3) $8.63 Warrants liability $ 704 $ — $ — PIPE Warrant liability — — 59 Liberty Warrants and Liberty Advisory Fee Warrant liability — — 1,182 Total Warrant Liabilities $ 704 $ — $ 1,241 Sponsor Earnout Liability $ — $ — $ 223 As of December 31, 2022 Fair value measurement using Financial instruments Quoted prices in active markets (Level 1) Significant observable inputs (Level 2) Significant unobservable inputs (Level 3) $8.63 Warrants liability $ 1,833 $ — $ — PIPE Warrant liability — — 311 Liberty Warrants and Liberty Advisory Fee Warrant liability — — 6,191 Total Warrant Liabilities $ 1,833 $ — $ 6,502 Sponsor Earnout Liability $ — $ — $ 1,353	As of December 31, 2022 Fair value measurement using Financial instruments Quoted prices Significant Significant $8.63 Warrants liability $ 1,833 $ — $ — PIPE Warrant liability — — 311 Liberty Warrants and Liberty Advisory Fee Warrant liability — — 6,191 Total Warrant Liabilities $ 1,833 $ — $ 6,502 Sponsor Earnout liability $ — $ — $ 1,353 As of December 31, 2021 Fair value measurement using Financial instruments Quoted prices Significant Significant Liabilities measured at fair value Cantor Loan $ — $ — $ 7,522 Columbia Warrant liability — — 143,237 Liabilities for which fair values are disclosed Notes $ — $ 180,356 $ — Promissory notes — 40,925 —
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block]	Liberty Warrants and Liberty Advisory Fee Warrant PIPE Warrant Columbia Warrant Sponsor Earnout Forfeiture Earnout Cantor Loan At June 30, 2022 $ 15,377 $ 952 $ — $ 3,111 $ — $ — Issues — — — — — — Remeasurement (gain)/loss (4,026 ) (415 ) — (537 ) — — Write-off of deferred costs — — — — — — Settlements — — — — — — At September 30, 2022 $ 11,351 $ 537 $ — $ 2,574 $ — $ — At June 30, 2023 $ 2,339 $ 109 $ — $ 504 $ — $ — Remeasurement (gain)/loss (1,157 ) (50 ) — (281 ) — — At September 30, 2023 $ 1,182 $ 59 $ — $ 223 $ — $ — Liberty Warrants and Liberty Advisory Fee Warrant PIPE Warrant Columbia Warrant Sponsor Earnout Forfeiture Earnout Cantor Loan At January 1, 2022 $ — $ — $ 143,237 $ — $ — $ 7,522 Issues 30,853 1,312 — 8,022 6,135 — Remeasurement (gain)/loss (1) (19,502 ) (775 ) (18,635 ) (5,448 ) (5,130 ) 489 Write-off of deferred costs — — 203 — — — Settlements (2) — — (124,805 ) — (1,005 ) (8,011 ) At September 30, 2022 $ 11,351 $ 537 $ — $ 2,574 $ — $ — At January 1, 2023 $ 6,191 $ 311 $ — $ 1,353 $ — $ — Remeasurement (gain)/loss (1) (5,009 ) (252 ) — (1,130 ) — — At September 30, 2023 $ 1,182 $ 59 $ — $ 223 $ — $ —	Liberty Warrants and Liberty Advisory Fee Warrant PIPE Warrant Columbia Warrant Sponsor Earnout Forfeiture Earnout Cantor Loan At January 1, 2021 $ — $ — $ — $ — $ — $ — Issues — — 161,432 — — 7,513 Remeasurement (gain)/loss (1) — — (17,992 ) — — 9 Amortization of deferred costs — — (203 ) — — — At December 31, 2021 — — 143,237 — — 7,522 Issues 30,853 1,312 — 8,022 6,135 — Remeasurement (gain)/loss (1) (24,662 ) (1,001 ) (18,635 ) (6,669 ) (5,130 ) 488 Write-off of deferred costs — — 203 — — — Settlements (2) — — (124,805 ) — (1,005 ) (8,010 ) At December 31, 2022 $ 6,191 $ 311 $ — $ 1,353 $ — $ —

Note 16 - Related Parties 1 (Ta

Note 16 - Related Parties 1 (Tables)	9 Months Ended	12 Months Ended
	Sep. 30, 2023	Dec. 31, 2022
Notes Tables
Schedule of Related Party Transactions [Table Text Block]	Three Months Ended September 30, Nine Months Ended September 30, 2023 2022 2023 2022 Convertible notes from related parties Interest expense on amounts owed to related parties $ — $ — $ — $ 44	December 31, 2022 2021 2020 Convertible notes debt from related parties Amounts owed to related parties $ — $ 13,028 $ — Interest expense $ 554 $ 620 $ 591

Note 1 - Nature of the Busine_3

Note 1 - Nature of the Business and Basis of Presentation (Details Textual) $ in Thousands	9 Months Ended		12 Months Ended
	Sep. 30, 2023 USD ($)	Sep. 30, 2022 USD ($)	Dec. 31, 2022 USD ($)	Dec. 31, 2021 USD ($)	Dec. 31, 2020 USD ($)
Number of Operating Segments	1		1
Retained Earnings (Accumulated Deficit)	$ (270,285)		$ (222,815)	$ (186,174)
Net Cash Provided by (Used in) Operating Activities	(36,132)	$ (54,763)	(68,462)	(28,439)	$ (11,174)
Cash and Cash Equivalents, at Carrying Value	$ 30,971		$ 76,528	$ 8,533

Note 2 - Summary of Significa_5

Note 2 - Summary of Significant Accounting Policies (Details Textual) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended		12 Months Ended
	Sep. 30, 2023	Sep. 30, 2022	Sep. 30, 2023	Sep. 30, 2022	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Equity Method Investment, Other than Temporary Impairment					$ 0
Payments to Acquire Equity Method Investments			$ 0	$ 3,604	3,653	$ 0	$ 0
Gain (Loss), Foreign Currency Transaction, after Tax	$ 1,800	$ 1,100	$ 3,700	$ 1,600	$ 1,576	$ 1,022	$ 594

Note 2 - Summary of Significa_6

Note 2 - Summary of Significant Accounting Policies - Summary of Allowance for Credit Losses (Details) - USD ($) $ in Thousands	9 Months Ended		12 Months Ended
	Sep. 30, 2023	Sep. 30, 2022	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Allowance for doubtful accounts as of beginning of period	$ 3,237	$ 1,794	$ 1,794	$ 0
Bad debt expense	80	1,736	1,736	1,794	$ 0
Write-offs			0	0
Foreign exchange and other			(293)	0
Allowance for doubtful accounts as of end of period	$ 3,317	$ 3,530	$ 3,237	$ 1,794	$ 0

Note 2 - Summary of Significa_7

Note 2 - Summary of Significant Accounting Policies - Schedule of Cash and Cash Equivalents (Details) - USD ($) $ in Thousands	Sep. 30, 2023	Dec. 31, 2022	Sep. 30, 2022	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Cash and cash equivalents	$ 30,971	$ 76,528		$ 8,533
Restricted cash	0	126		0
Restricted cash included in Other non-current assets	1,151	1,138		0
Total cash, cash equivalents and restricted cash	$ 32,122	$ 77,792	$ 97,307	$ 8,533	$ 17,267	$ 24,557

Note 2 - Summary of Significa_8

Note 2 - Summary of Significant Accounting Policies - Schedule of Cash Flow, Supplemental Disclosures (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Income tax, net of refunds	$ 758	$ 96	$ 59
Interest	$ 3,520	$ 49,283	$ 27,286

Note 4 - Reverse Recapitaliza_5

Note 4 - Reverse Recapitalization (Details Textual) $ / shares in Units, $ in Thousands				1 Months Ended	9 Months Ended	12 Months Ended
	Feb. 10, 2022 USD ($) $ / shares shares	Jan. 25, 2022 USD ($) $ / shares shares	Jan. 18, 2022 USD ($) $ / shares shares	Jul. 31, 2021 USD ($) $ / shares shares	Sep. 30, 2023	Dec. 31, 2022 USD ($)	Dec. 23, 2021 USD ($)
Proceeds From Reverse Recapitalization | $		$ 168,000				$ 168,000
Conversion of Stock, Shares Issued (in shares)		2,140,340
Recapitalization Exchange Ratio					3.3028	3.3028
C F V [Member] | Liberty Subscription Agreement [Member]
Proceeds from Issuance or Sale of Equity | $			$ 150,000
Canter Loan [Member] | Class A Common Stock Issued for Conversion of Promissory Note [Member]
Debt Conversion, Converted Instrument, Shares Issued (in shares)			788,021
Canter Loan [Member] | CF Securities [Member]
Debt Instrument, Face Amount | $							$ 7,500
Pipe Warrant [Member]
Class of Warrant or Right, Number of Securities Called by Warrants or Rights (in shares)		2,500,000
Class of Warrant or Right, Exercise Price of Warrants or Rights (in dollars per share) | $ / shares		$ 20
Proceeds from Issuance or Sale of Equity | $		$ 58,200
Forward Purchase Warrant [Member]
Class of Warrant or Right, Number of Securities Called by Warrants or Rights (in shares)				333,333
Class of Warrant or Right, Exercise Price of Warrants or Rights (in dollars per share) | $ / shares				$ 11.5
Proceeds from Issuance or Sale of Equity | $				$ 10,000
The 10 Dollar Liberty Warrant [Member] | C F V [Member]
Class of Warrant or Right, Number of Securities Called by Warrants or Rights (in shares)			5,000,000
Class of Warrant or Right, Exercise Price of Warrants or Rights (in dollars per share) | $ / shares			$ 10
The 15 Dollar Liberty Warrant [Member] | C F V [Member]
Class of Warrant or Right, Number of Securities Called by Warrants or Rights (in shares)			15,000,000
Class of Warrant or Right, Exercise Price of Warrants or Rights (in dollars per share) | $ / shares			$ 15
Advisory Fee Warrant [Member]
Class of Warrant or Right, Number of Securities Called by Warrants or Rights (in shares)	2,500,000
Class of Warrant or Right, Exercise Price of Warrants or Rights (in dollars per share) | $ / shares	$ 10
Class of Warrant or Right, Cash Portion of Advisory Fee | $	$ 1,250					$ 7,500
Class of Warrant or Right, Anniversary Period (Year)	18 years
Common Class A [Member]
Stock Issued During Period, Shares, New Issues (in shares)		5,816,770		1,250,000
Stock Issued During Period, Shares, Conversion of Convertible Securities (in shares)				1,250,000
Conversion of Stock, Shares Issued (in shares)		2,140,340
Common Class A [Member] | Transaction Fee Payment [Member]
Sale of Stock, Number of Shares Issued in Transaction (in shares)			2,058,229
Sale of Stock, Consideration Received on Transaction | $			$ 5,000
Common Class A [Member] | C F V [Member] | Liberty Subscription Agreement [Member]
Sale of Stock, Number of Shares Issued in Transaction (in shares)			20,000,000
Series X Preferred Stock [Member]
Conversion of Stock, Shares Converted (in shares)		2,033,230
Conversion of Stock, Amount Converted | $		$ 21,400

Note 4 - Reverse Recapitaliza_6

Note 4 - Reverse Recapitalization - Schedule of Reverse Recapitalization (Details)	Jan. 18, 2022 shares
Shares outstanding (in shares)	17,215,336
Issuance of shares for transaction fees (in shares)	2,058,229
Shares outstanding (in shares)	88,824,647
Forward Purchase Securities Agreement [Member]
Shares issued (in shares)	1,250,000
Cantor Loan Repayment [Member]
Shares issued (in shares)	788,021
Series A Preferred Stockholders [Member]
Shares issued (in shares)	7,968,316
Series B Preferred Stockholders [Member]
Shares issued (in shares)	4,597,928
Series B-1 Preferred Stockholders [Member]
Shares issued (in shares)	2,171,399
The 2018 Convertible Noteholders [Member]
Shares issued (in shares)	5,581,416
The 2019 Convertible Noteholders [Member]
Shares issued (in shares)	7,846,333
The 2020 Convertible Noteholders [Member]
Shares issued (in shares)	4,553,205
Redeemable Series X Preferred Stockholders [Member]
Shares issued (in shares)	2,140,340
Liberty Investors [Member]
Shares issued (in shares)	20,000,000
PIPE Investors [Member]
Shares issued (in shares)	5,816,770
CF V Sponsor [Member]
Shares issued (in shares)	6,837,354

Note 5 - Revenue from Contrac_5

Note 5 - Revenue from Contracts with Customers (Details Textual) $ in Thousands	3 Months Ended		9 Months Ended		12 Months Ended
	Sep. 30, 2023 USD ($)	Sep. 30, 2022 USD ($)	Sep. 30, 2023 USD ($)	Sep. 30, 2022 USD ($)	Dec. 31, 2022 USD ($)	Dec. 31, 2021 USD ($)	Dec. 31, 2020 USD ($)
Revenue from Contract with Customer, Excluding Assessed Tax	$ 1,196	$ 2,158	$ 4,380	$ 4,546	$ 6,012	$ 4,247	$ 0
Contract with Customer, Liability, Revenue Recognized			1,500	$ 900	$ 900	$ 500
Revenue Benchmark [Member] | Customer Concentration Risk [Member]
Number of Major Customers		1		1	2	1
Revenue Benchmark [Member] | Customer Concentration Risk [Member] | Two Customers [Member]
Revenue from Contract with Customer, Excluding Assessed Tax	$ 900		$ 4,400	$ 3,800	$ 4,800
Revenue Benchmark [Member] | Customer Concentration Risk [Member] | Two Customers [Member] | Minimum [Member]
Concentration Risk, Percentage	10%		10%	10%	10%
Revenue Benchmark [Member] | Customer Concentration Risk [Member] | One Customer [Member]
Revenue from Contract with Customer, Excluding Assessed Tax		$ 1,700				$ 3,900
Revenue Benchmark [Member] | Customer Concentration Risk [Member] | One Customer [Member] | Minimum [Member]
Concentration Risk, Percentage		10%				10%
Transferred over Time [Member]
Revenue from Contract with Customer, Excluding Assessed Tax	$ 413	$ 0	$ 1,236	$ 1,524	$ 1,600	$ 3,800
Transferred at Point in Time [Member]
Revenue from Contract with Customer, Excluding Assessed Tax	$ 783	$ 2,158	$ 3,144	$ 3,022	$ 4,400	$ 400

Note 5 - Revenue from Contrac_6

Note 5 - Revenue from Contracts with Customers - Revenue by Geography (Details) - USD ($) $ in Thousands		3 Months Ended				9 Months Ended				12 Months Ended
		Sep. 30, 2023		Sep. 30, 2022		Sep. 30, 2023		Sep. 30, 2022		Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Revenue		$ 1,196		$ 2,158		$ 4,380		$ 4,546		$ 6,012	$ 4,247	$ 0
Asia Pacific [Member]
Revenue	[2]	82	[1]	232	[1]	351	[1]	1,946	[1]	1,531	3,988
North America [Member]
Revenue	[2]	$ 588	[1]	$ 1,817	[1]	$ 2,467	[1]	$ 2,435	[1]	3,438	201
Other Countries [Member]
Revenue	[2]									$ 1,043	$ 58
[1]Certain comparative figures have been reclassified to conform to the current year presentation.[2]Revenue by geography is based on the geographical location of the customer.

Note 5 - Revenue from Contrac_7

Note 5 - Revenue from Contracts with Customers - Schedule of Contract Liabilities (Details) - USD ($) $ in Thousands	Sep. 30, 2023	Dec. 31, 2022	Dec. 31, 2021
Contract liabilities	$ 1,000	$ 1,000	$ 1,000
Current	3,286	1,941	935
Total	$ 4,286	$ 2,941	$ 1,935

Note 5 - Revenue from Contract

Note 5 - Revenue from Contract with Customer - Schedule of Remaining Performance Obligations 2 (Details) - USD ($) $ in Thousands	Sep. 30, 2023	Dec. 31, 2022
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2023-01-01
Remaining performance obligations		$ 6,422
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2023-10-01
Remaining performance obligations	$ 6,852
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2024-01-01
Remaining performance obligations	5,648	11,296
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2025-01-01
Remaining performance obligations	5,005	3,860
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2026-01-01
Remaining performance obligations	$ 1,000	$ 0

Note 5 - Revenue from Contrac_8

Note 5 - Revenue from Contract with Customer - Schedule of Remaining Performance Obligations (Details) (Parentheticals)	Sep. 30, 2023	Dec. 31, 2022
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2023-01-01
Remaining performance obligations, period (Year)		1 year
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2023-10-01
Remaining performance obligations, period (Year)	3 months
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2024-01-01
Remaining performance obligations, period (Year)	1 year	1 year
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2025-01-01
Remaining performance obligations, period (Year)	1 year	1 year
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2026-01-01
Remaining performance obligations, period (Year)	1 year	1 year

Note 6 - Warrant Liabilities (D

Note 6 - Warrant Liabilities (Details Textual) - USD ($) $ / shares in Units, $ in Thousands	1 Months Ended	9 Months Ended	12 Months Ended
	Mar. 31, 2021	Sep. 30, 2023	Dec. 31, 2022	May 06, 2022	Jan. 25, 2022	Jan. 24, 2022	Jan. 22, 2022	Jan. 18, 2022	Dec. 31, 2021	Mar. 08, 2021
Warrant Liability, Fair Value Disclosure		$ 1,945	$ 8,335						$ 143,237
Warrants and Rights Outstanding, Term (Year)				36 months
Fair Value Adjustment of Warrants		(6,390)	(47,000)
Warrant Liability, Reclassified to Equity			(124,805)
Liberty Warrants and Liberty Advisory Fee Warrant [Member]
Warrant Liability, Fair Value Disclosure		1,182	6,191					$ 30,900	0
Fair Value Adjustment of Warrants		(5,009)	(24,662)
Warrant Liability, Reclassified to Equity			0
Pipe Warrant [Member]
Warrant Liability, Fair Value Disclosure		59	311				$ 1,300		0
Class of Warrant or Right, Number of Securities Called by Warrants or Rights (in shares)					2,500,000
Class of Warrant or Right, Exercise Price of Warrants or Rights (in dollars per share)					$ 20
Fair Value Adjustment of Warrants		(252)	(1,001)
Warrant Liability, Reclassified to Equity			0
Columbia Warrant [Member]
Warrant Liability, Fair Value Disclosure			0						143,237	$ 161,200
Class of Warrant or Right, Exercise Price of Warrants or Rights (in dollars per share)	$ 2.51635975
Proceeds from Issuance of Warrants	$ 40,100
Warrants and Rights Outstanding, Term (Year)	25 years
Fair Value Adjustment of Warrants			(18,635)
Warrant Liability, Reclassified to Equity			(124,805)
Columbia Warrant [Member] | Common Stock [Member]
Class of Warrant or Right, Number of Securities Called by Warrants or Rights (in shares)	15,931,360
The 8.63 Warrants [Member]
Warrant Liability, Fair Value Disclosure		$ 704	$ 1,833		$ 4,900				$ 0
Class of Warrant or Right, Exercise Price of Warrants or Rights (in dollars per share)		$ 8.63	$ 8.63		$ 8.63	$ 11.5
Warrants and Rights Outstanding, Term (Year)					5 years
Fair Value Adjustment of Warrants		$ (1,129)	$ (2,702)
Warrant Liability, Reclassified to Equity			$ 0
Class of Warrant or Right, Redemption Price of Warrants or Rights (in dollars per share)					$ 13.5	$ 18
The 8.63 Warrants [Member] | Common Class A [Member]
Class of Warrant or Right, Number of Securities Called by Warrants or Rights (in shares)					8,333,333
The 8.63 Warrants [Member] | CF V Sponsor [Member]
Warrants and Rights Outstanding, Term (Year)					5 years
Stock Issued During Period, Shares, Warrants Exercised (in shares)			613,111
SPAC Public Warrants [Member | CF V Sponsor [Member] | Common Class A [Member]
Class of Warrant or Right, Number of Securities Called by Warrants or Rights (in shares)					8,333,333
SPAC Private Placement Warrants [Member] | CF V Sponsor [Member]
Class of Warrant or Right, Outstanding (in shares)					200,000
Forward Purchase Contract Warrant [Member] | CF V Sponsor [Member] | Common Class A [Member]
Class of Warrant or Right, Number of Securities Called by Warrants or Rights (in shares)					333,333

Note 6 - Warrant Liabilities -

Note 6 - Warrant Liabilities - Schedule of Warrant Liabilities (Details) - USD ($) $ in Thousands	9 Months Ended	12 Months Ended
	Sep. 30, 2023	Dec. 31, 2022
As of December 31, 2021	$ 8,335	$ 143,237
Warrants issued	0	37,037
Fair Value Adjustment of Warrants	(6,390)	(47,000)
Write-off of deferred costs		203
Settlements		(337)
Reclassification to equity		(124,805)
As of December 31, 2022	1,945	8,335
Liberty Warrants and Liberty Advisory Fee Warrant [Member]
As of December 31, 2021	6,191	0
Warrants issued	0	30,853
Fair Value Adjustment of Warrants	(5,009)	(24,662)
Write-off of deferred costs		0
Settlements		0
Reclassification to equity		0
As of December 31, 2022	1,182	6,191
Pipe Warrant [Member]
As of December 31, 2021	311	0
Warrants issued	0	1,312
Fair Value Adjustment of Warrants	(252)	(1,001)
Write-off of deferred costs		0
Settlements		0
Reclassification to equity		0
As of December 31, 2022	59	311
Columbia Warrant [Member]
As of December 31, 2021	0	143,237
Warrants issued		0
Fair Value Adjustment of Warrants		(18,635)
Write-off of deferred costs		203
Settlements		0
Reclassification to equity		(124,805)
As of December 31, 2022		0
The 8.63 Warrants [Member]
As of December 31, 2021	1,833	0
Warrants issued	0	4,872
Fair Value Adjustment of Warrants	(1,129)	(2,702)
Write-off of deferred costs		0
Settlements		(337)
Reclassification to equity		0
As of December 31, 2022	$ 704	$ 1,833

Note 7 - Earnout Liabilities (D

Note 7 - Earnout Liabilities (Details Textual) - USD ($) $ / shares in Units, $ in Thousands	Dec. 31, 2023	Sep. 30, 2023	Dec. 31, 2022	Jan. 25, 2022	Dec. 31, 2021	Jul. 05, 2021
Earnout Liability		$ 223	$ 1,353		$ 0
Sponsor Earnout [Member]
Earnout Liability		$ 223	1,353		0
Sponsor Earnout [Member] | Closing Price 1 [Member]
Contingent Consideration, Liability, Earnout Period, Stock Price Trigger (in dollars per share)						$ 12.5
Sponsor Earnout [Member] | Closing Price 2 [Member]
Contingent Consideration, Liability, Earnout Period, Stock Price Trigger (in dollars per share)						15
Sponsor Earnout [Member] | Closing Price 3 [Member]
Contingent Consideration, Liability, Earnout Period, Stock Price Trigger (in dollars per share)						$ 20
Sponsor Earnout [Member] | Common Class A [Member]
Contingent Consideration, Liability, Shares (in shares)						1,869,000
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number (in shares)	1,775,962	1,775,962
Forfeiture Earnout [Member]
Earnout Liability		$ 1,000	$ 1,000	$ 6,100	$ 0
Forfeiture Earnout [Member] | Closing Price 1 [Member]
Contingent Consideration, Liability, Earnout Period, Stock Price Trigger (in dollars per share)				$ 10
Forfeiture Earnout [Member] | Closing Price 2 [Member]
Contingent Consideration, Liability, Earnout Period, Stock Price Trigger (in dollars per share)				$ 15
Forfeiture Earnout [Member] | Common Class A [Member]
Contingent Consideration, Shares in Escrow (in shares)				310,127

Note 7 - Earnout Liabilities -

Note 7 - Earnout Liabilities - Schedule of Earnout Liabilities (Details) - USD ($) $ in Thousands	9 Months Ended	12 Months Ended
	Sep. 30, 2023	Dec. 31, 2022
Balance	$ 1,353	$ 0
Additions		14,157
Change in fair value of financial instruments		(11,799)
Reclassification to equity		(1,005)
Balance	223	1,353
Sponsor Earnout [Member]
Balance	1,353	0
Additions		8,022
Change in fair value of financial instruments	(1,130)	(6,669)
Reclassification to equity		0
Balance	223	1,353
Forfeiture Earnout [Member]
Balance	1,000	0
Additions		6,135
Change in fair value of financial instruments		(5,130)
Reclassification to equity		(1,005)
Balance	$ 1,000	$ 1,000

Note 7 - Earnout Liabilities _2

Note 7 - Earnout Liabilities - Schedule of Valuation Assumptions (Details) - Sponsor Earnout [Member]	Sep. 30, 2023	Dec. 31, 2022	Jan. 25, 2022
Measurement Input, Expected Term [Member]
Earnout liability, measurement input	3.32	4.07	5
Measurement Input, Expected Dividend Rate [Member]
Earnout liability, measurement input	0	0	0
Measurement Input, Price Volatility [Member]
Earnout liability, measurement input	0.673	0.504	0.30
Measurement Input, Risk Free Interest Rate [Member]
Earnout liability, measurement input	0.048	0.041	0.016
Measurement Input, Expected Number of Shares [Member]
Earnout liability, measurement input	1,775,962	1,775,962	1,842,759

Note 8 - Property and Equipme_5

Note 8 - Property and Equipment - Summary of Property and Equipment (Details) - USD ($) $ in Thousands		Sep. 30, 2023		Dec. 31, 2022		Dec. 31, 2021
Property and equipment, gross		$ 96,229		$ 87,143		$ 57,181
Less: Accumulated depreciation		(53,501)		(39,162)		(24,651)
Property and equipment, net		42,728		47,981		32,530
Property, Plant And Equipment And Operating Lease, Right-of-Use Assets	[1],[3]	52,059	[2]	56,152	[2],[4]	35,485	[4]
URUGUAY
Property, Plant And Equipment And Operating Lease, Right-of-Use Assets		37,991		43,134		33,208
ARGENTINA
Property, Plant And Equipment And Operating Lease, Right-of-Use Assets		930		1,346		1,250
SPAIN
Property, Plant And Equipment And Operating Lease, Right-of-Use Assets		828		729		791
NETHERLANDS
Property, Plant And Equipment And Operating Lease, Right-of-Use Assets		11,820		9,471		0
Other Countries [Member]
Property, Plant And Equipment And Operating Lease, Right-of-Use Assets		490		$ 1,472		236
Satellites in Orbit [Member]
Property and equipment, useful life (Year)				3 years
Property and equipment, gross				$ 54,370		43,716
Satellites Under Construction [Member]
Property and equipment, gross		16,032		22,194		10,558
Leasehold Improvements [Member]
Property and equipment, gross		$ 7,601		$ 6,433		769
Leasehold Improvements [Member] | Minimum [Member]
Property and equipment, useful life (Year)		5 years		5 years
Leasehold Improvements [Member] | Maximum [Member]
Property and equipment, useful life (Year)		10 years		10 years
Property, Plant and Equipment, Other Types [Member]
Property and equipment, gross		$ 4,227		$ 4,146		$ 2,138
Property, Plant and Equipment, Other Types [Member] | Minimum [Member]
Property and equipment, useful life (Year)		3 years		3 years
Property, Plant and Equipment, Other Types [Member] | Maximum [Member]
Property and equipment, useful life (Year)		10 years		10 years
[1]Non-current assets include property and equipment, net and operating lease right-of-use assets.[2]Presentation in the table is based on the geographic location of the entity that holds the assets.[3]We do not have any non-current assets in the country of incorporation of the holding company.[4]The presentation in the table above is based on the geographic location of the entity that holds the assets.

Note 9 - Additional Financial_5

Note 9 - Additional Financial Statement Information - Schedule of Prepaid and Other Current Assets (Details) - USD ($) $ in Thousands	Sep. 30, 2023	Dec. 31, 2022	Dec. 31, 2021
Prepaid expenses	$ 2,604	$ 1,767	$ 1,153
Advances to suppliers	228	588	829
Other current assets	413	843	713
Total	$ 3,245	$ 3,198	$ 2,695

Note 9 - Additional Financial_6

Note 9 - Additional Financial Statement Information - Schedule of Accrued Expenses and Other Liabilities (Details) - USD ($) $ in Thousands		Sep. 30, 2023	Dec. 31, 2022	Dec. 31, 2021
Accrued professional fees related to Merger(1)	[1]		$ 0	$ 16,263
Provisions		$ 66	71	2,934
Payroll and benefits payable		2,111	3,289	2,545
Other taxes payable		5,373	3,128	2,045
Other		430	451	2,200
Total		7,980	6,939	25,987
Accrued expenses and other liabilities		7,481	6,417	23,435
Other non-current liabilities		$ 499	$ 522	$ 2,552
[1]Refer to Note 4 (Reverse Recapitalization) for further details on the Merger.

Note 9 - Additional Financial_7

Note 9 - Additional Financial Statement Information - Schedule of Finance Costs, Net and Other Financial Income (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended		12 Months Ended
	Sep. 30, 2023	Sep. 30, 2022	Sep. 30, 2023	Sep. 30, 2022	Dec. 31, 2022	Dec. 31, 2021		Dec. 31, 2020
Interest expense	$ 0	$ 9	$ 3	$ 1,597	$ 1,596	$ 8,729		$ 43
Redeemable Series X preferred stock dividends	0	0	0	(97)	(97)	(974)		0
Other finance costs	(38)	(29)	(103)	(99)	(123)	(71)		0
Interest income	427	419	1,577	568	1,164	36		78
Total	$ 389	$ 381	$ 1,471	$ (1,225)	$ (652)	$ (9,738)	[1],[2]	$ 35	[1],[2]
[1]Under IFRS, all recognized leases are accounted for similarly to finance leases. Under U.S. GAAP, there is a dual classification on-balance sheet lease accounting model for lessees: finance and operating leases. Operating leases create a straight-line expense, and no interest expense is recognized on the lease liability.[2]Under IFRS, the redeemable Series X preferred shares and convertible notes contained conversion features that resulted in a bifurcated derivative component with changes in fair value recognized as gain or (loss). Under U.S. GAAP, the conversion features did not result in a material bifurcated embedded derivative, resulting in the elimination of the change in fair value of financial instruments, reduction in interest expense and preferred dividends expense, and increase in the gain (loss) on extinguishment of debt. Under IFRS, it was determined that the redeemable Series X preferred shares should be classified as a liability since there is a contractual obligation to deliver cash or another financial asset and certain conversion events being beyond our control. Under U.S. GAAP, it was determined that the redeemable Series X preferred shares should be classified as mezzanine equity since the shares are redeemable based on events outside of our control. Under IFRS, it was determined that the Columbia Warrant should be classified as equity since settlement would only occur by exchanging a fixed amount of cash for a fixed number of our own equity instruments. Changes in fair value are not recognized. Under U.S. GAAP, it was determined that the Columbia Warrant should be classified as a liability since the number and type of shares received could be different pre- and post- Merger. The Columbia Warrant is recorded at fair value with changes recognized in the Consolidated Statement of Operations and Comprehensive Loss. Additionally, the resulting gain (loss) on extinguishment of the amended convertible notes differed under IFRS versus U.S. GAAP.

Note 10 - Income Tax (Details T

Note 10 - Income Tax (Details Textual) - USD ($) Pure in Thousands, $ in Thousands	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020	Sep. 30, 2023
Unrecognized Tax Benefits	$ 3,889	$ 0	$ 0	$ 1,915
Unrecognized Tax Benefits that Would Impact Effective Tax Rate	$ 2,000
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent	0%	0%	0%
Operating Loss Carryforwards	$ 13,300	$ 20,900
Open Tax Year	2017 2018 2019 2020 2021 2022

Note 10 - Income Tax - Schedule

Note 10 - Income Tax - Schedule of Provision (Benefit) Income Tax (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended		12 Months Ended
	Sep. 30, 2023	Sep. 30, 2022	Sep. 30, 2023	Sep. 30, 2022	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Current					$ 2,972	$ 1,387	$ 186
Deferred tax expense (benefit)			$ 0	$ 5,126	1,601	(1,619)	(38)
Total provision for (benefit from) income tax	$ 4,069	$ 2,983	$ 6,193	$ 5,126	$ 4,573	$ (232)	$ 148

Note 10 - Income Tax - Schedu_2

Note 10 - Income Tax - Schedule of Unrecognized Tax Benefits (Details) $ in Thousands	12 Months Ended
	Dec. 31, 2022 USD ($)
Balance	$ 0
Increases (decreases) in tax positions related to the current period	0
Increases (decreases) in tax positions related to prior periods	3,889
Increases (decreases) related to prior year tax positions as a result of lapse of statute	0
Balance	$ 3,889

Note 10 - Income Tax - Schedu_3

Note 10 - Income Tax - Schedule of Reconciliation (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended		12 Months Ended
	Sep. 30, 2023	Sep. 30, 2022	Sep. 30, 2023	Sep. 30, 2022	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Loss before income tax	$ (13,550)	$ (11,840)	$ (41,277)	$ (17,818)	$ (32,068)	$ (96,537)	$ (21,381)
Provision for (benefit from) income tax at weighted-average statutory rates					0	0	0
U.S. state and local income tax, net of federal benefit					(3)	5	(4)
U.S. foreign-derived intangible income deduction					(141)	(200)	0
Argentina Tax Inflation Adjustment					239	(381)	(198)
Change in valuation allowances					4,283	3,648	1,198
Uncertain tax positions					2,293	0	0
Change in carryforward attributes					(1,740)	0	0
Effect of rates different than statutory					(423)	(3,300)	(828)
Tax credits					(112)	0	0
Other					177	(4)	(20)
Total provision for (benefit from) income tax	$ 4,069	$ 2,983	$ 6,193	$ 5,126	$ 4,573	$ (232)	$ 148

Note 10 - Income Tax - Schedu_4

Note 10 - Income Tax - Schedule of Deferred Tax Assets and Liabilities (Details) - USD ($) $ in Thousands	Dec. 31, 2022	Dec. 31, 2021
Stock-based compensation	$ 3,023	$ 2,053
Bad debt expense	415	407
Deferred financing costs	806	0
Other	193	419
Carried Forward	1,365	6,245
Total deferred income tax assets	5,802	9,124
Valuation allowance	(5,802)	(7,484)
Total deferred income tax assets (liabilities), net	$ 0	$ 1,640

Note 10 - Income Tax - Schedu_5

Note 10 - Income Tax - Schedule of Operating Loss and Tax Credit Carryforwards (Details) - USD ($) $ in Thousands	Dec. 31, 2022	Dec. 31, 2021
Carried Forward	$ 1,365	$ 6,245
Net Operating Loss	13,300	$ 20,900
The Argentine Tax Authority (AFIP) [Member]
Carried Forward	7,864
Net Operating Loss	0
Tax and Customs Administration, Netherlands [Member]
Carried Forward	2,856
Net Operating Loss	0
State Administration of Taxation, China [Member]
Carried Forward	2,258
Net Operating Loss	0
Internal Revenue Service (IRS) [Member]
Carried Forward	280
Net Operating Loss	0
General Taxation Directorate in Uruguay [Member]
Carried Forward	19
Net Operating Loss	$ 0

Note 11 - Stockholders' Equit_4

Note 11 - Stockholders' Equity (Details Textual) - USD ($) $ / shares in Units, $ in Thousands		9 Months Ended		12 Months Ended
	Apr. 06, 2022	Sep. 30, 2023	Sep. 30, 2022	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020	Feb. 14, 2022	Jan. 18, 2022	Jan. 17, 2022
Common Stock, Par or Stated Value Per Share (in dollars per share)		$ 0.0001		$ 0.0001	$ 0.0001
Common Stock, Shares, Outstanding (in shares)								88,824,647	17,215,336
Stock Repurchase Program, Authorized Amount							$ 5,000
Payments for Repurchase of Common Stock		$ 0	$ 8,603	$ 8,603	$ 0	$ 0
Hanover Holdings S A [Member]
Payments for Repurchase of Common Stock	$ 5,853
Common Class A [Member]
Common Stock, Par or Stated Value Per Share (in dollars per share)		$ 0.0001		$ 0.0001
Common Stock, Shares, Issued (in shares)		76,292,604		75,612,795
Common Stock, Shares, Outstanding (in shares)		76,292,604		75,612,795
Treasury Stock, Shares, Acquired (in shares)		0	516,123	516,123
Payments for Repurchase of Common Stock			$ 2,700	$ 2,700
Common Class A [Member] | Hanover Holdings S A [Member]
Treasury Stock, Shares, Acquired (in shares)	51,700
Common Class B [Member]
Common Stock, Par or Stated Value Per Share (in dollars per share)		$ 0.0001		$ 0.0001
Common Stock, Shares, Issued (in shares)		13,582,642		13,582,642
Common Stock, Shares, Outstanding (in shares)		13,582,642		13,582,642
Common Stock, Voting Interest		100%		100%
Common Class B [Member] | Chief Executive Officer [Member]
Common Stock, Shares, Outstanding (in shares)		13,582,642		13,582,642
Common Stock, Voting Interest		20.80%
Common Stock [Member]
Common Stock, Voting Interest				20.90%
Series A Preferred Stock [Member] | Hanover Holdings S A [Member]
Treasury Stock, Shares, Acquired (in shares)	134,735
Series B-1 Preferred Stock [Member] | Hanover Holdings S A [Member]
Treasury Stock, Shares, Acquired (in shares)	15,082

Note 11 - Stockholder's Equity

Note 11 - Stockholder's Equity - Schedule of Preferred Stock (Details)	Dec. 31, 2021 shares
Preferred stock, authorized (in shares)	8,740,398
Preferred stock, issued (in shares)	4,611,985
Series A Preferred Stock [Member]
Preferred stock, authorized (in shares)	4,723,330
Preferred stock, issued (in shares)	2,547,330
Series B Preferred Stock [Member]
Preferred stock, authorized (in shares)	3,117,915
Preferred stock, issued (in shares)	1,392,131
Series B-1 Preferred Stock [Member]
Preferred stock, authorized (in shares)	899,153
Preferred stock, issued (in shares)	672,524

Note 12 - Stock-based Compens_5

Note 12 - Stock-based Compensation (Details Textual) - USD ($) $ / shares in Units, $ in Thousands	9 Months Ended		12 Months Ended
	Sep. 30, 2023	Sep. 30, 2022	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross (in shares)	0	0	0
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period, Intrinsic Value			$ 75	$ 23,900	$ 9,700
Share-Based Payment Arrangement, Option [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Period (Year)			4 years
Share-Based Compensation Arrangement by Share-Based Payment Award, Expiration Period (Year)			10 years
Share-Based Payment Arrangement, Shares Withheld for Tax Withholding Obligation (in shares)	42,898		17,376
Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount	$ 870		$ 3,200
Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition (Year)			1 year 5 months 1 day
Restricted Stock Units (RSUs) [Member]
Share-Based Payment Arrangement, Shares Withheld for Tax Withholding Obligation (in shares)	116,783		56,649
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value (in dollars per share)	$ 2.43		$ 4.38
Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount	$ 5,900		$ 5,400
Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition (Year)	9 months 10 days		1 year 5 months 8 days

Note 12 - Stock-based Compens_6

Note 12 - Stock-based Compensation - Stock Options Activity (Details) - USD ($) $ / shares in Units, $ in Thousands	9 Months Ended		12 Months Ended
	Sep. 30, 2023	Sep. 30, 2022	Dec. 31, 2022	Dec. 31, 2021
Balance, options (in shares)	6,067,313	6,864,563	6,864,563
Balance, options, exercise price (in dollars per share)	$ 1.83	$ 2.05	$ 2.05
Balance, options, contractual term (Year)	1 year 9 months 10 days		2 years 25 days	2 years 4 months 9 days
Granted, options (in shares)	0	0	0
Granted, options, exercise (in dollars per share)			$ 0
Forfeited, options (in shares)	(425,178)		(574,299)
Forfeited, options, exercise price (in dollars per share)	$ 3.98		$ 4.56
Exercised, options (in shares)	(186,307)		(102,825)
Exercised, options, exercise price (in dollars per share)	$ 1.13		$ 1.12
Expired, options (in shares)	(177,430)		(120,126)
Expired, options, exercise price (in dollars per share)	$ 2.27		$ 2.6
Outstanding, options (in shares)	5,278,398		6,067,313	6,864,563
Outstanding, options, exercise price (in dollars per share)	$ 1.61		$ 1.83	$ 2.05
Outstanding, options, intrinsic value	$ 1,041		$ 10,818
Exercisable, options (in shares)	4,594,898		4,449,152
Exercisable, options, exercise price (in dollars per share)	$ 1.4		$ 1.31
Exercisable, options, contractual term (Year)	1 year 8 months 15 days		1 year 11 months 1 day
Exercisable, options, intrinsic value	$ 1,000		$ 8,832

Note 12 - Stock-based Compens_7

Note 12 - Stock-based Compensation - Schedule of Stock Options Valuation Assumptions (Details) - $ / shares	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Weighted-average fair value of options at the measurement date (grant date) (in dollars per share)	$ 0	$ 23.36	$ 6.31
Dividend yield (%)	0%	0%	0%
Expected volatility (%)	0%
Risk-free interest rate (%)	0%
Weighted average share price (in dollars per share)	$ 0	$ 6.79	$ 2.75
Minimum [Member]
Expected volatility (%)		61%	59%
Risk-free interest rate (%)		0.50%	0.40%
Maximum [Member]
Expected volatility (%)		72%	61%
Risk-free interest rate (%)		1.40%	0.50%

Note 12 - Stock-based Compens_8

Note 12 - Stock-based Compensation - RSU Activity (Details) - Restricted Stock Units (RSUs) [Member] - USD ($) $ in Thousands	9 Months Ended	12 Months Ended
	Sep. 30, 2023	Dec. 31, 2022
Outstanding unvested RSUs (in shares)	1,459,280	0
Granted during the year (in shares)	3,369,167	1,640,496
Forfeited during the year (in shares)	(559,809)	(60,823)
Vested during the year (in shares)	(494,287)	(120,393)
Expired during the year (in shares)		0
Outstanding unvested RSUs (in shares)	3,774,351	1,459,280
Outstanding unvested RSUs at December 31, 2022	$ 4,416	$ 1,940

Note 12 - Stock-based Compens_9

Note 12 - Stock-based Compensation - Schedule of Stock-based Compensation Expense (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended		12 Months Ended
	Sep. 30, 2023	Sep. 30, 2022	Sep. 30, 2023	Sep. 30, 2022	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Share-Based Payment Arrangement, Expense	$ 1,414	$ 2,139	$ 4,254	$ 6,624	$ 8,368	$ 10,881	$ 1,732
General and Administrative Expense [Member]
Share-Based Payment Arrangement, Expense	884	554	2,714	2,240	2,406	5,274	1,235
Research and Development Expense [Member]
Share-Based Payment Arrangement, Expense	312	781	933	1,753	3,631	1,968	382
Other Operating Income (Expense) [Member]
Share-Based Payment Arrangement, Expense	$ 218	$ 804	$ 607	$ 2,631	$ 2,331	$ 3,639	$ 115

Note 13 - Redeemable Preferre_3

Note 13 - Redeemable Preferred Stock (Details Textual) - USD ($) $ / shares in Units, $ in Millions	Jan. 25, 2022	Sep. 30, 2023	Dec. 31, 2022	Dec. 31, 2021
Temporary Equity, Par or Stated Value Per Share (in dollars per share)			$ 0.0001	$ 0.0001
Conversion of Stock, Shares Issued (in shares)	2,140,340
Series X Preferred Stock [Member]
Temporary Equity, Par or Stated Value Per Share (in dollars per share)	$ 0.0001
Temporary Equity, Dividend Rate, Percentage	7%
Conversion of Stock, Shares Converted (in shares)	2,033,230
Conversion of Stock, Amount Converted	$ 21.4
Preferred Stock, Convertible, Conversion Price (in dollars per share)	$ 10
Temporary Equity, Shares Issued (in shares)		0	0
Temporary Equity, Shares Outstanding (in shares)		0	0

Note 14 - Net Loss Per Share (D

Note 14 - Net Loss Per Share (Details Textual)	9 Months Ended	12 Months Ended
	Sep. 30, 2023	Dec. 31, 2022
Recapitalization Exchange Ratio	3.3028	3.3028

Note 14 - Net Loss Per Share -

Note 14 - Net Loss Per Share - Schedule of Net Loss Per Share (Details) - USD ($) $ / shares in Units, $ in Thousands	3 Months Ended		9 Months Ended		12 Months Ended
	Sep. 30, 2023	Sep. 30, 2022	Sep. 30, 2023	Sep. 30, 2022	Dec. 31, 2022		Dec. 31, 2021		Dec. 31, 2020
Net loss	$ (17,619)	$ (14,823)	$ (47,470)	$ (22,944)	$ (36,641)		$ (96,305)		$ (21,529)
Basic weighted-average common shares outstanding (in shares)	89,739,310	89,002,430	89,476,065	81,221,550	83,188,276	[1]	16,655,634	[1],[2]	16,029,826	[1],[2]
Basic loss per share for the period attributable to common stockholders (in dollars per share)	$ (0.2)	$ (0.17)	$ (0.53)	$ (0.28)	$ (0.44)		$ (5.78)	[2]	$ (1.34)	[2]
Adjustment to numerator - Change in fair value of Columbia Warrant liability	$ 0	$ (18,635)	$ 0	$ (18,635)	$ (18,635)		$ 0		$ 0
Dilutive numerator	$ (17,619)	$ (33,458)	$ (47,470)	$ (41,579)	$ (55,276)		$ (96,305)		$ (21,529)
Columbia Warrant (in shares)	0	1,410,657	0	1,410,657	609,873		0		0
Diluted weighted-average common shares outstanding (in shares)	89,739,310	90,413,087	89,476,065	82,632,207	83,798,149		16,655,634	[2]	16,029,826	[2]
Diluted loss per share for the period attributable to common stockholders (in dollars per share)	$ (0.2)	$ (0.37)	$ (0.53)	$ (0.5)	$ (0.66)		$ (5.78)	[2]	$ (1.34)	[2]
[1]After applying the 3.3028 Exchange Ratio as described in Note 4 (Reverse Recapitalization).[2]The change in net loss in the adoption of U.S. GAAP as described in items a-d above impacted net loss per share as follows:

Note 14 - Net Loss Per Share _2

Note 14 - Net Loss Per Share - Schedule of Antidilutive Securities (Details) - shares	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Antidilutive Securities (in shares)	58,487,423	29,441,138	13,434,712
Warrant [Member]
Antidilutive Securities (in shares)	49,184,868	15,931,360	0
Sponsor Earnout Shares [Member]
Antidilutive Securities (in shares)	1,775,962	0	0
Stock Options [Member]
Antidilutive Securities (in shares)	6,067,313	6,864,563	4,694,314
Restricted Stock Units (RSUs) [Member]
Antidilutive Securities (in shares)	1,459,280	0	0
Redeemable Convertible Preferred Stock [Member]
Antidilutive Securities (in shares)	0	6,645,215	8,740,398

Note 15 - Fair Value Measurem_5

Note 15 - Fair Value Measurement and Financial Instruments (Details Textual) - USD ($) $ / shares in Units, $ in Thousands	Sep. 30, 2023	Dec. 31, 2022	Jan. 25, 2022	Jan. 24, 2022
Canter Loan [Member]
Fair Value, Option, Aggregate Differences, Long-Term Debt Instruments		$ 22
The 8.63 Warrants [Member]
Class of Warrant or Right, Exercise Price of Warrants or Rights (in dollars per share)	$ 8.63	$ 8.63	$ 8.63	$ 11.5

Note 15 - Fair Value Measurem_6

Note 15 - Fair Value Measurements and Financial Instruments - Schedule of Assets and Liabilities at Fair Value (Details) - USD ($) $ in Thousands	Sep. 30, 2023	Dec. 31, 2022	Jan. 25, 2022	Jan. 22, 2022	Jan. 18, 2022	Dec. 31, 2021
Total Warrant Liabilities	$ 1,945	$ 8,335				$ 143,237
Earnout liabilities	223	1,353				0
Fair Value, Inputs, Level 1 [Member]
Total Warrant Liabilities	704	1,833
Earnout liabilities	0	0
Fair Value, Inputs, Level 1 [Member] | Borrowings [Member]
Liabilities, fair value						0
Fair Value, Inputs, Level 1 [Member] | Columbia Warrant [Member]
Liabilities, fair value						0
Fair Value, Inputs, Level 1 [Member] | Notes Payable to Banks [Member]
Notes payable, fair value						0
Fair Value, Inputs, Level 1 [Member] | Promissory Note [Member]
Notes payable, fair value						0
Fair Value, Inputs, Level 2 [Member]
Total Warrant Liabilities	0	0
Earnout liabilities	0	0
Fair Value, Inputs, Level 2 [Member] | Borrowings [Member]
Liabilities, fair value						0
Fair Value, Inputs, Level 2 [Member] | Columbia Warrant [Member]
Liabilities, fair value						0
Fair Value, Inputs, Level 2 [Member] | Notes Payable to Banks [Member]
Notes payable, fair value						180,356
Fair Value, Inputs, Level 2 [Member] | Promissory Note [Member]
Notes payable, fair value						40,925
Fair Value, Inputs, Level 3 [Member]
Total Warrant Liabilities	1,241	6,502
Earnout liabilities	223	1,353
Fair Value, Inputs, Level 3 [Member] | Borrowings [Member]
Liabilities, fair value						7,522
Fair Value, Inputs, Level 3 [Member] | Columbia Warrant [Member]
Liabilities, fair value						143,237
Fair Value, Inputs, Level 3 [Member] | Notes Payable to Banks [Member]
Notes payable, fair value						0
Fair Value, Inputs, Level 3 [Member] | Promissory Note [Member]
Notes payable, fair value						0
The 8.63 Warrants [Member]
Total Warrant Liabilities	704	1,833	$ 4,900			0
The 8.63 Warrants [Member] | Fair Value, Inputs, Level 1 [Member]
Total Warrant Liabilities	704	1,833
The 8.63 Warrants [Member] | Fair Value, Inputs, Level 2 [Member]
Total Warrant Liabilities	0	0
The 8.63 Warrants [Member] | Fair Value, Inputs, Level 3 [Member]
Total Warrant Liabilities	0	0
Pipe Warrant [Member]
Total Warrant Liabilities	59	311		$ 1,300		0
Pipe Warrant [Member] | Fair Value, Inputs, Level 1 [Member]
Total Warrant Liabilities	0	0
Pipe Warrant [Member] | Fair Value, Inputs, Level 2 [Member]
Total Warrant Liabilities	0	0
Pipe Warrant [Member] | Fair Value, Inputs, Level 3 [Member]
Total Warrant Liabilities	59	311
Liberty Warrants and Liberty Advisory Fee Warrant [Member]
Total Warrant Liabilities	1,182	6,191			$ 30,900	$ 0
Liberty Warrants and Liberty Advisory Fee Warrant [Member] | Fair Value, Inputs, Level 1 [Member]
Total Warrant Liabilities	0	0
Liberty Warrants and Liberty Advisory Fee Warrant [Member] | Fair Value, Inputs, Level 2 [Member]
Total Warrant Liabilities	0	0
Liberty Warrants and Liberty Advisory Fee Warrant [Member] | Fair Value, Inputs, Level 3 [Member]
Total Warrant Liabilities	$ 1,182	$ 6,191

Note 15 - Fair Value Measurem_7

Note 15 - Fair Value Measurements and Financial Instruments - Reconciliation of Level 3 Measurements (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended				12 Months Ended
	Sep. 30, 2023	Sep. 30, 2022	Sep. 30, 2023		Sep. 30, 2022		Dec. 31, 2022		Dec. 31, 2021
Borrowings [Member]
Balance	$ 0	$ 0	$ 0		$ 7,522		$ 7,522		$ 0
Issues		0			0		0		7,513
Remeasurement (gain)/loss(1)	0	0	0	[1]	489	[1]	488	[2]	9	[2]
Amortization of deferred costs									0
Write-off of deferred costs		0			0		0
Settlements (2)		0			(8,011)	[3]	(8,010)	[3]
Balance	0	0	0		0		0		7,522
Sponsor Earnout [Member]
Balance	504	3,111	1,353		0		0		0
Issues		0			8,022		8,022		0
Remeasurement (gain)/loss(1)	(281)	(537)	(1,130)	[1]	(5,448)	[1]	(6,669)	[2]	0	[2]
Amortization of deferred costs									0
Write-off of deferred costs		0			0		0
Settlements (2)		0			0	[3]	0	[3]
Balance	223	2,574	223		2,574		1,353		0
Forfeiture Earnout [Member]
Balance	0	0	0		0		0		0
Issues		0			6,135		6,135		0
Remeasurement (gain)/loss(1)	0	0	0	[1]	(5,130)	[1]	(5,130)	[2]	0	[2]
Amortization of deferred costs									0
Write-off of deferred costs		0			0		0
Settlements (2)		0			(1,005)	[3]	(1,005)	[3]
Balance	0	0	0		0		0		0
Liberty Warrants and Liberty Advisory Fee Warrant [Member]
Balance	2,339	15,377	6,191		0		0		0
Issues		0			30,853		30,853		0
Remeasurement (gain)/loss(1)	(1,157)	(4,026)	(5,009)	[1]	(19,502)	[1]	(24,662)	[2]	0	[2]
Amortization of deferred costs									0
Write-off of deferred costs		0			0		0
Settlements (2)		0			0	[3]	0	[3]
Balance	1,182	11,351	1,182		11,351		6,191		0
Pipe Warrant [Member]
Balance	109	952	311		0		0		0
Issues		0			1,312		1,312		0
Remeasurement (gain)/loss(1)	(50)	(415)	(252)	[1]	(775)	[1]	(1,001)	[2]	0	[2]
Amortization of deferred costs									0
Write-off of deferred costs		0			0		0
Settlements (2)		0			0	[3]	0	[3]
Balance	59	537	59		537		311		0
Columbia Warrant [Member]
Balance	0	0	0		143,237		143,237		0
Issues		0			0		0		161,432
Remeasurement (gain)/loss(1)	0	0	0	[1]	(18,635)	[1]	(18,635)	[2]	(17,992)	[2]
Amortization of deferred costs									(203)
Write-off of deferred costs		0			203		203
Settlements (2)		0			(124,805)	[3]	(124,805)	[3]
Balance	$ 0	$ 0	$ 0		$ 0		$ 0		$ 143,237
[1]Recognized in the Condensed Consolidated Statements of Operations and Comprehensive Loss for the nine months ended September 30, 2023 and 2022, respectively.[2]Recognized in the Consolidated Statements of Operations and Comprehensive Loss for the years ended December 31, 2022 and 2021, respectively.[3]These liabilities were settled in connection with the Merger. See Note 4 (Recapitalization Transaction).

Note 16 - Related Parties (Deta

Note 16 - Related Parties (Details Textual) $ in Thousands	12 Months Ended
	Dec. 31, 2022 USD ($)
OS [Member]
Related Party Transaction, Amounts of Transaction	$ 456

Note 16 - Related Parties - Sch

Note 16 - Related Parties - Schedule of Related Party Transactions (Details) - Related Party [Member] - USD ($) $ in Thousands	3 Months Ended		9 Months Ended		12 Months Ended
	Sep. 30, 2023	Sep. 30, 2022	Sep. 30, 2023	Sep. 30, 2022	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Amounts owed to related parties					$ 0	$ 13,028	$ 0
Interest Expense [Member]
Related Party Transaction, Amounts of Transaction	$ 0	$ 0	$ 0	$ 44	$ 554	$ 620	$ 591

Note 17 - Debt (Details Textual

Note 17 - Debt (Details Textual) - USD ($) $ / shares in Units, $ in Thousands			1 Months Ended	12 Months Ended
	May 09, 2022	Jan. 25, 2022	Jul. 31, 2021	Dec. 31, 2022	Dec. 31, 2021		Dec. 31, 2020	[1]	Mar. 08, 2021
Gain (Loss) on Extinguishment of Debt				$ 0	$ (37,216)	[1]	$ (9,240)
Treasury Stock, Value, Reacquired		$ 170,900
Columbia Warrants [Member]
Warrant Liability, Reclassifications To Equity				$ 124,800
Cantor Loan [Member]
Debt Conversion, Converted Instrument, Shares Issued (in shares)	26,050
Debt Instrument, Conversion Feature, Volume-Weighted Average Price (in dollars per share)		$ 8
Debt Instrument, Converted Instrument, Additional Shares Issued or Issuable (in shares)		197,005
Columbia Loan [Member]
Loans Payable									$ 40,100
Common Class A [Member]
Stock Issued During Period, Shares, Conversion of Convertible Securities (in shares)			1,250,000
Common Class A [Member] | Cantor Loan [Member]
Stock Issued During Period, Shares, Conversion of Convertible Securities (in shares)				788,021
Debt Instrument, Conversion Feature, Volume-Weighted Average Price (in dollars per share)		$ 10
Convertible Debt [Member]
Gain (Loss) on Extinguishment of Debt					$ 37,216
Convertible Debt [Member] | Common Class A [Member]
Debt Conversion, Converted Instrument, Shares Issued (in shares)		17,980,954
[1]Under IFRS, the redeemable Series X preferred shares and convertible notes contained conversion features that resulted in a bifurcated derivative component with changes in fair value recognized as gain or (loss). Under U.S. GAAP, the conversion features did not result in a material bifurcated embedded derivative, resulting in the elimination of the change in fair value of financial instruments, reduction in interest expense and preferred dividends expense, and increase in the gain (loss) on extinguishment of debt. Under IFRS, it was determined that the redeemable Series X preferred shares should be classified as a liability since there is a contractual obligation to deliver cash or another financial asset and certain conversion events being beyond our control. Under U.S. GAAP, it was determined that the redeemable Series X preferred shares should be classified as mezzanine equity since the shares are redeemable based on events outside of our control. Under IFRS, it was determined that the Columbia Warrant should be classified as equity since settlement would only occur by exchanging a fixed amount of cash for a fixed number of our own equity instruments. Changes in fair value are not recognized. Under U.S. GAAP, it was determined that the Columbia Warrant should be classified as a liability since the number and type of shares received could be different pre- and post- Merger. The Columbia Warrant is recorded at fair value with changes recognized in the Consolidated Statement of Operations and Comprehensive Loss. Additionally, the resulting gain (loss) on extinguishment of the amended convertible notes differed under IFRS versus U.S. GAAP.

Note 17 - Debt - Summary of Deb

Note 17 - Debt - Summary of Debt (Details) $ in Thousands	Dec. 31, 2021 USD ($)
Long-Term Debt, Gross	$ 108,473
Less deferred financing costs	0
Total debt less deferred financing fees	108,473
Less: Current portion	0
Total non-current debt, net of deferred financing fees	108,473
Convertible Debt [Member] | A2018 Convertible Notes [Member]
Long-Term Debt, Gross	19,862
Convertible Debt [Member] | A2019 Convertible Notes [Member]
Long-Term Debt, Gross	27,498
Convertible Debt [Member] | A2020 Convertible Notes [Member]
Long-Term Debt, Gross	15,294
Loans Payable [Member] | Cantor Loan [Member]
Long-Term Debt, Gross	7,522
Notes Payable, Other Payables [Member]
Long-Term Debt, Gross	$ 38,297

Note 18 - Leases (Details Textu

Note 18 - Leases (Details Textual)	Dec. 31, 2022
Operating Lease, Weighted Average Remaining Lease Term (Year)	5 years 7 months 28 days
Operating Lease, Weighted Average Discount Rate, Percent	4.60%
Minimum [Member]
Lessee, Operating Lease, Term of Contract (Year)	2 years
Maximum [Member]
Lessee, Operating Lease, Term of Contract (Year)	10 years

Note 18 - Leases - Changes in O

Note 18 - Leases - Changes in Operating Lease ROU Assets (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Balance as of beginning of period	$ 2,955	$ 1,403
Lease expense	(1,701)	(494)	$ (247)
Foreign exchange differences	115	(48)
Additions	7,171	2,119
Disposals	(322)	0
Transfers	(47)	(25)
Balance as of end of period	$ 8,171	$ 2,955	$ 1,403

Note 18 - Leases - Changes in_2

Note 18 - Leases - Changes in Operating Lease Liabilities (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended		12 Months Ended
	Sep. 30, 2023	Sep. 30, 2022	Sep. 30, 2023	Sep. 30, 2022	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Balance as of beginning of period			$ 8,239	$ 3,068	$ 3,068	$ 1,415
Additions to operating lease liabilities					7,171	2,119
Operating Lease, Expense	$ 600	$ 500	1,900	$ 1,400	314	54	$ 51
Foreign exchange differences					(293)	(48)
Disposals					(329)	0
Payments					(1,692)	(472)
Balance as of end of period					8,239	3,068	$ 1,415
Operating lease liabilities	2,034		2,034		2,176	985
Total non-current	$ 7,641		$ 7,641		$ 6,063	$ 2,083

Note 18 - Leases - Summary of L

Note 18 - Leases - Summary of Lease Costs (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended		12 Months Ended
	Sep. 30, 2023	Sep. 30, 2022	Sep. 30, 2023	Sep. 30, 2022	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Right-of-use assets					$ 1,701	$ 494	$ 247
Operating lease liabilities	$ 600	$ 500	$ 1,900	$ 1,400	314	54	51
Total lease expense			$ 2,112	$ 1,475	$ 2,015	$ 548	$ 298

Note 18 - Leases - Maturity of

Note 18 - Leases - Maturity of Operating Lease Liability (Details) - USD ($) $ in Thousands	Sep. 30, 2023	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
2023		$ 2,484
2024		2,235
2025		824
2026		603
2027 and thereafter		3,166
Total remaining lease payments		9,312
Less imputed interest		(1,073)
Present value of lease liability		8,239	$ 3,068	$ 1,415
Operating lease liabilities	$ 2,034	2,176	985
Total non-current	$ 7,641	$ 6,063	$ 2,083

Note 19 - Adoption of U.S. GA_3

Note 19 - Adoption of U.S. GAAP (Details Textual)	9 Months Ended	12 Months Ended
	Sep. 30, 2023	Dec. 31, 2022
Recapitalization Exchange Ratio	3.3028	3.3028

Note 19 - Adoption of U.S. GA_4

Note 19 - Adoption of U.S. GAAP - Accounting Standards Update and Change in Accounting Principle (Details) - USD ($) $ / shares in Units, $ in Thousands		3 Months Ended		9 Months Ended		12 Months Ended
		Sep. 30, 2023	Sep. 30, 2022	Sep. 30, 2023	Sep. 30, 2022	Dec. 31, 2022		Dec. 31, 2021		Dec. 31, 2020		Jun. 30, 2023	Jun. 30, 2022	Dec. 31, 2019
Revenue		$ 1,196	$ 2,158	$ 4,380	$ 4,546	$ 6,012		$ 4,247		$ 0
Cost of sales		1,046	969	3,159	2,298	3,284		1,876		0
General administrative expenses		5,865	6,308	15,732	30,917	37,191		36,640	[1],[2]	8,003	[1],[2]
Research and development		2,169	3,941	7,996	9,657	13,055		9,636	[3]	5,924	[3]
Depreciation expense		5,420	4,031	14,030	10,516	14,326		10,728	[3]	3,031	[3]
Other operating expenses, net		4,852	6,992	17,930	20,728	29,023		14,002		5,449
Total costs and expenses		19,352	22,241	58,847	74,116	96,879		72,882		22,407
Operating loss		(18,156)	(20,083)	(54,467)	(69,570)	(90,867)		(68,635)		(22,407)
Finance costs, net		389	381	1,471	(1,225)	(652)		(9,738)	[2],[4]	35	[2],[4]
Change in fair value of financial instruments		1,940	6,270	7,520	50,866	58,311		17,983	[4]	9,637	[4]
Gain (loss) on extinguishment of debt						0		(37,216)	[4]	(9,240)	[4]
Other income (expense), net		2,277	1,592	4,199	2,111	1,140		1,069	[2]	594	[2]
Total other income (expense), net		4,606	8,243	13,190	51,752	58,799		(27,902)		1,026
Loss before income tax		(13,550)	(11,840)	(41,277)	(17,818)	(32,068)		(96,537)		(21,381)
Income tax		4,069	2,983	6,193	5,126	4,573		(232)		148
Net loss available to common stockholders		(17,619)	(14,823)	(47,470)	(22,944)	(36,641)		(96,305)		(21,529)
Foreign currency translation loss, net of tax		(294)	(373)	(218)	(695)	(226)		(86)		0
Comprehensive loss		$ (17,913)	$ (15,196)	$ (47,688)	$ (23,639)	$ (36,867)		$ (96,391)		$ (21,529)
Basic loss for the period attributable to common stockholders (in dollars per share)		$ (0.2)	$ (0.17)	$ (0.53)	$ (0.28)	$ (0.44)		$ (5.78)	[5]	$ (1.34)	[5]
Basic weighted-average common shares outstanding (in shares)		89,739,310	89,002,430	89,476,065	81,221,550	83,188,276	[6]	16,655,634	[5],[6]	16,029,826	[5],[6]
Diluted loss for the period attributable to common stockholders (in dollars per share)		$ (0.2)	$ (0.37)	$ (0.53)	$ (0.5)	$ (0.66)		$ (5.78)	[5]	$ (1.34)	[5]
Diluted weighted-average common shares outstanding (in shares)		89,739,310	90,413,087	89,476,065	82,632,207	83,798,149		16,655,634	[5]	16,029,826	[5]
Cash and cash equivalents		$ 30,971		$ 30,971		$ 76,528		$ 8,533
Accounts receivable, net of allowance of $3,317 and $3,237, respectively		1,718		1,718		1,388		1,196
Prepaid expenses and other current assets		3,245		3,245		3,198		2,695
Total current assets		35,934		35,934		81,240		12,424
Property and equipment, net		42,728		42,728		47,981		32,530
Operating lease right-of-use assets		9,331		9,331		8,171		2,955		$ 1,403
Deferred income tax assets						0		1,640
Other non-current assets		5,349		5,349		6,463		369
Total assets		93,342		93,342		143,855		49,918
Accounts payable						9,850		6,650
Debt						0		108,473
Warrant liabilities		1,945		1,945		8,335		143,237
Operating lease liabilities		2,034		2,034		2,176		985
Contract liabilities		3,286		3,286		1,941		935
Accrued expenses and other liabilities		7,481		7,481		6,417		23,435
Total current liabilities		21,461		21,461		30,072		283,715
Operating lease liabilities		7,641		7,641		6,063		2,083
Contract liabilities		1,000		1,000		1,000		1,000
Other non-current liabilities		499		499		522		2,552
Total liabilities		30,601		30,601		37,657		289,350
Redeemable preferred stock						0		21,306
Treasury stock, at cost: 516,123 shares at September 30, 2023, and 516,123 shares at December 31, 2022		(8,603)		(8,603)		(8,603)		(170,949)
Additional paid-in capital		342,159		342,159		337,928		96,471
Accumulated other comprehensive loss		(530)		(530)		(312)		(86)
Accumulated deficit		(270,285)		(270,285)		(222,815)		(186,174)
Total stockholders’ equity (deficit)		62,741	$ 118,129	62,741	$ 118,129	106,198		(260,738)		(25,828)		$ 79,245	$ 132,000	$ (5,449)
Total liabilities, redeemable preferred stock and stockholders’ equity (deficit)		93,342		93,342		143,855		49,918
Research and development		2,169	3,941	7,996	9,657	13,055		9,636	[3]	5,924	[3]
Other operating expenses		4,852	6,992	17,930	20,728	29,023		14,002		5,449
Increase (decrease) to loss before income tax		(13,550)	(11,840)	(41,277)	(17,818)	(32,068)		(96,537)		(21,381)
Research and development		2,169	3,941	7,996	9,657	13,055		9,636	[3]	5,924	[3]
Depreciation expense		5,420	4,031	14,030	10,516	14,326		10,728	[3]	3,031	[3]
Other operating expenses		4,852	6,992	17,930	20,728	29,023		14,002		5,449
Loss before income tax		(13,550)	(11,840)	(41,277)	(17,818)	(32,068)		(96,537)		(21,381)
General and administrative expenses		5,865	6,308	15,732	30,917	37,191		36,640	[1],[2]	8,003	[1],[2]
Finance costs, net		389	381	1,471	(1,225)	(652)		(9,738)	[2],[4]	35	[2],[4]
Other income, net		2,277	1,592	4,199	2,111	1,140		1,069	[2]	594	[2]
Operating lease liabilities						8,239		3,068		1,415
Total non-current		7,641		7,641		6,063		2,083
Change in fair value of financial instruments		1,940	6,270	7,520	50,866	58,311		17,983	[4]	9,637	[4]
Loss on extinguishment of debt						0		(37,216)	[4]	(9,240)	[4]
Net loss		$ (17,619)	$ (14,823)	$ (47,470)	$ (22,944)	$ (36,641)		$ (96,305)		$ (21,529)
Basic weighted-average common shares outstanding (in shares)		89,739,310	89,002,430	89,476,065	81,221,550	83,188,276	[6]	16,655,634	[5],[6]	16,029,826	[5],[6]
Basic loss per share for the period attributable to common stockholders (in dollars per share)		$ (0.2)	$ (0.17)	$ (0.53)	$ (0.28)	$ (0.44)		$ (5.78)	[5]	$ (1.34)	[5]
Dilutive numerator		$ (17,619)	$ (33,458)	$ (47,470)	$ (41,579)	$ (55,276)		$ (96,305)		$ (21,529)
Diluted loss per share for the period attributable to common stockholders (in dollars per share)		$ (0.2)	$ (0.37)	$ (0.53)	$ (0.5)	$ (0.66)		$ (5.78)	[5]	$ (1.34)	[5]
Previously Reported [Member]
Revenue								$ 4,247		$ 0
Cost of sales								1,876		0
General administrative expenses	[1],[2]							36,649		8,127
Research and development	[3]							9,640		5,878
Depreciation expense	[3]							10,825		3,182
Other operating expenses, net								14,002		5,476
Total costs and expenses								72,992		22,663
Operating loss								(68,745)		(22,663)
Finance costs, net	[2],[4]							(11,769)		(22)
Change in fair value of financial instruments	[4]							(42,102)		(84,224)
Gain (loss) on extinguishment of debt	[4]							3,576		(7,466)
Other income (expense), net	[2]							1,067		597
Total other income (expense), net								(49,228)		(91,115)
Loss before income tax								(117,973)		(113,778)
Income tax								(232)		148
Net loss available to common stockholders								(117,741)		(113,926)
Foreign currency translation loss, net of tax								(86)		0
Comprehensive loss								$ (117,827)		$ (113,926)
Basic loss for the period attributable to common stockholders (in dollars per share)	[5]							$ (7.07)		$ (7.11)
Basic weighted-average common shares outstanding (in shares)	[5]							16,655,634		16,029,826
Diluted loss for the period attributable to common stockholders (in dollars per share)	[5]							$ (7.07)		$ (7.11)
Diluted weighted-average common shares outstanding (in shares)	[5]							16,655,634		16,029,826
Cash and cash equivalents								$ 8,533
Accounts receivable, net of allowance of $3,317 and $3,237, respectively								1,196
Prepaid expenses and other current assets								2,695
Total current assets								12,424
Property and equipment, net								33,586
Operating lease right-of-use assets								2,663
Deferred income tax assets								1,640
Other non-current assets								369
Total assets								50,682
Accounts payable								6,650
Debt								246,189
Warrant liabilities								0
Operating lease liabilities								891
Contract liabilities								935
Accrued expenses and other liabilities								23,435
Total current liabilities								278,100
Operating lease liabilities								1,908
Contract liabilities								1,000
Other non-current liabilities								2,552
Total liabilities								283,560
Redeemable preferred stock								0
Treasury stock, at cost: 516,123 shares at September 30, 2023, and 516,123 shares at December 31, 2022								(170,949)
Additional paid-in capital								235,909
Accumulated other comprehensive loss								(86)
Accumulated deficit								(297,752)
Total stockholders’ equity (deficit)								(232,878)
Total liabilities, redeemable preferred stock and stockholders’ equity (deficit)								50,682
Research and development	[3]							9,640		$ 5,878
Other operating expenses								14,002		5,476
Increase (decrease) to loss before income tax								(117,973)		(113,778)
Research and development	[3]							9,640		5,878
Depreciation expense	[3]							10,825		3,182
Other operating expenses								14,002		5,476
Loss before income tax								(117,973)		(113,778)
General and administrative expenses	[1],[2]							36,649		8,127
Finance costs, net	[2],[4]							(11,769)		(22)
Other income, net	[2]							1,067		597
Total non-current								1,908
Change in fair value of financial instruments	[4]							(42,102)		(84,224)
Loss on extinguishment of debt	[4]							3,576		(7,466)
Net loss								$ (117,741)		$ (113,926)
Basic weighted-average common shares outstanding (in shares)	[5]							16,655,634		16,029,826
Basic loss per share for the period attributable to common stockholders (in dollars per share)	[5]							$ (7.07)		$ (7.11)
Diluted loss per share for the period attributable to common stockholders (in dollars per share)	[5]							$ (7.07)		$ (7.11)
Revision of Prior Period, Adjustment [Member]
Revenue								$ 0		$ 0
Cost of sales								0		0
General administrative expenses	[1],[2]							(9)		(124)
Research and development	[3]							(4)		46
Depreciation expense	[3]							(97)		(151)
Other operating expenses, net								0		(27)
Total costs and expenses								(110)		(256)
Operating loss								110		256
Finance costs, net	[2],[4]							2,031		57
Change in fair value of financial instruments	[4]							60,085		93,861
Gain (loss) on extinguishment of debt	[4]							(40,792)		(1,774)
Other income (expense), net	[2]							2		(3)
Total other income (expense), net								21,326		92,141
Loss before income tax								21,436		92,397
Income tax								0		0
Net loss available to common stockholders								21,436		92,397
Foreign currency translation loss, net of tax								0		0
Comprehensive loss								$ 21,436		$ 92,397
Basic loss for the period attributable to common stockholders (in dollars per share)	[5]							$ 1.29		$ 5.76
Basic weighted-average common shares outstanding (in shares)	[5]							0		0
Diluted loss for the period attributable to common stockholders (in dollars per share)	[5]							$ 1.29		$ 5.76
Diluted weighted-average common shares outstanding (in shares)	[5]							0		0
Cash and cash equivalents								$ 0
Accounts receivable, net of allowance of $3,317 and $3,237, respectively								0
Prepaid expenses and other current assets								0
Total current assets								0
Property and equipment, net								(1,056)
Operating lease right-of-use assets								292
Deferred income tax assets								0
Other non-current assets								0
Total assets								(764)
Accounts payable								0
Debt								(137,716)
Warrant liabilities								143,237
Operating lease liabilities								94
Contract liabilities								0
Accrued expenses and other liabilities								0
Total current liabilities								5,615
Operating lease liabilities								175
Contract liabilities								0
Other non-current liabilities								0
Total liabilities								5,790
Redeemable preferred stock								21,306
Treasury stock, at cost: 516,123 shares at September 30, 2023, and 516,123 shares at December 31, 2022								0
Additional paid-in capital								(139,438)
Accumulated other comprehensive loss								0
Accumulated deficit								111,578
Total stockholders’ equity (deficit)								(27,860)
Total liabilities, redeemable preferred stock and stockholders’ equity (deficit)								(764)
Research and development	[3]							(4)		$ 46
Other operating expenses								0		(27)
Increase (decrease) to loss before income tax								21,436		92,397
Research and development	[3]							(4)		46
Depreciation expense	[3]							(97)		(151)
Other operating expenses								0		(27)
Loss before income tax								21,436		92,397
General and administrative expenses	[1],[2]							(9)		(124)
Finance costs, net	[2],[4]							2,031		57
Other income, net	[2]							2		(3)
Total non-current								175
Change in fair value of financial instruments	[4]							60,085		93,861
Loss on extinguishment of debt	[4]							(40,792)		(1,774)
Net loss								$ 21,436		$ 92,397
Basic weighted-average common shares outstanding (in shares)	[5]							0		0
Basic loss per share for the period attributable to common stockholders (in dollars per share)	[5]							$ 1.29		$ 5.76
Diluted loss per share for the period attributable to common stockholders (in dollars per share)	[5]							$ 1.29		$ 5.76
Revision of Prior Period, Adjustment [Member] | I F R S Impact on Share Based Compensation [Member]
Research and development								$ 0		$ (89)
Other operating expenses, net								0		(27)
Loss before income tax								(80)		(252)
Additional paid-in capital								542
Accumulated deficit								(542)
Total liabilities, redeemable preferred stock and stockholders’ equity (deficit)								0
General and administrative expenses								(80)		(136)
Research and development								0		(89)
Other operating expenses								0		(27)
Increase (decrease) to loss before income tax								(80)		(252)
Research and development								0		(89)
Other operating expenses								0		(27)
Loss before income tax								(80)		(252)
Revision of Prior Period, Adjustment [Member] | I F R S Impact on Research and Development [Member]
Research and development								(4)		135
Depreciation expense								(97)		(151)
Other operating expenses, net								0		0
Loss before income tax								(101)		(16)
Property and equipment, net								(1,056)
Total assets								(1,056)
Accumulated deficit								(1,056)
Total liabilities, redeemable preferred stock and stockholders’ equity (deficit)								(1,056)
Research and development								(4)		135
Other operating expenses								0		0
Increase (decrease) to loss before income tax								(101)		(16)
Research and development								(4)		135
Depreciation expense								(97)		(151)
Other operating expenses								0		0
Loss before income tax								(101)		(16)
Revision of Prior Period, Adjustment [Member] | I F R S Impact on Leases [Member]
General administrative expenses								71		12
Finance costs, net								(49)		(57)
Other income (expense), net								(2)		3
Loss before income tax								20		(42)
Operating lease right-of-use assets								292
Total assets								292
Operating lease liabilities								175
Accumulated deficit								23
Total liabilities, redeemable preferred stock and stockholders’ equity (deficit)								292
Increase (decrease) to loss before income tax								20		(42)
Loss before income tax								20		(42)
General and administrative expenses								71		12
Finance costs, net								(49)		(57)
Other income, net								(2)		3
Operating lease liabilities								94
Total non-current								175
Revision of Prior Period, Adjustment [Member] | I F R S Impact on Financial Instruments [Member]
Finance costs, net								(1,982)		0
Change in fair value of financial instruments								(60,085)		(93,861)
Gain (loss) on extinguishment of debt								40,792		1,774
Loss before income tax								(21,275)		(92,087)
Debt								(137,716)
Warrant liabilities								143,237
Redeemable preferred stock								21,306
Additional paid-in capital								(139,980)
Accumulated deficit								113,153
Total liabilities, redeemable preferred stock and stockholders’ equity (deficit)								0
Increase (decrease) to loss before income tax								(21,275)		(92,087)
Loss before income tax								(21,275)		(92,087)
Finance costs, net								(1,982)		0
Change in fair value of financial instruments								(60,085)		(93,861)
Loss on extinguishment of debt								40,792		1,774
Revision of Prior Period, Adjustment [Member] | I F R S Impact on Earnings Per Share [Member]
Net loss available to common stockholders								$ (96,305)		$ (21,529)
Basic loss for the period attributable to common stockholders (in dollars per share)								$ (5.78)		$ (1.34)
Basic weighted-average common shares outstanding (in shares)								16,655,634		16,029,826
Diluted loss for the period attributable to common stockholders (in dollars per share)								$ (5.78)		$ (1.34)
Net loss								$ (96,305)		$ (21,529)
Basic weighted-average common shares outstanding (in shares)								16,655,634		16,029,826
Basic loss per share for the period attributable to common stockholders (in dollars per share)								$ (5.78)		$ (1.34)
Dilutive numerator								$ (96,305)		$ (21,529)
Diluted weighted-average common shares outstanding (in shares)								16,655,634		16,029,826
Diluted loss per share for the period attributable to common stockholders (in dollars per share)								$ (5.78)		$ (1.34)
[1]Certain awards granted by us have a service inception date preceding the grant date. Under IFRS, this resulted in the recognition of stock-based compensation expense prior to the grant date. Under U.S. GAAP, the stock-based compensation expense shall not be recognized until authorization at the grant date.[2]Under IFRS, all recognized leases are accounted for similarly to finance leases. Under U.S. GAAP, there is a dual classification on-balance sheet lease accounting model for lessees: finance and operating leases. Operating leases create a straight-line expense, and no interest expense is recognized on the lease liability.[3]Under IFRS, certain development expenditures may be capitalized. Under U.S. GAAP, all of our costs relating to R&D activities are expensed as incurred.[4]Under IFRS, the redeemable Series X preferred shares and convertible notes contained conversion features that resulted in a bifurcated derivative component with changes in fair value recognized as gain or (loss). Under U.S. GAAP, the conversion features did not result in a material bifurcated embedded derivative, resulting in the elimination of the change in fair value of financial instruments, reduction in interest expense and preferred dividends expense, and increase in the gain (loss) on extinguishment of debt. Under IFRS, it was determined that the redeemable Series X preferred shares should be classified as a liability since there is a contractual obligation to deliver cash or another financial asset and certain conversion events being beyond our control. Under U.S. GAAP, it was determined that the redeemable Series X preferred shares should be classified as mezzanine equity since the shares are redeemable based on events outside of our control. Under IFRS, it was determined that the Columbia Warrant should be classified as equity since settlement would only occur by exchanging a fixed amount of cash for a fixed number of our own equity instruments. Changes in fair value are not recognized. Under U.S. GAAP, it was determined that the Columbia Warrant should be classified as a liability since the number and type of shares received could be different pre- and post- Merger. The Columbia Warrant is recorded at fair value with changes recognized in the Consolidated Statement of Operations and Comprehensive Loss. Additionally, the resulting gain (loss) on extinguishment of the amended convertible notes differed under IFRS versus U.S. GAAP.[5]The change in net loss in the adoption of U.S. GAAP as described in items a-d above impacted net loss per share as follows:[6]After applying the 3.3028 Exchange Ratio as described in Note 4 (Reverse Recapitalization).

Note 21 - Equity Method Inves_2

Note 21 - Equity Method Investment (Details Textual) - USD ($) $ in Thousands		9 Months Ended		12 Months Ended
	May 06, 2022	Sep. 30, 2023	Sep. 30, 2022	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Payments to Acquire Equity Method Investments		$ 0	$ 3,604	$ 3,653	$ 0	$ 0
Warrants and Rights Outstanding, Term (Year)	36 months
OS [Member]
Equity Method Investment, Ownership Percentage	5%
Payments to Acquire Equity Method Investments	$ 3,700
OS [Member] | Warrant [Member]
Class of Warrant or Right, Outstanding (in shares)	524,715

Note 22 - Subsequent Events (De

Note 22 - Subsequent Events (Details Textual)	Mar. 08, 2023	Mar. 07, 2023
Subsequent Event [Member] | Common Class B [Member]
Common Stock, Votes Per Share	1.472467906	1.463844005

Note 1 - Nature of the Busine_4

Note 1 - Nature of the Business and Basis of Presentation 1 (Details Textual) $ in Thousands	9 Months Ended		12 Months Ended
	Sep. 30, 2023 USD ($)	Sep. 30, 2022 USD ($)	Dec. 31, 2022 USD ($)	Dec. 31, 2021 USD ($)	Dec. 31, 2020 USD ($)
Number of Operating Segments	1		1
Retained Earnings (Accumulated Deficit)	$ (270,285)		$ (222,815)	$ (186,174)
Net Cash Provided by (Used in) Operating Activities	(36,132)	$ (54,763)	(68,462)	(28,439)	$ (11,174)
Cash and Cash Equivalents, at Carrying Value	$ 30,971		$ 76,528	$ 8,533

Note 2 - Summary of Significa_9

Note 2 - Summary of Significant Accounting Policies 1 (Details Textual) $ in Thousands	3 Months Ended		9 Months Ended		12 Months Ended
	Sep. 30, 2023 USD ($)	Sep. 30, 2022 USD ($)	Sep. 30, 2023 USD ($)	Sep. 30, 2022 USD ($)	Dec. 31, 2022 USD ($)	Dec. 31, 2021 USD ($)	Dec. 31, 2020 USD ($)
Revenue from Contract with Customer, Excluding Assessed Tax	$ 1,196	$ 2,158	$ 4,380	$ 4,546	$ 6,012	$ 4,247	$ 0
Gain (Loss), Foreign Currency Transaction, after Tax	1,800	1,100	3,700	1,600	1,576	1,022	594
Operating Lease, Expense	$ 600	$ 500	$ 1,900	$ 1,400	$ 314	$ 54	$ 51
Accounts Receivable [Member] | Customer Concentration Risk [Member]
Number of Major Customers	2		2		1
Accounts Receivable [Member] | Customer Concentration Risk [Member] | Two Customers [Member]
Concentration Risk, Percentage			84%
Accounts Receivable [Member] | Customer Concentration Risk [Member] | One Customer [Member]
Concentration Risk, Percentage					72%
Revenue Benchmark [Member] | Customer Concentration Risk [Member]
Number of Major Customers		1		1	2	1
Revenue Benchmark [Member] | Customer Concentration Risk [Member] | Two Customers [Member]
Revenue from Contract with Customer, Excluding Assessed Tax	$ 900		$ 4,400	$ 3,800	$ 4,800
Revenue Benchmark [Member] | Customer Concentration Risk [Member] | Two Customers [Member] | Minimum [Member]
Concentration Risk, Percentage	10%		10%	10%	10%
Revenue Benchmark [Member] | Customer Concentration Risk [Member] | One Customer [Member]
Revenue from Contract with Customer, Excluding Assessed Tax		$ 1,700				$ 3,900
Revenue Benchmark [Member] | Customer Concentration Risk [Member] | One Customer [Member] | Minimum [Member]
Concentration Risk, Percentage		10%				10%

Note 2 - Summary of Signific_10

Note 2 - Summary of Significant Accounting Policies - Summary of Allowance for Credit Losses 1 (Details) - USD ($) $ in Thousands	9 Months Ended		12 Months Ended
	Sep. 30, 2023	Sep. 30, 2022	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Allowance for doubtful accounts as of beginning of period	$ 3,237	$ 1,794	$ 1,794	$ 0
Bad debt expense	80	1,736	1,736	1,794	$ 0
Allowance for doubtful accounts as of end of period	$ 3,317	$ 3,530	$ 3,237	$ 1,794	$ 0

Note 2 - Summary of Signific_11

Note 2 - Summary of Significant Accounting Policies - Schedule of Cash and Cash Equivalents 1 (Details) - USD ($) $ in Thousands	Sep. 30, 2023	Dec. 31, 2022	Sep. 30, 2022	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Cash and cash equivalents	$ 30,971	$ 76,528		$ 8,533
Restricted cash	0	126		0
Restricted cash included in Other non-current assets	1,151	1,138		0
Total cash, cash equivalents and restricted cash	$ 32,122	$ 77,792	$ 97,307	$ 8,533	$ 17,267	$ 24,557

Note 4 - Reverse Recapitaliza_7

Note 4 - Reverse Recapitalization 1 (Details Textual) $ / shares in Units, $ in Thousands				1 Months Ended	9 Months Ended	12 Months Ended
	Feb. 10, 2022 USD ($) $ / shares shares	Jan. 25, 2022 USD ($) $ / shares shares	Jan. 18, 2022 USD ($) $ / shares shares	Jul. 31, 2021 USD ($) $ / shares shares	Sep. 30, 2023	Dec. 31, 2022 USD ($)	Dec. 23, 2021 USD ($)
Proceeds From Reverse Recapitalization | $		$ 168,000				$ 168,000
Conversion of Stock, Shares Issued (in shares)		2,140,340
Recapitalization Exchange Ratio					3.3028	3.3028
C F V [Member] | Liberty Subscription Agreement [Member]
Proceeds from Issuance or Sale of Equity | $			$ 150,000
Canter Loan [Member] | Class A Common Stock Issued for Conversion of Promissory Note [Member]
Debt Conversion, Converted Instrument, Shares Issued (in shares)			788,021
Canter Loan [Member] | CF Securities [Member]
Debt Instrument, Face Amount | $							$ 7,500
Pipe Warrant [Member]
Class of Warrant or Right, Number of Securities Called by Warrants or Rights (in shares)		2,500,000
Class of Warrant or Right, Exercise Price of Warrants or Rights (in dollars per share) | $ / shares		$ 20
Proceeds from Issuance or Sale of Equity | $		$ 58,200
Forward Purchase Warrant [Member]
Class of Warrant or Right, Number of Securities Called by Warrants or Rights (in shares)				333,333
Class of Warrant or Right, Exercise Price of Warrants or Rights (in dollars per share) | $ / shares				$ 11.5
Proceeds from Issuance or Sale of Equity | $				$ 10,000
The 10 Dollar Liberty Warrant [Member] | C F V [Member]
Class of Warrant or Right, Number of Securities Called by Warrants or Rights (in shares)			5,000,000
Class of Warrant or Right, Exercise Price of Warrants or Rights (in dollars per share) | $ / shares			$ 10
The 15 Dollar Liberty Warrant [Member] | C F V [Member]
Class of Warrant or Right, Number of Securities Called by Warrants or Rights (in shares)			15,000,000
Class of Warrant or Right, Exercise Price of Warrants or Rights (in dollars per share) | $ / shares			$ 15
Advisory Fee Warrant [Member]
Class of Warrant or Right, Number of Securities Called by Warrants or Rights (in shares)	2,500,000
Class of Warrant or Right, Exercise Price of Warrants or Rights (in dollars per share) | $ / shares	$ 10
Class of Warrant or Right, Cash Portion of Advisory Fee | $	$ 1,250					$ 7,500
Class of Warrant or Right, Anniversary Period (Year)	18 years
Common Class A [Member]
Stock Issued During Period, Shares, New Issues (in shares)		5,816,770		1,250,000
Conversion of Stock, Shares Issued (in shares)		2,140,340
Common Class A [Member] | Transaction Fee Payment [Member]
Sale of Stock, Number of Shares Issued in Transaction (in shares)			2,058,229
Sale of Stock, Consideration Received on Transaction | $			$ 5,000
Common Class A [Member] | C F V [Member] | Liberty Subscription Agreement [Member]
Sale of Stock, Number of Shares Issued in Transaction (in shares)			20,000,000
Series X Preferred Stock [Member]
Conversion of Stock, Shares Converted (in shares)		2,033,230
Conversion of Stock, Amount Converted | $		$ 21,400

Note 4 - Reverse Recapitaliza_8

Note 4 - Reverse Recapitalization - Schedule of Reverse Recapitalization 1 (Details)	Jan. 18, 2022 shares
Shares outstanding (in shares)	17,215,336
Issuance of shares for transaction fees (in shares)	2,058,229
Shares outstanding (in shares)	88,824,647
Forward Purchase Securities Agreement [Member]
Shares issued (in shares)	1,250,000
Cantor Loan Repayment [Member]
Shares issued (in shares)	788,021
Series A Preferred Stockholders [Member]
Shares issued (in shares)	7,968,316
Series B Preferred Stockholders [Member]
Shares issued (in shares)	4,597,928
Series B-1 Preferred Stockholders [Member]
Shares issued (in shares)	2,171,399
The 2018 Convertible Noteholders [Member]
Shares issued (in shares)	5,581,416
The 2019 Convertible Noteholders [Member]
Shares issued (in shares)	7,846,333
The 2020 Convertible Noteholders [Member]
Shares issued (in shares)	4,553,205
Redeemable Series X Preferred Stockholders [Member]
Shares issued (in shares)	2,140,340
Liberty Investors [Member]
Shares issued (in shares)	20,000,000
PIPE Investors [Member]
Shares issued (in shares)	5,816,770
CF V Sponsor [Member]
Shares issued (in shares)	6,837,354

Note 5 - Revenue from Contrac_9

Note 5 - Revenue from Contracts with Customers 1 (Details Textual) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended		12 Months Ended
	Sep. 30, 2023	Sep. 30, 2022	Sep. 30, 2023	Sep. 30, 2022	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Revenue from Contract with Customer, Excluding Assessed Tax	$ 1,196	$ 2,158	$ 4,380	$ 4,546	$ 6,012	$ 4,247	$ 0
Contract with Customer, Liability, Revenue Recognized			$ 1,500	$ 900	$ 900	$ 500

Note 5 - Revenue from Contra_10

Note 5 - Revenue from Contracts with Customers - Disaggregation of Revenue 1 (Details) - USD ($) $ in Thousands		3 Months Ended				9 Months Ended				12 Months Ended
		Sep. 30, 2023		Sep. 30, 2022		Sep. 30, 2023		Sep. 30, 2022		Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Revenue		$ 1,196		$ 2,158		$ 4,380		$ 4,546		$ 6,012	$ 4,247	$ 0
Asia Pacific [Member]
Revenue	[2]	82	[1]	232	[1]	351	[1]	1,946	[1]	1,531	3,988
Europe [Member]
Revenue	[1],[2]	513		43		1,506		80
North America [Member]
Revenue	[2]	588	[1]	1,817	[1]	2,467	[1]	2,435	[1]	3,438	201
South America [Member]
Revenue	[1],[2]	13		66		56		85
Transferred over Time [Member]
Revenue		413		0		1,236		1,524		1,600	3,800
Transferred at Point in Time [Member]
Revenue		$ 783		$ 2,158		$ 3,144		$ 3,022		$ 4,400	$ 400
[1]Certain comparative figures have been reclassified to conform to the current year presentation.[2]Revenue by geography is based on the geographical location of the customer.

Note 5 - Revenue from Contra_11

Note 5 - Revenue from Contracts with Customers - Schedule of Contract Liabilities 1 (Details) - USD ($) $ in Thousands	Sep. 30, 2023	Dec. 31, 2022	Dec. 31, 2021
Contract liabilities	$ 1,000	$ 1,000	$ 1,000
Current	3,286	1,941	935
Total	$ 4,286	$ 2,941	$ 1,935

Note 5 - Revenue from Contra_12

Note 5 - Revenue from Contract with Customer - Schedule of Remaining Performance Obligations 1 2 (Details) - USD ($) $ in Thousands	Sep. 30, 2023	Dec. 31, 2022
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2023-01-01
Remaining performance obligations		$ 6,422
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2023-10-01
Remaining performance obligations	$ 6,852
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2024-01-01
Remaining performance obligations	5,648	11,296
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2025-01-01
Remaining performance obligations	5,005	3,860
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2026-01-01
Remaining performance obligations	$ 1,000	$ 0

Note 5 - Revenue from Contra_13

Note 5 - Revenue from Contract with Customer - Schedule of Remaining Performance Obligations 1 (Details) (Parentheticals)	Sep. 30, 2023	Dec. 31, 2022
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2023-01-01
Remaining performance obligations, period (Year)		1 year
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2023-10-01
Remaining performance obligations, period (Year)	3 months
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2024-01-01
Remaining performance obligations, period (Year)	1 year	1 year
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2025-01-01
Remaining performance obligations, period (Year)	1 year	1 year
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2026-01-01
Remaining performance obligations, period (Year)	1 year	1 year

Note 6 - Warrant Liabilities _2

Note 6 - Warrant Liabilities 1 (Details Textual) - USD ($) $ / shares in Units, $ in Thousands	9 Months Ended
	Sep. 30, 2022	Sep. 30, 2023	Dec. 31, 2022	May 06, 2022	Jan. 25, 2022	Jan. 24, 2022	Jan. 22, 2022	Jan. 18, 2022	Dec. 31, 2021
Warrant Liability, Fair Value Disclosure		$ 1,945	$ 8,335						$ 143,237
Warrants and Rights Outstanding, Term (Year)				36 months
Liberty Warrants and Liberty Advisory Fee Warrant [Member]
Warrant Liability, Fair Value Disclosure		1,182	6,191					$ 30,900	0
Pipe Warrant [Member]
Warrant Liability, Fair Value Disclosure		59	311				$ 1,300		0
Class of Warrant or Right, Exercise Price of Warrants or Rights (in dollars per share)					$ 20
Class of Warrant or Right, Number of Securities Called by Warrants or Rights (in shares)					2,500,000
The 8.63 Warrants [Member]
Warrant Liability, Fair Value Disclosure		$ 704	$ 1,833		$ 4,900				$ 0
Class of Warrant or Right, Exercise Price of Warrants or Rights (in dollars per share)		$ 8.63	$ 8.63		$ 8.63	$ 11.5
Warrants and Rights Outstanding, Term (Year)					5 years
Class of Warrant or Right, Redemption Price of Warrants or Rights (in dollars per share)					$ 13.5	$ 18
The 8.63 Warrants [Member] | Private Placement Warrants [Member]
Class of Warrant or Right, Number of Securities Called by Warrants or Rights (in shares)					200,000
The 8.63 Warrants [Member] | Common Class A [Member]
Class of Warrant or Right, Number of Securities Called by Warrants or Rights (in shares)					8,333,333
Class of Warrant or Right, Unissued (in shares)					333,333
Public Warrants [Member] | Common Class A [Member]
Stock Issued During Period, Shares, Warrants Exercised (in shares)	613,111

Note 6 - Warrant Liabilities _3

Note 6 - Warrant Liabilities - Schedule of Warrant Liabilities 1 (Details) - USD ($) $ in Thousands	9 Months Ended	12 Months Ended
	Sep. 30, 2023	Dec. 31, 2022
As of December 31, 2021	$ 8,335	$ 143,237
Warrants issued	0	37,037
Fair Value Adjustment of Warrants	(6,390)	(47,000)
As of December 31, 2022	1,945	8,335
Liberty Warrants and Liberty Advisory Fee Warrant [Member]
As of December 31, 2021	6,191	0
Warrants issued	0	30,853
Fair Value Adjustment of Warrants	(5,009)	(24,662)
As of December 31, 2022	1,182	6,191
Pipe Warrant [Member]
As of December 31, 2021	311	0
Warrants issued	0	1,312
Fair Value Adjustment of Warrants	(252)	(1,001)
As of December 31, 2022	59	311
The 8.63 Warrants [Member]
As of December 31, 2021	1,833	0
Warrants issued	0	4,872
Fair Value Adjustment of Warrants	(1,129)	(2,702)
As of December 31, 2022	$ 704	$ 1,833

Note 7 - Earnout Liabilities _3

Note 7 - Earnout Liabilities 1 (Details Textual) - USD ($) $ / shares in Units, $ in Thousands	Dec. 31, 2023	Sep. 30, 2023	Dec. 31, 2022	Jan. 25, 2022	Dec. 31, 2021	Jul. 05, 2021
Earnout Liability		$ 223	$ 1,353		$ 0
Sponsor Earnout [Member]
Earnout Liability		$ 223	1,353		0
Sponsor Earnout [Member] | Closing Price 1 [Member]
Contingent Consideration, Liability, Earnout Period, Stock Price Trigger (in dollars per share)						$ 12.5
Sponsor Earnout [Member] | Closing Price 2 [Member]
Contingent Consideration, Liability, Earnout Period, Stock Price Trigger (in dollars per share)						15
Sponsor Earnout [Member] | Closing Price 3 [Member]
Contingent Consideration, Liability, Earnout Period, Stock Price Trigger (in dollars per share)						$ 20
Sponsor Earnout [Member] | Common Class A [Member]
Contingent Consideration, Liability, Shares (in shares)						1,869,000
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number (in shares)	1,775,962	1,775,962
Forfeiture Earnout [Member]
Earnout Liability		$ 1,000	$ 1,000	$ 6,100	$ 0
Forfeiture Earnout [Member] | Closing Price 1 [Member]
Contingent Consideration, Liability, Earnout Period, Stock Price Trigger (in dollars per share)				$ 10
Forfeiture Earnout [Member] | Closing Price 2 [Member]
Contingent Consideration, Liability, Earnout Period, Stock Price Trigger (in dollars per share)				$ 15
Forfeiture Earnout [Member] | Common Class A [Member]
Contingent Consideration, Shares in Escrow (in shares)				310,127

Note 7 - Earnout Liabilities _4

Note 7 - Earnout Liabilities - Schedule of Earnout Liabilities 1 (Details) - USD ($) $ in Thousands	9 Months Ended	12 Months Ended
	Sep. 30, 2023	Dec. 31, 2022
Balance	$ 1,353	$ 0
Change in fair value of financial instruments		(11,799)
Balance	223	1,353
Sponsor Earnout [Member]
Balance	1,353	0
Change in fair value of financial instruments	(1,130)	(6,669)
Balance	$ 223	$ 1,353

Note 7 - Earnout Liabilities _5

Note 7 - Earnout Liabilities - Schedule of Valuation Assumptions 1 (Details) - Sponsor Earnout [Member]	Sep. 30, 2023	Dec. 31, 2022	Jan. 25, 2022
Measurement Input, Expected Term [Member]
Earnout liability, measurement input	3.32	4.07	5
Measurement Input, Expected Dividend Rate [Member]
Earnout liability, measurement input	0	0	0
Measurement Input, Price Volatility [Member]
Earnout liability, measurement input	0.673	0.504	0.30
Measurement Input, Risk Free Interest Rate [Member]
Earnout liability, measurement input	0.048	0.041	0.016
Measurement Input, Expected Number of Shares [Member]
Earnout liability, measurement input	1,775,962	1,775,962	1,842,759

Note 8 - Property and Equipme_6

Note 8 - Property and Equipment - Summary of Property and Equipment 1 (Details) - USD ($) $ in Thousands		Sep. 30, 2023		Dec. 31, 2022		Dec. 31, 2021
Property and equipment, gross		$ 96,229		$ 87,143		$ 57,181
Less: Accumulated depreciation		(53,501)		(39,162)		(24,651)
Property and equipment, net		42,728		47,981		32,530
Property, Plant And Equipment And Operating Lease, Right-of-Use Assets	[1],[3]	52,059	[2]	56,152	[2],[4]	35,485	[4]
URUGUAY
Property, Plant And Equipment And Operating Lease, Right-of-Use Assets		37,991		43,134		33,208
ARGENTINA
Property, Plant And Equipment And Operating Lease, Right-of-Use Assets		930		1,346		1,250
SPAIN
Property, Plant And Equipment And Operating Lease, Right-of-Use Assets		828		729		791
NETHERLANDS
Property, Plant And Equipment And Operating Lease, Right-of-Use Assets		11,820		9,471		0
Other Countries [Member]
Property, Plant And Equipment And Operating Lease, Right-of-Use Assets		490		1,472		236
Satellites and Other Equipment [Member]
Property and equipment, gross		68,369		54,370
Satellites Under Construction [Member]
Property and equipment, gross		16,032		22,194		10,558
Leasehold Improvements [Member]
Property and equipment, gross		7,601		6,433		769
Property, Plant and Equipment, Other Types [Member]
Property and equipment, gross		$ 4,227		$ 4,146		$ 2,138
Minimum [Member] | Satellites and Other Equipment [Member]
Property and equipment, useful life (Year)		3 years
Minimum [Member] | Leasehold Improvements [Member]
Property and equipment, useful life (Year)		5 years		5 years
Minimum [Member] | Property, Plant and Equipment, Other Types [Member]
Property and equipment, useful life (Year)		3 years		3 years
Maximum [Member] | Satellites and Other Equipment [Member]
Property and equipment, useful life (Year)		5 years
Maximum [Member] | Leasehold Improvements [Member]
Property and equipment, useful life (Year)		10 years		10 years
Maximum [Member] | Property, Plant and Equipment, Other Types [Member]
Property and equipment, useful life (Year)		10 years		10 years
[1]Non-current assets include property and equipment, net and operating lease right-of-use assets.[2]Presentation in the table is based on the geographic location of the entity that holds the assets.[3]We do not have any non-current assets in the country of incorporation of the holding company.[4]The presentation in the table above is based on the geographic location of the entity that holds the assets.

Note 9 - Additional Financial_8

Note 9 - Additional Financial Statement Information - Schule of Prepaid and Other Current Assets 1 (Details) - USD ($) $ in Thousands	Sep. 30, 2023	Dec. 31, 2022	Dec. 31, 2021
Prepaid expenses	$ 2,604	$ 1,767	$ 1,153
Advances to suppliers	228	588	829
Other current assets	413	843	713
Total	$ 3,245	$ 3,198	$ 2,695

Note 9 - Additional Financial_9

Note 9 - Additional Financial Statement Information - Schedule of Accrued Expenses and Other Liabilities 1 (Details) - USD ($) $ in Thousands	Sep. 30, 2023	Dec. 31, 2022	Dec. 31, 2021
Provisions	$ 66	$ 71	$ 2,934
Payroll and benefits payable	2,111	3,289	2,545
Other taxes payable	5,373	3,128	2,045
Other	430	451	2,200
Total	7,980	6,939	25,987
Accrued expenses and other liabilities	7,481	6,417	23,435
Other non-current liabilities	$ 499	$ 522	$ 2,552

Note 9 - Additional Financia_10

Note 9 - Additional Financial Statement Information - Schedule of Finance Costs, Net and Other Financial Income 1 (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended		12 Months Ended
	Sep. 30, 2023	Sep. 30, 2022	Sep. 30, 2023	Sep. 30, 2022	Dec. 31, 2022	Dec. 31, 2021		Dec. 31, 2020
Interest expense	$ 0	$ 9	$ 3	$ 1,597	$ 1,596	$ 8,729		$ 43
Redeemable Series X preferred stock dividends	0	0	0	(97)	(97)	(974)		0
Other finance costs	(38)	(29)	(103)	(99)	(123)	(71)		0
Interest income	427	419	1,577	568	1,164	36		78
Total	$ 389	$ 381	$ 1,471	$ (1,225)	$ (652)	$ (9,738)	[1],[2]	$ 35	[1],[2]
[1]Under IFRS, all recognized leases are accounted for similarly to finance leases. Under U.S. GAAP, there is a dual classification on-balance sheet lease accounting model for lessees: finance and operating leases. Operating leases create a straight-line expense, and no interest expense is recognized on the lease liability.[2]Under IFRS, the redeemable Series X preferred shares and convertible notes contained conversion features that resulted in a bifurcated derivative component with changes in fair value recognized as gain or (loss). Under U.S. GAAP, the conversion features did not result in a material bifurcated embedded derivative, resulting in the elimination of the change in fair value of financial instruments, reduction in interest expense and preferred dividends expense, and increase in the gain (loss) on extinguishment of debt. Under IFRS, it was determined that the redeemable Series X preferred shares should be classified as a liability since there is a contractual obligation to deliver cash or another financial asset and certain conversion events being beyond our control. Under U.S. GAAP, it was determined that the redeemable Series X preferred shares should be classified as mezzanine equity since the shares are redeemable based on events outside of our control. Under IFRS, it was determined that the Columbia Warrant should be classified as equity since settlement would only occur by exchanging a fixed amount of cash for a fixed number of our own equity instruments. Changes in fair value are not recognized. Under U.S. GAAP, it was determined that the Columbia Warrant should be classified as a liability since the number and type of shares received could be different pre- and post- Merger. The Columbia Warrant is recorded at fair value with changes recognized in the Consolidated Statement of Operations and Comprehensive Loss. Additionally, the resulting gain (loss) on extinguishment of the amended convertible notes differed under IFRS versus U.S. GAAP.

Note 10 - Income Tax 1 (Details

Note 10 - Income Tax 1 (Details Textual) $ in Millions	9 Months Ended
	Sep. 30, 2023 USD ($)
Unrecognized Tax Benefits, Decrease Resulting from Foreign Tax Exposure	$ 0.2

Note 10 - Income Tax - Schedu_6

Note 10 - Income Tax - Schedule of Components of Income Tax Expense (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended		12 Months Ended
	Sep. 30, 2023	Sep. 30, 2022	Sep. 30, 2023	Sep. 30, 2022	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Loss before income tax	$ (13,550)	$ (11,840)	$ (41,277)	$ (17,818)	$ (32,068)	$ (96,537)	$ (21,381)
Provision for income tax	$ 4,069	$ 2,983	$ 6,193	$ 5,126	$ 4,573	$ (232)	$ 148
Effective tax rate	(30.00%)	(25.20%)	(15.00%)	(28.80%)

Note 10 - Income Tax - Schedu_7

Note 10 - Income Tax - Schedule of Unrecognized Tax Benefits 1 (Details) $ in Thousands	9 Months Ended
	Sep. 30, 2023 USD ($)
Balance	$ 3,889
Increases (decreases) in tax positions related to prior periods	(1,974)
Balance	$ 1,915

Note 11 - Stockholders' Equit_5

Note 11 - Stockholders' Equity 1 (Details Textual) - USD ($) $ / shares in Units, $ in Thousands		9 Months Ended		12 Months Ended
	Apr. 06, 2022	Sep. 30, 2023	Sep. 30, 2022	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020	Feb. 14, 2022	Jan. 18, 2022	Jan. 17, 2022
Common Stock, Par or Stated Value Per Share (in dollars per share)		$ 0.0001		$ 0.0001	$ 0.0001
Common Stock, Shares, Outstanding (in shares)								88,824,647	17,215,336
Stock Repurchase Program, Authorized Amount							$ 5,000
Payments for Repurchase of Common Stock		$ 0	$ 8,603	$ 8,603	$ 0	$ 0
Hanover Holdings S A [Member]
Payments for Repurchase of Common Stock	$ 5,853
Common Class A [Member]
Common Stock, Par or Stated Value Per Share (in dollars per share)		$ 0.0001		$ 0.0001
Common Stock, Shares, Issued (in shares)		76,292,604		75,612,795
Common Stock, Shares, Outstanding (in shares)		76,292,604		75,612,795
Treasury Stock, Shares, Acquired (in shares)		0	516,123	516,123
Payments for Repurchase of Common Stock			$ 2,700	$ 2,700
Common Class A [Member] | Hanover Holdings S A [Member]
Treasury Stock, Shares, Acquired (in shares)	51,700
Common Class B [Member]
Common Stock, Par or Stated Value Per Share (in dollars per share)		$ 0.0001		$ 0.0001
Common Stock, Shares, Issued (in shares)		13,582,642		13,582,642
Common Stock, Shares, Outstanding (in shares)		13,582,642		13,582,642
Common Stock, Voting Interest		100%		100%
Common Class B [Member] | Chief Executive Officer [Member]
Common Stock, Shares, Outstanding (in shares)		13,582,642		13,582,642
Common Stock, Voting Interest		20.80%
Series A Preferred Stock [Member] | Hanover Holdings S A [Member]
Treasury Stock, Shares, Acquired (in shares)	134,735
Series B-1 Preferred Stock [Member] | Hanover Holdings S A [Member]
Treasury Stock, Shares, Acquired (in shares)	15,082

Note 11 - Stockholder's Equit_2

Note 11 - Stockholder's Equity - Schedule of Preferred Stock 1 (Details)	Dec. 31, 2021 shares
Preferred stock, authorized (in shares)	8,740,398
Preferred stock, issued (in shares)	4,611,985
Series A Preferred Stock [Member]
Preferred stock, authorized (in shares)	4,723,330
Preferred stock, issued (in shares)	2,547,330
Series B Preferred Stock [Member]
Preferred stock, authorized (in shares)	3,117,915
Preferred stock, issued (in shares)	1,392,131
Series B-1 Preferred Stock [Member]
Preferred stock, authorized (in shares)	899,153
Preferred stock, issued (in shares)	672,524

Note 12 - Stock-based Compen_10

Note 12 - Stock-based Compensation 1 (Details Textual) - USD ($) $ / shares in Units, $ in Thousands	9 Months Ended		12 Months Ended
	Sep. 30, 2023	Sep. 30, 2022	Dec. 31, 2022
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross (in shares)	0	0	0
Share-Based Payment Arrangement, Option [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Period (Year)			4 years
Share-Based Compensation Arrangement by Share-Based Payment Award, Expiration Period (Year)			10 years
Share-Based Payment Arrangement, Shares Withheld for Tax Withholding Obligation (in shares)	42,898		17,376
Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount	$ 870		$ 3,200
Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition (Year)			1 year 5 months 1 day
Restricted Stock Units (RSUs) [Member]
Share-Based Payment Arrangement, Shares Withheld for Tax Withholding Obligation (in shares)	116,783		56,649
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value (in dollars per share)	$ 2.43		$ 4.38
Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount	$ 5,900		$ 5,400
Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition (Year)	9 months 10 days		1 year 5 months 8 days

Note 12 - Stock-based Compen_11

Note 12 - Stock-based Compensation - Stock Options Activity 1 (Details) - USD ($) $ / shares in Units, $ in Thousands	9 Months Ended	12 Months Ended
	Sep. 30, 2023	Dec. 31, 2022	Dec. 31, 2021
Balance, options (in shares)	6,067,313	6,864,563
Balance, options, exercise price (in dollars per share)	$ 1.83	$ 2.05
Balance, options, contractual term (Year)	1 year 9 months 10 days	2 years 25 days	2 years 4 months 9 days
Forfeited, options (in shares)	(425,178)	(574,299)
Forfeited, options, exercise price (in dollars per share)	$ 3.98	$ 4.56
Exercised, options (in shares)	(186,307)	(102,825)
Exercised, options, exercise price (in dollars per share)	$ 1.13	$ 1.12
Expired, options (in shares)	(177,430)	(120,126)
Expired, options, exercise price (in dollars per share)	$ 2.27	$ 2.6
Outstanding, options (in shares)	5,278,398	6,067,313	6,864,563
Outstanding, options, exercise price (in dollars per share)	$ 1.61	$ 1.83	$ 2.05
Outstanding, options, intrinsic value	$ 1,041	$ 10,818
Exercisable, options (in shares)	4,594,898	4,449,152
Exercisable, options, exercise price (in dollars per share)	$ 1.4	$ 1.31
Exercisable, options, contractual term (Year)	1 year 8 months 15 days	1 year 11 months 1 day
Exercisable, options, intrinsic value	$ 1,000	$ 8,832

Note 12 - Stock-based Compen_12

Note 12 - Stock-based Compensation - RSU Activity 1 (Details) - Restricted Stock Units (RSUs) [Member] - USD ($) $ in Thousands	9 Months Ended	12 Months Ended
	Sep. 30, 2023	Dec. 31, 2022
Outstanding unvested RSUs (in shares)	1,459,280	0
Granted during the year (in shares)	3,369,167	1,640,496
Forfeited during the year (in shares)	(559,809)	(60,823)
Vested during the year (in shares)	(494,287)	(120,393)
Outstanding unvested RSUs (in shares)	3,774,351	1,459,280
Outstanding unvested RSUs at December 31, 2022	$ 4,416	$ 1,940

Note 12 - Stock-based Compen_13

Note 12 - Stock-based Compensation - Schedule of Stock-based Compensation Expense 1 (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended		12 Months Ended
	Sep. 30, 2023	Sep. 30, 2022	Sep. 30, 2023	Sep. 30, 2022	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Share-Based Payment Arrangement, Expense	$ 1,414	$ 2,139	$ 4,254	$ 6,624	$ 8,368	$ 10,881	$ 1,732
General and Administrative Expense [Member]
Share-Based Payment Arrangement, Expense	884	554	2,714	2,240	2,406	5,274	1,235
Research and Development Expense [Member]
Share-Based Payment Arrangement, Expense	312	781	933	1,753	3,631	1,968	382
Other Operating Income (Expense) [Member]
Share-Based Payment Arrangement, Expense	$ 218	$ 804	$ 607	$ 2,631	$ 2,331	$ 3,639	$ 115

Note 13 - Redeemable Preferre_4

Note 13 - Redeemable Preferred Stock 1 (Details Textual) - USD ($) $ / shares in Units, $ in Millions	Jan. 25, 2022	Sep. 30, 2023	Dec. 31, 2022	Dec. 31, 2021
Temporary Equity, Par or Stated Value Per Share (in dollars per share)			$ 0.0001	$ 0.0001
Conversion of Stock, Shares Issued (in shares)	2,140,340
Series X Preferred Stock [Member]
Temporary Equity, Par or Stated Value Per Share (in dollars per share)	$ 0.0001
Temporary Equity, Dividend Rate, Percentage	7%
Conversion of Stock, Shares Converted (in shares)	2,033,230
Conversion of Stock, Amount Converted	$ 21.4
Preferred Stock, Convertible, Conversion Price (in dollars per share)	$ 10
Temporary Equity, Shares Issued (in shares)		0	0
Temporary Equity, Shares Outstanding (in shares)		0	0

Note 14 - Net Loss Per Share _3

Note 14 - Net Loss Per Share 1 (Details Textual)	9 Months Ended	12 Months Ended
	Sep. 30, 2023	Dec. 31, 2022
Recapitalization Exchange Ratio	3.3028	3.3028

Note 14 - Net Loss Per Share _4

Note 14 - Net Loss Per Share - Schedule of Net Loss Per Share 1 (Details) - USD ($) $ / shares in Units, $ in Thousands	3 Months Ended		9 Months Ended		12 Months Ended
	Sep. 30, 2023	Sep. 30, 2022	Sep. 30, 2023	Sep. 30, 2022	Dec. 31, 2022		Dec. 31, 2021		Dec. 31, 2020
Net loss	$ (17,619)	$ (14,823)	$ (47,470)	$ (22,944)	$ (36,641)		$ (96,305)		$ (21,529)
Basic weighted-average common shares outstanding (in shares)	89,739,310	89,002,430	89,476,065	81,221,550	83,188,276	[1]	16,655,634	[1],[2]	16,029,826	[1],[2]
Basic loss per share for the period attributable to common stockholders (in dollars per share)	$ (0.2)	$ (0.17)	$ (0.53)	$ (0.28)	$ (0.44)		$ (5.78)	[2]	$ (1.34)	[2]
Adjustment to numerator - Change in fair value of Columbia Warrant liability	$ 0	$ (18,635)	$ 0	$ (18,635)	$ (18,635)		$ 0		$ 0
Dilutive numerator	$ (17,619)	$ (33,458)	$ (47,470)	$ (41,579)	$ (55,276)		$ (96,305)		$ (21,529)
Columbia Warrant (in shares)	0	1,410,657	0	1,410,657	609,873		0		0
Diluted weighted-average common shares outstanding (in shares)	89,739,310	90,413,087	89,476,065	82,632,207	83,798,149		16,655,634	[2]	16,029,826	[2]
Diluted loss per share for the period attributable to common stockholders (in dollars per share)	$ (0.2)	$ (0.37)	$ (0.53)	$ (0.5)	$ (0.66)		$ (5.78)	[2]	$ (1.34)	[2]
[1]After applying the 3.3028 Exchange Ratio as described in Note 4 (Reverse Recapitalization).[2]The change in net loss in the adoption of U.S. GAAP as described in items a-d above impacted net loss per share as follows:

Note 15 - Fair Value Measurem_8

Note 15 - Fair Value Measurement and Financial Instruments 1 (Details Textual) - $ / shares	9 Months Ended	12 Months Ended
	Sep. 30, 2023	Dec. 31, 2022	Jan. 25, 2022	Jan. 24, 2022
Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate		0%
Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate		0%
Sponsor Earnout [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Term (Year)	3 years 3 months 18 days
Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate	67%
Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate	4.80%
PIPE Warrant, Liberty Warrants, and Liberty Advisory Fee Warrant [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Term (Year)	3 years 4 months 24 days
Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate	67%
Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate	4.80%
The 8.63 Warrants [Member]
Class of Warrant or Right, Exercise Price of Warrants or Rights (in dollars per share)	$ 8.63	$ 8.63	$ 8.63	$ 11.5

Note 15 - Fair Value Measurem_9

Note 15 - Fair Value Measurements and Financial Instruments - Schedule of Assets and Liabilities at Fair Value 1 (Details) - USD ($) $ in Thousands	Sep. 30, 2023	Dec. 31, 2022	Jan. 25, 2022	Jan. 22, 2022	Jan. 18, 2022	Dec. 31, 2021
Total Warrant Liabilities	$ 1,945	$ 8,335				$ 143,237
Earnout liabilities	223	1,353				0
Fair Value, Inputs, Level 1 [Member]
Total Warrant Liabilities	704	1,833
Earnout liabilities	0	0
Fair Value, Inputs, Level 2 [Member]
Total Warrant Liabilities	0	0
Earnout liabilities	0	0
Fair Value, Inputs, Level 3 [Member]
Total Warrant Liabilities	1,241	6,502
Earnout liabilities	223	1,353
The 8.63 Warrants [Member]
Total Warrant Liabilities	704	1,833	$ 4,900			0
The 8.63 Warrants [Member] | Fair Value, Inputs, Level 1 [Member]
Total Warrant Liabilities	704	1,833
The 8.63 Warrants [Member] | Fair Value, Inputs, Level 2 [Member]
Total Warrant Liabilities	0	0
The 8.63 Warrants [Member] | Fair Value, Inputs, Level 3 [Member]
Total Warrant Liabilities	0	0
Pipe Warrant [Member]
Total Warrant Liabilities	59	311		$ 1,300		0
Pipe Warrant [Member] | Fair Value, Inputs, Level 1 [Member]
Total Warrant Liabilities	0	0
Pipe Warrant [Member] | Fair Value, Inputs, Level 2 [Member]
Total Warrant Liabilities	0	0
Pipe Warrant [Member] | Fair Value, Inputs, Level 3 [Member]
Total Warrant Liabilities	59	311
Liberty Warrants and Liberty Advisory Fee Warrant [Member]
Total Warrant Liabilities	1,182	6,191			$ 30,900	$ 0
Liberty Warrants and Liberty Advisory Fee Warrant [Member] | Fair Value, Inputs, Level 1 [Member]
Total Warrant Liabilities	0	0
Liberty Warrants and Liberty Advisory Fee Warrant [Member] | Fair Value, Inputs, Level 2 [Member]
Total Warrant Liabilities	0	0
Liberty Warrants and Liberty Advisory Fee Warrant [Member] | Fair Value, Inputs, Level 3 [Member]
Total Warrant Liabilities	$ 1,182	$ 6,191

Note 15 - Fair Value Measure_10

Note 15 - Fair Value Measurements and Financial Instruments - Reconciliation of Level 3 Measurements 1 (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended				12 Months Ended
	Sep. 30, 2023	Sep. 30, 2022	Sep. 30, 2023		Sep. 30, 2022		Dec. 31, 2022		Dec. 31, 2021
Borrowings [Member]
Balance	$ 0	$ 0	$ 0		$ 7,522		$ 7,522		$ 0
Issues		0			0		0		7,513
Remeasurement (gain)/loss(1)	0	0	0	[1]	489	[1]	488	[2]	9	[2]
Write-off of deferred costs		0			0		0
Settlements (2)		0			(8,011)	[3]	(8,010)	[3]
Balance	0	0	0		0		0		7,522
Sponsor Earnout [Member]
Balance	504	3,111	1,353		0		0		0
Issues		0			8,022		8,022		0
Remeasurement (gain)/loss(1)	(281)	(537)	(1,130)	[1]	(5,448)	[1]	(6,669)	[2]	0	[2]
Write-off of deferred costs		0			0		0
Settlements (2)		0			0	[3]	0	[3]
Balance	223	2,574	223		2,574		1,353		0
Forfeiture Earnout [Member]
Balance	0	0	0		0		0		0
Issues		0			6,135		6,135		0
Remeasurement (gain)/loss(1)	0	0	0	[1]	(5,130)	[1]	(5,130)	[2]	0	[2]
Write-off of deferred costs		0			0		0
Settlements (2)		0			(1,005)	[3]	(1,005)	[3]
Balance	0	0	0		0		0		0
Liberty Warrants and Liberty Advisory Fee Warrant [Member]
Balance	2,339	15,377	6,191		0		0		0
Issues		0			30,853		30,853		0
Remeasurement (gain)/loss(1)	(1,157)	(4,026)	(5,009)	[1]	(19,502)	[1]	(24,662)	[2]	0	[2]
Write-off of deferred costs		0			0		0
Settlements (2)		0			0	[3]	0	[3]
Balance	1,182	11,351	1,182		11,351		6,191		0
Pipe Warrant [Member]
Balance	109	952	311		0		0		0
Issues		0			1,312		1,312		0
Remeasurement (gain)/loss(1)	(50)	(415)	(252)	[1]	(775)	[1]	(1,001)	[2]	0	[2]
Write-off of deferred costs		0			0		0
Settlements (2)		0			0	[3]	0	[3]
Balance	59	537	59		537		311		0
Columbia Warrant [Member]
Balance	0	0	0		143,237		143,237		0
Issues		0			0		0		161,432
Remeasurement (gain)/loss(1)	0	0	0	[1]	(18,635)	[1]	(18,635)	[2]	(17,992)	[2]
Write-off of deferred costs		0			203		203
Settlements (2)		0			(124,805)	[3]	(124,805)	[3]
Balance	$ 0	$ 0	$ 0		$ 0		$ 0		$ 143,237
[1]Recognized in the Condensed Consolidated Statements of Operations and Comprehensive Loss for the nine months ended September 30, 2023 and 2022, respectively.[2]Recognized in the Consolidated Statements of Operations and Comprehensive Loss for the years ended December 31, 2022 and 2021, respectively.[3]These liabilities were settled in connection with the Merger. See Note 4 (Recapitalization Transaction).

Note 16 - Related Parties 1 (De

Note 16 - Related Parties 1 (Details Textual) - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2023	Dec. 31, 2022	Dec. 31, 2021
Accounts Payable, Trade, Current		$ 9,850	$ 6,650
OS [Member]
Related Party Transaction, Purchases from Related Party	$ 1,400
Accounts Payable, Trade, Current	$ 700

Note 16 - Related Parties - S_2

Note 16 - Related Parties - Schedule of Related Party Transactions 1 (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended		12 Months Ended
	Sep. 30, 2023	Sep. 30, 2022	Sep. 30, 2023	Sep. 30, 2022	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Related Party [Member] | Interest Expense [Member]
Related Party Transaction, Amounts of Transaction	$ 0	$ 0	$ 0	$ 44	$ 554	$ 620	$ 591